0001144204-12-029772.txt : 20120515 0001144204-12-029772.hdr.sgml : 20120515 20120515171852 ACCESSION NUMBER: 0001144204-12-029772 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 9 CONFORMED PERIOD OF REPORT: 20120331 FILED AS OF DATE: 20120515 DATE AS OF CHANGE: 20120515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fuse Science, Inc. CENTRAL INDEX KEY: 0000842722 STANDARD INDUSTRIAL CLASSIFICATION: INVESTORS, NEC [6799] IRS NUMBER: 870460247 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-22991 FILM NUMBER: 12846065 BUSINESS ADDRESS: STREET 1: 6135 NW 167TH STREET STREET 2: #E21 CITY: MIAMI STATE: FL ZIP: 33015 BUSINESS PHONE: 305-503-3873 MAIL ADDRESS: STREET 1: 6135 NW 167TH STREET STREET 2: #E21 CITY: MIAMI STATE: FL ZIP: 33015 FORMER COMPANY: FORMER CONFORMED NAME: Double Eagle Holdings, Ltd. DATE OF NAME CHANGE: 20070123 FORMER COMPANY: FORMER CONFORMED NAME: ONSPAN NETWORKING INC DATE OF NAME CHANGE: 20010214 FORMER COMPANY: FORMER CONFORMED NAME: NETWORK SYSTEMS INTERNATIONAL INC DATE OF NAME CHANGE: 19960516 10-Q 1 v313070_10q.htm FORM 10-Q

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

Quarterly Report Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

For Quarter Ended: March 31, 2012

Commission File Number: 000-22991

Fuse Science, Inc.

(Exact name of small business issuer as specified in its charter)

NEVADA		87-0460247
(State or other jurisdiction of		(IRS Employer
incorporation or organization)		Identification No.)

6135 NW 167 Street Suite E-21 Miami Lakes, FL 33015

(Address of principal executive office)

(305) 503-3873

(Issuer’s telephone number)

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨ No x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer ¨ Smaller reporting company x.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

The number of shares outstanding of registrant’s common stock, par value $0.001 per share, as of May 11, 2012 was 126,202,256.

FUSE SCIENCE, INC. AND SUBSIDIARIES

(DEVELOPMENT STAGE COMPANIES)

INDEX

		Page
		No.

Part I	Financial Information

Item 1:	Condensed Consolidated Financial Statements (Unaudited)

	Balance Sheets as of March 31, 2012 and September 30, 2011	3
	Statements of Operations – For the Three Months Ended March 31, 2012 and 2011	4
	Statement of Operations – For the Six Months Ended March 31, 2012 and 2011	5
	Statements of Changes in Stockholders’ Deficit - From Inception (January 20, 2009) Through March 31, 2012	6
	Statements of Cash Flows – For the Six Months Ended March 31, 2012 and 2011 and from inception (January 20, 2009) through March 31, 2012	8
	Notes to Financial Statements	10
Item 2:	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
Item 3:	Quantitative and Qualitative Disclosure about Market Risk	30
Item 4:	Controls and Procedures	30

Part II	Other Information	31

Item 5:	Other Information	31
Item 6:	Exhibits	31

PART 1: FINANCIAL INFORMATION

ITEM 1: FINANCIAL STATEMENTS

FUSE SCIENCE, INC. AND SUBSIDIARIES

(Development Stage Companies)

Condensed Consolidated Balance Sheets

March 31, 2012 and September 30, 2011

	March 31,			September 30,
	2012			2011
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	1,064,541		$	147,907
Accounts receivable		3,597			-
Inventory		70,320			-
Prepaid expenses		613,786			59,264
Deferred financing costs		778,029			-
Total current assets		2,530,273			207,171
Other assets:
Available-for-sale investments		14,040			8,320
Deferred financing costs		472,413
IT Property, net		13,062			-
Intellectual property, net		133,024			126,917
Total other assets		632,539			135,237

Total assets	$	3,162,812		$	342,408

LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable	$	223,286		$	342,009
Accounts payable - related parties		35,349			28,558
Deferred sales		300			-
Convertible notes payable, net		503,156			606,976
Accrued expenses		128,213			21,684
Total current liabilities		890,304			999,227

Convertible note payable, net		339,434			-

Commitments and contingencies		-			-

STOCKHOLDERS’ DEFICIT
Preferred stock, $0.001 par value; authorized 10,000,000 shares; no shares issued and outstanding; $100 per share liquidation preference		-			-
Common stock, $.001 par value; authorized 400,000,000 shares; 119,982,297 and 93,612,039 shares issued and outstanding at March 31, 2012		-			-
and September 30, 2010, respectively		119,892			93,612
Additional paid-in capital		28,034,931			12,667,350
Stock options		(4,938,896	)		(680,711	)
Non-controlling interest		(126,344	)		(126,344	)
Deferred consulting fees		(724,060	)		(541,558	)
Accumulated other comprehensive income (loss)		8,310			2,590
Accumulated deficit:
During the development stage		(10,563,905	)		(2,194,904	)
Other		(9,876,854	)		(9,876,854	)
Total accumulated deficit		(20,440,759	)		(12,071,758	)
Total stockholders’ deficit		1,933,074			(656,819	)
Total liabilities and stockholders’ deficit	$	3,162,812		$	342,408

See accompanying notes to condensed consolidated financial statements.

FUSE SCIENCE, INC. AND SUBSIDIARIES

(Development Stage Companies)

Condensed Consolidated Statements of Operations

Three Months Ended March 31, 2012 and 2011

(Unaudited)

Revenue	2012			2011
Sales, net	$	24,174		$	-
Cost of sales		5,866			-
		18,308			-
Expenses:
Related party services		-			3,000
General and administrative expense		1,874,182			171,139
Total expenses		1,874,182			174,139
Loss from operations		(1,855,874	)		(174,139	)
Other income (expense):
Interest expense – stockholders		(965,695	)		(3,510	)
Beneficial conversion feature		(4,726,906	)
Other expense		-			35
Gain on extinguishment of debt		178,702			-
Other expense		(5,513,899	)		(3,475	)
Net loss		(7,369,773	)		(177,614	)

Loss per share, basic and diluted	$	(0.06	)	$	(0.00	)

Weighted average shares outstanding		117,203,169			51,727,575

Net loss		(7,369,773	)		(177,614	)

Unrealized (loss) gain on available-for-sale securities (none attributed to the non-controlling interest)		(4,520	)		1,060
Net comprehensive loss	$	(7,374,293	)	$	(176,554	)

See accompanying notes to condensed consolidated financial statements.

FUSE SCIENCE, INC. AND SUBSIDIARIES

(Development Stage Companies)

Condensed Consolidated Statements of Operations

Six Months Ended March 31, 2012 and 2011 and from Inception

(January 20, 2009) through March 31, 2012

(Unaudited)

	2012			2011			Development Stage Inception (January 20, 2009) Through March 31, 2012
Revenue
Sales, net	$	24,174		$	-		$	24,174
Management income – affiliate		-			-			11,366
Total income		24,174			-			35,540
Cost of sales		5,866			-			5,867
		18,308			-			29,673
Expenses:
Related party services		-			6,000			6,000
General and administrative expense		2,685,666			188,302			4,415,159
Total expenses		2,685,666			194,302			4,421,159
Loss from operations		(2,667,358	)		(194,302	)		(4,391,486	)
Other income (expense):
Interest and other income		-			-			9,629
Interest expense		(1,005,408	)		(7,433	)		(1,050,554	)
Beneficial conversion feature of convertible notes payable		(4,875,089	)		-			(5,247,400	)
Realized loss		-			2,383			(15,552	)
Other than temporary decline in available-for-sale securities		-			-			(50,900	)
Gain on extinguishment of debt		178,702			-			178,702
Other expense		(5,701,795	)		(5,050	)		(6,176,075	)

Loss before non-controlling interest		(8,369,153	)		(199,352	)		(10,567,561	)
Non-controlling interest		-			-			3,504
Net loss		(8,369,153	)		(199,352	)		(10,564,057	)

Loss per share, basic and diluted	$	(0.07	)	$	(0.00	)

Weighted average shares outstanding		114,228,944			51,322,292

Other comprehensive income
Net loss		(8,369,153	)		(199,352	)		(10,564,057	)

Unrealized gain on available-for-sale securities		8,310			7,903			4,430
Net comprehensive loss	$	(8,360,843	)	$	(191,449	)	$	(10,559,627	)

See accompanying notes to condensed consolidated financial statements.

FUSE SCIENCE, INC. AND SUBSIDIARIES

(Development Stage Companies)

Consolidated Statements of Changes in Stockholders’ Deficit

From Inception (January 20, 2009) Through March 31, 2012

(Unaudited)

	Preferred Stock				Common Stock				Additional Paid-in			Intrinsic Value of Common Stock
	Shares		Par		Shares		Par		Capital			Options

Balance, January 20, 2009		-	$	-		50,925,820	$	50,926	$	9,946,022		$	-
Unrealized loss from available-for-sale securities		-		-		-		-		-
Net loss		-		-		-		-		-			-
Balance, September 30, 2009		-		-		50,925,820		50,926		9,946,022			-
Unrealized loss from available-for-sale securities		-		-		-		-		-
Net loss		-		-		-		-		-			-
Balance, September 30, 2010		-		-		50,925,820		50,926		9,946,022			-
Unrealized gain from available-for-sale securities		-		-		-		-		-			-
Common stock issued for:
Services		-		-		11,850,000		11,850		1,140,150			-
Convertible notes payable		-		-		5,539,219		5,539		134,517			-
License		-		-		2,000,000		2,000		76,000			-
Acquisition of FS Research and Development, Inc.						23,297,000		23,297		(23,297	)
Convertible notes payable:
Detachable warrants		-		-		-		-		310,775			-
Beneficial conversion feature		-		-		-		-		372,311			-
Stock options granted		-		-		-		-		710,872			(710,872	)
Amortize value of stock options		-		-		-		-		-			30,161
Net loss		-		-		-		-		-			-
Balance, September 30, 2011		-		-		93,612,039		93,612		12,667,350			(680,711	)
Unrealized gain from available-for-sale securities				-		-		-		-			-
Common stock issued for
Convertible notes payable						18,063,330		18,063		535,855			-
Deferred consulting fees		-		-		300,000		300		82,740			-
Convertible notes payable:
Detachable warrants		-		-		7,917,601		7,917		4,443,034			-
Beneficial conversion feature		-		-		-		-		4,811,693			-
Stock options granted		-		-		-		-		5,494,259			(4,894,793	)
Amortize stock options		-		-		-		-		-			636,608
Net loss
Balance, March 31, 2012		-	$	-		119,892,297	$	119,892	$	28,034,931		$	(4,938,896	)

See accompanying notes to condensed consolidated financial statements.

FUSE SCIENCE, INC. AND SUBSIDIARIES

(Development Stage Companies)

Consolidated Statements of Changes in Stockholders’ Deficit, Continued

From Inception (January 20, 2009) Through March 31, 2012

(Unaudited)

							Accumulated
	Non			Deferred			Other			Accumulated Deficit
	Controlling			Consulting			Comprehensive			Development
	Interest			Fees			Income			Stage			Other			Total

Balance, January 20, 2009	$	-		$	-		$	279,470		$	-		$	(9,999,694	)	$	276,724
Unrealized loss from available-for-sale securities		-			-			(248,385	)		-			-			(248,385	)
Net loss		-			-			-			(97,895	)		-			(97,895	)
Balance, September 30, 2009		-			-			31,085			(97,895	)		(9,999,694	)		(69,556	)
Non-controlling interest					(126,340	)		-			3,500			122,840			-
Unrealized loss from available-for-sale securities		-						(31,538	)		-			-			(31,538	)
Net loss		(4	)					-			(80,348	)		-			(80,352	)
Balance, September 30, 2010		(126,344	)		-			(453	)		(174,743	)		(9,876,854	)		(181,446	)
Unrealized gain from available-for-sale securities		-			-			3,043			-			-			3,043
Common stock issued for:
Services		-			(609,000	)		-			-			-			543,000
Convertible notes payable		-			-			-			-			-			140,056
License		-			-			-			-			-			78,000
Acquisition of FS Research & Developmet, Inc.		-			-			-			-			-			-
Convertible notes payable:
Detachable warrants		-			-			-			-			-			310,775
Beneficial conversion feature		-			-			-			-			-			372,311
Amortize deferred consulting		-			67,442			-			-			-			67,442
Amortize intrinsic value of stock options		-			-			-			-			-			30,161
Net loss		-						-			(2,020,161	)		-			(2,020,161	)
Balance, September 30, 2011		(126,344	)		(541,558	)		2,590			(2,194,904	)		(9,876,854	)		(656,819	)
Unrealized gain from available-for-sale securities		-			-			5,720			-			-			5,720
Common stock issued for
Convertible notes payable		-			-			-			-			-			553,918
Deferred consulting fees					(83,040	)											-
Convertible notes payable:
Detachable warrants		-			-			-			-			-			4,443,034
Beneficial conversion feature		-			-			-			-			-			4,811,694
Stock option grants		-			(444,963	)		-			-			-
Amortize stock options		-			-			-			-			-			799,179
Amortize deferred consulting		-			345,501			-			-			-			345,501
Net loss		-			-			-			(8,369,153	)		-			(8,369,153	)
Balance, March 31, 2012	$	(126,344	)	$	(724,060	)	$	8,310		$	(10,563,905	)	$	(9,876,854	)	$	1,933,074

See accompanying notes to condensed consolidated financial statements.

FUSE SCIENCE, INC. AND SUBSIDIARIES

(Development Stage Companies)

Condensed Consolidated Statements of Cash Flows

Six Months Ended March 31, 2012 and 2011 and from Inception

(January 20, 2009) through March 31, 2012

(Unaudited)

	2012			2011			Development Stage Inception (January 20, 2009) Through March 31, 2012

Operating activities:
Net loss	$	(8,369,153	)	$	(199,352	)	$	(10,564,057	)
Adjustments to reconcile net increase (decrease) in net assets from operations to net cash used in operating activities:
Amortization:
Gain from extinguishment of debt		(178,702	)					(178,702	)
Intellectual property		682			-			1,765
Deferred consulting fees		514,800			-			582,242
Stock options		636,608			-			666,769
Other than temporary decline in available-for-sale securities		4,430			-			55,330
Interest settled with common stock		30,425			-			30,425
Deferred financing cost		156,445						156,445
Common stock issued for services		-			144,000			543,000
Convertible notes payable:
Amortization of detachable warrants		756,719			-			769,470
Beneficial conversion feature		4,875,089			-			5,247,400
Investment received for management services		-			-			(8,800	)
Accrued interest income		-			-			(4,909	)
Gain on sale of investment		-			(2,348	)		15,552
Non-controlling interest		-			-			(3,504	)
Changes in operating assets and liabilities:
Accounts receivable and accrued interest - related parties		-			-			(4,686	)
Inventory		(70,320	)		-			(70,320	)
Prepaid expenses		(554,522	)		5,000			(613,786	)
Accounts payable and accrued expenses		19,597			12,777			375,763
Accounts payable and accrued expenses - related parties		-			(11,551	)		6,617
Deferred sales		300			-			300
Advances from related parties for working capital		-			-			6,660
Net cash used in operating activities		(2,177,602	)		(56,474	)		(2,991,026	)
Investing activities:
Proceeds from investments		-			52,876			75,876
Additions to IT assets		(13,750	)		-			(13,750	)
Intellectual property		(7,440	)		(35,000	)		(57,440	)
Net cash (used in) provided by investing activities		(21,190	)		17,876			4,686
Financing activities:
Loan proceeds		3,534,359			32,785			4,466,009
Loan repayment		(219,359	)		(2,660	)		(222,019	)
Proceed from warrants exercise		430,000			-			430,000
Financing fees		(629,574	)		-			(629,574	)
Net cash provided by (used in) financing activities		3,115,426			(30,125	)		4,044,416
Net increase (decrease) in cash and cash equivalents		916,634			(8,473	)		1,058,076
Cash and cash equivalents, beginning of period		147,907			8,619			6,465
Cash and cash equivalents, end of period	$	1,064,541		$	146		$	1,064,541

See accompanying notes to condensed consolidated financial statements.

FUSE SCIENCE, INC. AND SUBSIDIARIES

(Development Stage Companies)

Condensed Consolidated Statements of Cash Flows, Continued

Six Months Ended March 31, 2012 and 2011 and from Inception

(January 20, 2009) through March 31, 2012

(Unaudited)

	2012		2011		Development Stage Inception (January 20, 2009) Through March 31, 2012

Supplemental Cash Flow Information:

Non-cash investing and financing activities:
Common stock issued for convertible notes payable and accrued interest	$	555,425	$	-	$	1,227,247
Notes payable issued to acquire investment	$	-	$	-	$	100,000
Warrant issued for financing fees	$	620,867	$	-	$	620,867
Common stock issued for license	$	-	$	-	$	78,000
Common stock issued to acquire Fuse Science, Inc.	$	-	$	-	$	23,297

See accompanying notes to condensed consolidated financial statements.

FUSE SCIENCE, INC. AND SUBSIDIARIES

(DEVELOPMENT STAGE COMPANIES)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICY

CONSOLIDATION POLICY AND HISTORY OF BUSINESS

The consolidated financial statements of the Company include the accounts of the Company, Fuse Science, Inc. (“FUSE”) and FS Consumer Products Group, Inc., a Florida corporation, its wholly-owned subsidiaries and Ultimate Social Network, Inc. (“USN”) its 60%-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation. The Company was originally incorporated in 1985 in Nevada. Its common stock now trades on the OTCQB under the symbol DROP.PK.

DEVELOPMENT STAGE

From 2007 to January 20, 2009, the Company operated as a “business development company” (“BDC”) under the Investment Company Act of 1940. At the time the Company withdrew its election to operate as a BDC on January 20, 2009, the Company had limited resources and did not have sufficient capital to complete its business plans. Accordingly, the operations of the Company, is presented as those of a development stage enterprise, from January 20, 2009, which is treated as its inception for financial reporting purposes.

BASIS OF PRESENTATION

The accompanying unaudited interim consolidated financial statements have been prepared by the Company in accordance with generally accepted accounting principles for interim financial information. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. The information furnished in the interim consolidated financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. Operating results for the six months ended March 31, 2012 are not necessarily indicative of the results that may be expected for the full year. These interim consolidated financial statements should be read in conjunction with the Company’s most recent audited consolidated financial statements and notes thereto dated September 30, 2011.

USE OF ESTIMATES

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

REVENUE RECOGNITION

The Company records revenue when all of the following have occurred: (1) persuasive evidence of an arrangement exists, (2) product has been shipped or delivered, (3) the sales price to the customer is fixed or determinable, and (4) collectability is reasonably assured. The Company’s customers may return ordered items for a refund. The Company also provides customers incentives to purchase products at a discount. For the period ended March 31, 2012 we have record sales discount, returns and allowances of $738 which is netted against sales for the three months and the six months then ended.

INVENTORIES

Inventories consist of items or products manufactured for resale and packaging material used to produce such products. Inventories are valued at average cost and adjusted to reflect lower of cost or market. Allowances for inventory obsolescence are determined based upon the specific facts and circumstances and market conditions. As of March 31, 2012 and September 30, 2011, no obsolescence reserves were considered.

INVESTMENTS

Investments are classified into the following categories:

Trading securities reported at fair value with unrealized gains and losses included in earnings;

Available-for-sale securities reported at fair value with unrealized gains and losses, net of applicable deferred income taxes, reported in other comprehensive income;

Held-to-maturity securities and other investments reported at amortized cost; and

Investments using the equity method of accounting.

Stock-based Compensation

The compensation cost relating to share-based payment transactions (including the cost of all employee stock options) is required to be recognized in the financial statements. That cost is measured based on the estimated fair value of the equity or liability instruments issued. A wide range of share-based compensation arrangements including share options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans are included. The Company’s financial statements would include an expense for all share-based compensation arrangements granted on or after January 1, 2006 and for any such arrangements that are modified, cancelled or repurchased after that date based on the grant-date estimated fair value.

INTANGIBLE ASSETS

Other intangible assets primarily consist of intellectual property. We apply an impairment evaluation whenever events or changes in business circumstances indicate that the carrying value of our intangible assets may not be recoverable. Other intangible assets are amortized on a straight-line basis over their estimated economic lives. We believe that the straight-line method of amortization reflects an appropriate allocation of the cost of the intangible assets to earnings in proportion to the amount of economic benefits obtained annually by the Company.

IMPAIRMENT OF LONG-LIVED ASSETS

The Company evaluates its long-lived assets and intangible assets for impairment whenever events change or if circumstances indicate that the carrying amount of any assets may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to the expected future net undiscounted cash flows generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is the excess of the carrying amount over the fair value of the asset.

FAIR VALUE

The Company adopted fair value accounting for certain financial assets and liabilities that have been evaluated at least annually. The standard defines fair value as the price at which an asset could be exchanged in a current transaction between knowledgeable, willing parties. A liability’s fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. Management has determined that it will not, at this time, adopt fair value accounting for nonfinancial assets or liabilities currently recorded in the financial statements, which includes investments carried at cost, deposits and other assets. Impairment analyses will be made of all assets using fair value measurements.

NEW ACCOUNTING PRONOUNCEMENTS

We have evaluated all recent accounting pronouncements through March 31, 2012 and find none that would have a material impact on the financial statements of the Company.

RECLASSIFICATION

Certain reclassifications have been made in the condensed consolidated financial statements at September 30, 2011 and for the three months and six month ended March 31, 2011 to conform to the March 31, 2012 presentation. The reclassifications had no effect on net loss.

2. GOING CONCERN

The Company has not established sources of revenue sufficient to fund the development of business, projected operating expenses and commitments for the next twelve months. The Company had a net loss from operations of $7,369,773 and recognized an unrealized loss on investments of $4,520 resulting in a comprehensive loss of $7,374,293 during the three months ended March 31, 2012. Included in this loss, the Company recorded non-cash compensation of $1,113,256 which relates to contracts entered into by the Company for current and future services undertaken for marketing and promotional activities by brand athletes through endorsement contracts, as well as contracts with consultants to provide professional services and employment contract with the Company’s key employees. At March 31, 2012, current assets are $2,530,273 and current liabilities are $890,304.

The Company intends to continue to raise necessary capital from different financing sources including private placements of its restricted securities, including common stock and convertible notes. The Company has demonstrated an ability to raise funds as needed to fund operations and investments. During the quarter ended March 31, 2012, the Company issued 10% secured senior convertible promissory note in the amounts of $3,169,359 (“February 2012 Notes”). The February 2012 Notes include two sets of Warrants-A and Warrants-B. Warrants-A are five-year warrants to purchase 15,092,186 shares of the common stock at $.26 per share. Warrants-B note are seven-months warrants to purchase 15,092,186 shares of the common stock at $.21 per share. The warrants are subjected to certain price adjustment based on subsequent issuance of additional convertible notes and mandatory conversion if the market value of the Company’s common stock exceeds 250% for 20 consecutive days.

In December 2011, the Company also issued two 90-Day 8% Senior Subordinated Convertible Promissory Notes with Subscription Options (the “December Notes”) in the amounts of $75,000 and $60,000. An additional December Note in the principal amount of $50,000 was issued in January 2012. These notes were extinguished as a result of being rolled into the February 2012 Notes with additional principal of 15% of the face value of the note. In the event the Company did not undertake the subsequent financing, the December Notes with accrued interest would convert into Units consisting of 10 shares of the Company’s common stock and warrants to purchase an additional six shares of the Company’s common stock. The number of units issuable upon the conversion would be equal to the value of note plus accrued interest divided by $1.50. If the subsequent financing did not take place, the December Notes would include five-year warrants to purchase 300,000 and 240,000 shares of common stock respectively at a price of $0.18 per share. However, the December Notes were converted in to subscriptions for the securities sold in the subsequent financing. There can be no assurance in any case that the Company will secure sufficient funding to fully implement the Company’s business plan.

These conditions raise serious doubt about the Company’s ability to continue as a going concern.

INVESTMENTS

While the Company was operating as a BDC from 2007 until withdrawing such election on January 20, 2009 and for a period thereafter, there were a number of relationships established which resulted in the majority of the Company’s investments being considered investments in affiliates. Currently, all of those relationships have ceased and the Company no longer has an affiliate relationship with its investments. Available-for-sale investments may be summarized as follows:

			Unrecognized
			Holding			Fair
	Cost		Gains (Losses)			Value
March 31, 2012
Efftec International, Inc.	$	4,200	$	(2,400	)	$	1,800
North American Energy		1,530		10,710			12,240
	$	5,730	$	8,310		$	14,040

September 30, 2011
Efftec International, Inc.	$	4,200	$	(2,000	)	$	2,200
North American Energy		1,530		4,590			6,120
	$	5,730	$	2,590		$	8,320

Efftec International, Inc. (“EFFI”) has developed an Internet-based chiller tool. EFFI installs and sells this tool to its customer base. At March 31, 2012, the Company valued its investment in EFFI at $1,600 based on its posted bid price on that date. The Company did not sell any shares during the period. The Company owns 20,000 shares on March 31, 2012.

North American Energy Resources, Inc. (“NAEY”) is an oil and gas development and production company with operations currently in Oklahoma. The Company valued its investment in NAEY shares at its posted trading price at December 30, 2011. The Company owns 153,000 shares on March 31, 2012.

Fair value for both available-for-sale securities is based on level one inputs, the posted bid/last trading price on March 30, 2012 and September 31, 2011.

DISTRIBUTION AGREEMENT

On February 27, 2012, we entered into licensing and distribution agreements with Mission Product Holdings, Inc. (“Mission”), who develops, manufactures and markets the Mission Athletecare™ line of skincare products. Pursuant to the license agreement, Fuse granted Mission a restricted license to use Fuse’s proprietary transdermal delivery technology in connection with the development, manufacture and marketing of Mission Athletecare™ skincare products. Under the distribution agreement, Mission has agreed to offer for sale and distribute Fuse’s line of existing and planned sports nutrition products to a network of food, drug and sporting goods retailers that currently carry the Mission brand.

As part of the distribution agreement, the Company will make sales to Mission at an agreed upon price. The Company agrees that should it sell the products directly to the consumers at a price less than the agreed price, the charge to Mission be reduced so that Mission will be less than the lowest price being charged by the Company to consumers for the remainder of the term, Furthermore, the Company will pay Mission a one-time bonus of $50,000 for purchases in excess of $2,000,000, incremental to the first $150,000 and $25,000 for every $1,000,000 in purchases made thereafter. The $650,000 paid to Mission as part of this agreement is included in prepaid assets on the balance sheet as of March 31, 2012 and will be amortized to marketing expense over the next ten months. As March 31, 2012, the prepaid balance amounted to $585,000.

In addition to the foregoing, Mission granted warrants to the Company to acquire a minority equity position in Mission. Should the Company exercise these warrants, the Company will account for the investment at cost as a result of not having significant influence over Mission.

INTELLECTUAL PROPERTY

The Company has licensed sublingual, buccal, and transdermal delivery systems for bioactive agents that the Company believes can, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the GI tract and enter the blood stream directly. The technology facilitates the passing of bioactives through the oral mucosa in contrast to gastrointestinal absorption, in order to achieve the same desired effect. By utilizing the skin’s innate bioelectric signaling system coupled with our iontopheritic delivery vehicle, we are able to deliver bioactives efficaciously through both the dermal and buccal mucosal. The technology penetrates the mucosa and epithelium to achieve complete and enhanced absorption. It is the Company’s belief that the technology will facilitate the delivery of a wide range of product formulations such as aspirin, OTC pain, allergy, and cough and cold medications, as well as energy sources, electrolytes and other pharmaceutical applications.

CONVERTIBLE PROMISSORY NOTES

The Company had the following convertible notes payable at March 31, 2012 and September 30, 2011.

	March, 31			September 30,
	2012			2011
Convertible notes payable with interest at 12%	$	20,000		$	20,000
8% One year senior secured convertible promissory note due June 20, 2012		-			327,405	*
8% One year senior secured convertible promissory note due September 9, 2012		315,147			259,571
8% One year senior secured convertible promissory note due October 25, 2012		152,889			-
10% Two year senior secured convertible promissory note due February 7, 2014		1,183,215			-
Discount on Warrants		(843,781	)		-
	$	827,470		$	606,976

	March 31, 2012		September 30, 2011
Current	$	503,156	$	606,976
Long term	$	339,434	$	-

Convertible notes payable includes one note in the amount of $5,000 which is convertible at $0.025 per share and one note in the amount of $15,000 which is convertible at $0.03 per share.

* These notes were originally issued with a face value of $525,000. During the quarter ended December 31, 2011, several note holders converted the notes into stock, on or around the last day of the reporting period, resulting in a reduction of $495,000 to the face value of the notes. The remaining note holder converted his note with a face value of $30,000 for 1,633,667 shares of the Company’s common stock as of March 31, 2012. A total of 17,396,663 shares were converted for by notholders during the six months ending March 31, 2012. As a result of the conversion of these notes, unamortized discount of $186,739 was charged to interest expense for the period ending March 31, 2012.

The terms of our 8% One Year Senior Subordinated Secured Convertible Promissory Notes are summarized as follows:

Due Date	Face Value		Conversion Rate		Number of Warrants
February 7, 2014	$	3,169,359		See below		30,184,372
September 9, 2012	$	360,000	$	0.12		3,000,000
October 25, 2012	$	180,000	$	0.12		750,000

On January 4, 2012, we executed an agreement for additional December Notes with a face value of $50,000 bearing 8% interest rate and maturing in 90 days. Similar to the previous notes issued in December 2011, these notes are convertible into Units consisting of 10 shares of the Company’s common stock and warrants to purchase an additional six shares of the Company’s common stock at a strike price $.18 per shares. The notes are convertible at $1.50 per unit/$.15 per share. The Company measured the fair value of these instruments and recorded a discount of $28,508 on the note for proceeds which were allocated to the warrants. In addition, a beneficial conversion of $145,175 was immediately expenses as a result of the notes are available for conversion immediately after execution of the agreement.

On February 9, 2012, the terms of our December Notes with were significantly modified and the note holders were now included as part of the February 2012 Notes. Detailed below is the face values of the December Notes prior to modification of the terms:

Due Date	Face Value		Unit Conversion Rate**		Number of Warrants
March 22, 2012	$	75,000	$	1.50		300,000
March 29, 2012	$	60,000	$	1.50		240,000
April 4, 2012	$	50,000	$	1.50		200,000

** Each unit consists of ten shares of the Company’s common stock and warrants to purchase six additional shares of the Company’s stock

As a result of the terms of the December Notes, we recognized a gain on the extinguishment of the debt due the fact that the present value of the cash flow of the old notes/December Notes and the new notes/February 2012 Notes being more than 10%. The face values of the notes were increased, as well as the interest rate increased from 8% to 10 and the maturity date was extended from 90 days to two years. As a result, a gain on the extinguishment of the debt of $211,419 was record to settle the December Notes. The face values of December Notes amount to $185,000 and accrued interest of $1,642. In addition, the Company wrote of the fair value allocated to the warrants issued with these notes from additional paid in capital for $71,225 along with the beneficial conversion features of $211,038 from additional paid in capital. Unamortized discount of $70,844 associated with the December Notes was recognized.

On February 9, 2012, we consummated a private placement of (i) $3,169,359 in principal amount of Notes (“February 2012 Notes”) which is inclusive of the modified December Notes and (ii) the February 2012 Warrants, consisting of (a) series A warrants to purchase an aggregate of 15,092,185 shares of common stock (the “Series A Warrants”) and (b) series B warrants to purchase an aggregate of 15,092,185 shares of common stock (the “Series B Warrants”) at a purchase price of $3,169,359 in a private placement to a group of institutional and accredited investors pursuant to a Securities Purchase Agreement, dated as of February 7, 2012. The Notes are convertible into shares of the Company’s common stock, and are entitled to earn interest which may be paid in cash or in shares of common stock. The February 2012 Warrants are exercisable into shares of common stock. The convertible shares are all subject to standard anti-dilution provisions.

The February 2012 Notes are two (2) year senior convertible notes with an aggregate principal amount of $3,169,359. The February 2012 Notes will accrue interest at a rate of ten percent (10%) per annum beginning on February 9, 2012, which will be paid on January 15, April 15, July 15 and October 15 of each year to the record note holder of each note. The interest accrued is payable in interest shares, although the Company may, at its option and upon written notice to each note holder of the February 2012 Notes, make such interest payments in cash or in a combination of cash and interest shares.

The Series A Warrants have a term of five (5) years from the Closing Date and the Series B Warrants have a term of seven (7) months from the Closing Date. Each of the Series A Warrants and the Series B Warrants is immediately exercisable upon issuance into an aggregate of 15,092,185 fully paid and non-assessable Exercise Shares at an initial exercise price of $.026 per share in the case of the Class A Warrants and $0.21 per share in the case of the Class B Warrants

The February 2012 Notes contain a standard “blocker” provision so that no holder shall have the right to convert any portion of its Convertible Notes to the extent that, after giving effect to such conversion, the note holder and its affiliates would beneficially own in excess of 4.99% of the number of shares of common stock outstanding immediately after giving effect to such conversion. By written notice to the Company, a holder may increase or decrease such percentage to any other percentage, provided that any such increase will not be effective until the sixty-first (61st) day after such notice is delivered and such percentage may not, in any event, exceed 9.99%.

Any note holder of the February 2012 Notes is entitled to convert the notes into conversion shares at any time by delivery of a notice of conversion to the Company. On or before the third trading day after receipt of the conversion notice, the Company must deliver to the note holder such number of conversion shares to which the note holder is entitled pursuant to the conversion. The number of conversion shares the note holder will receive upon conversion of the Notes will be determined by dividing the amount of principal being converted plus any accrued and unpaid interest by the conversion price effective at the time of the conversion. The February 2012 Notes have an initial conversion price of $0.21 however it is subject to reset depending on the filing of the registration statement. At no time, however, will the Conversion Price be reset below $0.12 per share as a result of a conversion price adjustment.

The Company received net proceeds in the amount of $2,391,500 after offering cost of $558,500 and non-cash settlement for the $219,359. In recording the transaction, the Company allocate the face value of the notes between the estimated the fair values of the February 2012 Notes, the Series A Warrants and Series B Warrants. As a result, the February 2012 Notes were discounted by $1, 421,848 for Series A Warrants and $892,776 Series B Warrants. The carrying value of the February 2012 Notes as of the day of the transaction amounted to $854,735. The Company also recorded a beneficial conversion feature of $4,729,374 representing the difference between the market value of the converted shares as of February 9, 2012 and the amount of the total proceeds allocated to the carrying value of the Notes. The beneficial conversion feature was expensed in the unaudited condensed consolidated statement of operation, as a result the February 2012 Notes being available for conversion 3 days after consummation of the agreement. The discount associated with Series A Warrant is amortized over the life of the note and the discount associated with Series B Warrants is amortized over six months as a result of that being exercisable in seven months.

In connection with the February 2012 Notes, the Company paid the placement agent, a placement fee of $236,000 and issued to the placement agent and its designees, the placement agent warrants, consisting of five-year warrants to purchase an aggregate of 1,366,868 shares of common stock at an exercise price of $0.26 per share and seven-month warrants to purchase an aggregate of 1,366,868 shares of common stock at an exercise price of $0.21 per share. The Company recorded an asset related to financing charge that will be amortized over life of the February 2012 Notes and seven months - to the extent that the financing charge relates to Series B Warrants which expire in seven months after the consummation date. Total deferred financing cost recorded in the balance sheet as of February 9, 2012 amounted to $1,406,885 of which $594,574 relates to fees paid in cash to the placement agent, attorneys and other third parties. Also include in the total deferred financing charge is $477,494 which represents fair value of the Series A Warrants issue to the placement agent and $299,818 relating to the fair value of Series B Warrants which were provided to the placement agent. As of March 31, 2012, deferred financing fees of $156,445 is charged to interest expense in the unaudited condensed consolidated statement of operation. As of March 31, 2012, short term deferred financing cost amounts to $778,028 and the remaining balance of $472,413 in recorded in other assets long term.

The fair value of each warrant on the date issued was estimated using the Black-Scholes valuation model. The following assumptions were used for the calculation of the warrants granted in September, October and December 2011.

	11-Sep		11-Dec		12-Mar (A Warrants)		12-Mar (B Warrants)
Expected term		5 years		5 years		5 years		6 months
Expected average volatility		309%		296%		163.06%		163.06%
Expected dividend yield		0%		0%		0%		0%
Risk-free interest rate		3.50%		2.90%		.82%		.11%

The recorded discount on the convertible notes payable is being amortized to interest expense over the life of the note or seven months for the discount associated with Series B Warrants and is summarized as follows as of March 31, 2012.

			Debt Discount
Due Date	Face Value		Initial Value		Amortization			Discount		Carrying Value

February 4, 2014	$	3,169,359	$	854,735	$	(328,480	)	$	1,986,144	$	1,183,215
September 9, 2012		360,000		264,514		(50,633	)		44,853		315,147
October 25, 2012		180,000		133,948		(18,941	)		27,111		152,890
	$	3,709,359	$	1,253,197	$	(398,054	)	$	2,058,108	$	1,651,252

7.	WARRANT EXERCISES

In January 2012, we entered into agreements with holders of outstanding warrants to purchase 3,583,333 shares of our common stock at an exercise price of $0.12 per share. These warrants were originally issued with our first round of private financing completed in May and June 2011. Pursuant to these agreements (i) such holders agreed to exercise their warrants for cash, (ii) we agreed to (a) issue to each of such holders an additional five (5) year warrant entitling them to purchase a number of shares equal to that acquired upon exercise of their Initial Warrants at an exercise price of $0.25 per share (the “ January 2012 Warrants ”) and (b) grant them certain registration rights under the Securities Act of 1933 with respect to the shares issued upon exercise of the Initial Warrants and issuable upon exercise of the January 2012 Warrants. The January 2012 Warrants also provides for cashless exercise and for anti-dilution adjustments in the event of stock dividends, stock splits, recapitalizations and similar transactions. The January 2012 Warrants generated gross proceeds of $430,000. The Company recorded the cash receive of $430,000 and a discount of $847,034 as the difference between the fair value of the new warrants of $1,337,086 issued and the shares that were delivered to the investor as a result of exercising the warrants. The discount associated with the new issue will be amortized over the life of the new warrants. For the period ended March 31, 2012, amortization of $38,253 is charged to interest expense in the unaudited condensed consolidated statement of operation.

In addition to the January 2012 warrants, we had cashless exercises of warrants for 1,644,268 shares. As a result of the shares being exercised, we adjust the additional paid in capital for the value of the warrants exercised.

8.	RELATED PARTY TRANSACTIONS

The Company operated as a BDC until it withdrew its election to be treated as a BDC on January 20, 2009. While operating as a BDC, a part of its operations and consistent with the operating parameters of a BDC, the Company developed a number of relationships with its portfolio company investments, including members of the Company’s board of directors becoming officers and directors of its portfolio company investments. The Company made loans to the portfolio companies and entered into management agreements with the portfolio companies. As a result of operating as a BDC and then converting to an operating company, a number of its previous relationships were originally required to be categorized as related party transactions. As a result of changes in relationships, with the Company no longer being actively involved in the operation of the investments, these investments are no longer considered related party transactions. Other related party amounts and transactions are described as follows:

While operating as a BDC the Company had management contracts and made loans to its 60% owned subsidiary USN. These transactions are eliminated in consolidation with USN.

Related party amounts included in the balance sheet may be summarized as follows:

Accounts payable - related parties:

	March 31, 2012		September 30, 2011

Hank Durschlag	$	16,178	$	16,178
Rubin Hanan		5,706		-
Aitan Zacharin		13,465		12,554
	$	35,349	$	28,732

Hank Durschlag is a former officer and director in Double Eagle Holdings, LTD. Mr. Durschlag is not involved in any operational matters related to Fuse Science and these payments relate to remaining obligations to him in his former capacity. Rubin Hanan is a shareholder, the Company’s President and Chief Operating Officer and, effective March 14, 2011, a director. Aitan Zacharin is a shareholder, the Company’s Chief Marketing Officer and Chief Information Officer and a director.

Transactions with related parties in the statement of operations for the three months ended March 31, 2012 and September 30, 2011 include:

	2012		2011
Prior CEO compensation	$	10,000	$	3,000
New officer compensation		59,000		-
	$	69,000	$	3,000

STOCKHOLDERS’ EQUITY

Common stock

At March 31, 2012 and September 30, 2011, the Company had 400,000,000 shares authorized and 119,892,297 and 93,612,039 shares issued and outstanding, respectively, of its $0.001 par value common stock.

Transactions during the six month period ended March 31, 2012

Convertible debt

During the six month ended March 31, 2012, the Company executed convertible notes (“February 2012 Notes”) with several accredited investors in the amount of $3,169,359. The February 2012 Notes are convertible at $.21cents per shares. In addition to the convertible notes, the investors are issued warrants to purchase 15,092,186 of the Company’s Series A Warrants and 15,092,186 of the Company’s Series B Warrants.

Common Stock

During the three months ended December 31, 2011, the Company issued 16,999,997 shares of common stock upon conversion for convertible notes payable with a principal balance and accrued interest of $516,767. An additional, 1,063,333 of shares of common stock were issued upon conversion of convertible notes payable with a principal balance and accrued interest of $31,900 during the period from January 1, 2012 to March 31, 2012.

Warrants

In January 2012 several holders of warrants exercise their warrants to acquired 3,583,333 of the Company’s common stock for $430,000. In addition, the holders received new five year warrants to purchase the Company’s common stock at an exercise price of $.25 per share. Several warrant holder also completed a cashless exercise of 1,644,268 of the Company’s shares.

Options

During the three months ended March 31, 2012, the Company granted options to acquire up to 1,150,000 shares of its common stock to athletes for endorsement services, consultants for services performed or to be performed. The intrinsic value of $131,447 for the options was determined using the Black-Scholes method. These options were expensed immediately as a result of these options being issued to for certain contingencies which have been satisfied.

In addition, 2,100,000 of options with and intrinsic value of $442,947 were issued to employees and directors during the quarter ended March 31, 2012.

10.

COMMITMENTS AND CONTINGENCIES

Consulting Agreement - The Company entered into a consulting agreement with Hank Durschlag, its former CEO, under which he should receive $100,000 over the next year. In addition, in accordance with the terms of his patent assignment and technology transfer agreement if, and when utilized, Mr. Durschlag is entitled to royalties on Fuse Science sales as follows:

Sales Range		Commission Rate

$0 - $100,000		0.00%
$100,001 - $10,000,000		5.00%
$10,000,001 - $50,000,000		2.50%

Employment and Consulting Agreements- The Company entered into at-will basis employment agreements with Adam Adler, Aitan Zacharin and Brian Tuffin under the same terms and conditions: $18,000 monthly salary, provided the Company has adequate funds to make such payment; monthly car allowance of $1,000; and a discretionary performance bonus. The Company is also a party to a consulting agreement with an entity owned by Rubin Hanan who became the Company’s President and Chief Operating Officer on November 28, 2011. Mr. Hanan is compensated pursuant to that consulting agreement.

11.

DISCLOSURES ABOUT FAIR VALUE

Assets and liabilities measured at fair value on a recurring basis are summarized in the following tables according to FASB ASC 820 pricing levels.

	Fair Value Measurement Using
	Recorded value		Quoted prices in active markets of identical assets (Level 1)		Significant other observable inputs (Level 2)		Significant Unobservable Inputs (Level 3)

March 31, 2012
Assets:
Available-for-sale securities	$	14,040	$	14,040	$	-	$	-

September 30, 2011
Assets:
Available-for-sale securities	$	12,320	$	12,320	$	-	$	-

At March 31, 2012 and September 30, 2011, the Company's available-for-sale equity securities were valued using Level 1 inputs as summarized above. Level 1 inputs are based on unadjusted prices for identical assets in active markets that the Company can access.

Level 2 inputs are based on quoted prices for similar assets other than quoted prices in Level 1, quoted prices in markets that are not yet active, or other inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets. The Company does not have any investments that are measured on a recurring basis using Level 2 inputs.

Level 3 inputs have significant inputs which are not observable. The Company does not have any investments that are measured on a recurring basis using Level 3 inputs.

Certain assets are not carried at fair value on a recurring basis, including investments accounted for under the equity and cost methods. Accordingly, such investments are only included in the fair value hierarchy disclosure when the investment is subject to re-measurement at fair value after initial recognition and the resulting re-measurement is reflected in the consolidated financial statements.

ITEM 2:

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

FORWARD LOOKING STATEMENTS

From time to time, the Company may publish forward-looking statements relative to such matters as anticipated financial performance, business prospects, technological developments and similar matters. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements. All statements other than statements of historical fact included in this section or elsewhere in this report are, or may be deemed to be, forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. Important factors that could cause actual results to differ materially from those discussed in such forward-looking statements include, future financial performance, future operations, competitive advantages, brand image, ability to meet market demand, sufficiency of resources and funding operations and liquidity and capital needs.

CRITICAL ACCOUNTING ESTIMATES AND POLICIES

“Management’s Discussion and Analysis of Financial Condition and Results of Operations” discusses our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. On an on-going basis, we will evaluate our estimates and judgments, including those related to revenue recognition, valuation of investments, accrued expenses, financing operations, contingencies and litigation. We will base our estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. The most significant accounting estimates inherent in the preparation of our financial statements include estimates as to the appropriate carrying value of certain assets and liabilities which are not readily apparent from other sources. These accounting policies are described at relevant sections in this discussion and analysis and in the “Notes to Financial Statements” included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2011.

RESULTS OF OPERATIONS

For the Three Months Ended March 31, 2012 and 2011 (unaudited):

	Three months ended March 31,
	2012			2011
Sales	$	24,174		$	-
Gross profit	$	18,308		$	-
General and administrative expenses	$	(1,874,182	)	$	(174,139	)
Loss from operations	$	(1,855,874	)	$	(174,139	)
Other expenses	$	(5,513,899	)	$	(3,475	)
Net Loss	$	(7,369,773	)	$	(177,714	)
Net loss per common share – basic and diluted	$	(0.06	)	$	(0.0	)

Sales

Sales were $24,174 for the three months ended March 31, 2012, as compared to $ 0 for the comparable three months ended March 31, 2011. The increase in sales is due to a limited roll out of Enerjel™, our initial product, through internet sales while the Company focuses on a full retail roll out through its establishment of distribution partnerships.

Gross Profit

Gross profit percentage during the three months ended March 31, 2012 was 75.7%. Sales for the period consisted of Enerjel™, the Company’s currently marketed product. Sales were made exclusively through the Company’s website and for a short test period through Amazon.com.

General and Administrative Expenses

	For the Three Months Ended March 31,
	2012		2011
BCF	$	4,726,906	$	-
Interest expense		965,695		3,475
Marketing		733,515		-
Professional Fees		563,780		-
Salary and benefits		423,038		144,000
Other expense		153,849		30,139

Total expense	$	7,566,783	$	177,614

Beneficial Conversion Feature

Beneficial conversion feature was $4,726,906 for the three months ended March 31, 2012, as compared to $0 for the three months ended March 31, 2011, an increase of $4.7 million. This was due primarily to the consummation of the February 2012 Notes which are convertible at $.21 per share into common stock. The amount expensed for the period represents the excess fair value of the converted shares over the proceeds allocated to the notes.

Interest Expense

Interest expense was $965,596 for the three months ended March 31, 2012, as compared to interest expense of $3,475 for the three months ended March 31, 2011. The increase was due primarily to several convertible notes which were executed between June 2011 and March 2012. Several note holders have already converted there notes into common stock. During the period ended March 31, 2012, 17,396,663 of common stock were issued to settle convertible debt with a face value of $525,000. Included in the amount is amortization of financing charge of approximately $156,000, amortization of debts discounts associated with the notes issued as well as unamortized discounts which removed from the books as a result of the notes being converted.

Marketing Expense

The increase in marketing expense of $733,516 for the three months ended March 31, 2012, from $0 for the three months ended March 31, 2011 is due to the Company’s effort to market its products which is heavily influenced by athlete endorser relationships designed to drive brand awareness and trial. During the period ended March 31, 2012, the Company entered in to a distribution and marketing agreement with Mission which included comprehensive marketing services and heavy commercialization efforts during the first 10 months of the distribution and marketing agreement. The Company paid Mission approximately $650,000 which is therefore being amortized over 10 months. Also included is other marketing cost relating to the launch of Enerjel™ and non-cash payments to endorsers of $289,147.

Professional Fees Expense

Professional fees expense increased by $563,780 for the three months ended March 31, 2012, from $0 for the three months ended March 31, 2011. This increase was due to the Company’s requirements for legal, accounting and consulting services related to the Company’s ongoing day-to-day business dealings and execution of its business plan, including, accounting, financial reporting and SEC compliance. Professional fee expense increase includes $84,057 in non-cash compensation.

Payroll

Payroll expense increased by $279,038 to $423,038 for the three months ended March 31, 2012 from $144,000 for the three months ended March 31, 2011. The increase was due to an increase in personnel headcount. The payroll increase includes $192,791 in non-cash compensation.

Other expenses

Other general and administrative expense increased from $30,139 in the three months ended March 31, 2011 to $153,849 in the three months ended March 31, 2012. This increase is primarily a result of the increased travel to third party manufacturing plant, increased investor relations activities and reporting as well as expenses associated with the Company’s fund raising activities and expenses related to other early stage development activities of the business.

Other Income

Other income for the three months ended March 31, 2012 and 2011 (unaudited) was as follows:

		2012				2011
Realized gain on extinguishment of debt		$	178,702			$	-

The increase of $178,702 in the three months ended March 31, 2012 is primarily due to a gain on the early extinguishment of the December 2011 Notes. The notes were modified and included in the February 2012 Notes. As a result of the modification being significant - due to the present value cash flow of the February 2012 Notes debt were greater than 10%, we recorded a gain of $178,702.

Loss from Operations

Loss from operations for the three months ended March 31, 2012, was $1,855,874 as compared to $174,139 for the comparable three months ended March 31, 2011. The increase in operating loss is primarily attributable to the use of equity incentives that underpin the Company’s aggressive marketing plan through the use of iconic athletes to gain brand recognition for the company’s currently marketed and future products. The increase is also due to an increase in salary expense, travel and professional fees associated with new business operations that were not present during the same period last year.

Net Loss

Net loss for the three months ended March 31, 2012, was $7,369,773 or loss per share of $(0.06), as compared to $177,614 or loss per share of $(0.00) for the comparable three months ended March 31, 2011.

Inflation did not have a material impact on the Company’s operations for the period. Other than the foregoing, management knows of no trends, demands, or uncertainties that are reasonably likely to have a material impact on the Company’s results of operations.

For the Six Months Ended March 31, 2012 and 2012 (unaudited):

	Six months ended March 31,
	2012			2011
Sales	$	24,174		$	-
Gross profit	$	18,307		$	-
General and administrative expenses	$	(2,685,666	)	$	(194,302	)
Loss from operations	$	(2,667,358	)	$	(194,302	)
Other expense	$	(5,701,795	)	$	(5,050	)
Net Loss	$	(8,369,153	)	$	(199,352	)
Net loss per common share – basic and diluted	$	(0.07	)	$	(0.00	)

Sales

Sales were $24,178 for the six months ended March 31, 2012. The company had no sales for the comparable six months ended March 31, 2011. The increase in sales is due to a limited roll out of enerjel through internet sales while the Company focuses on a full retail roll out through its establishment of distribution partnerships with Mission and GNC.

Gross Profit

Gross profit percentage during the six months ended March 31, 2012 was 75.7%. Sales for the period consisted of enerjel, the Company’s currenlty marketed product. Sales were made exclusively through the Company’s website and for a short test period through Amazon.com.

	For The Six Months Ended March 31,
	2012		2011
BCF	$	4,875,089	$	-
Interest expense		1,005,408		5,050
Marketing expense		1,129,816		-
Professional Fees		867,526		-
Salary and benefits		493,841		144,000
Other expense		194,483		50,337

Total expense	$	8,566,163	$	199,352

General and Administrative Expenses

Beneficial Conversion Feature

Beneficial conversion feature was $4,875,089 for the six months ended March 31, 2012, as compared to of $0 for the six months ended March 31, 2011, an increase of $4.8 million. This was due primarily to the consummation of the February 2012 Notes which are convertible at $.21 per share into common stock. The amount expensed for the period represents the excess fair value of the converted shares over the proceeds allocated to the notes.

Interest Expense

Interest expense was $1,005,408 for the six months ended March 31, 2012, as compared to interest expense of $5,050 for the six months ended March 31, 2011. The increase was due primarily to several convertible notes which were executed between June 2011 and March 2012. Several note holders have already converted their notes in to common stock. During the period ended March 31, 2012, 17,396,663 of common stock were issued to settle convertible debt with a face value of $525,000. Also included in the amount is amortization of financing charge of approximately $156,000, amortization of debts discounts associated with the notes issued as well as unamortized discounts which were removed from the books as a result of the notes being converted.

Marketing Expense

The increase in marketing expense of $1,129,816 for the six months ended March 31, 2012, from $0 for the six months ended March 31, 2011 was due to the Company’s efforts to market its products which is heavily influenced by athlete endorser relationships designed to drive brand awareness and trial. During the period ended March 31, 2012, the Company entered in to a distribution and marketing agreement with Mission which included comprehensive marketing services and heavy commercialization efforts during the first 10 months of the distribution and marketing agreement. The Company paid Mission approximately $650,000 which is therefore being amortized over 10 months. Also included is other marketing cost relating to the launch of Enerjel™included is non-cash payments to endorsers of $498,288.

Professional Fees Expense

Professional fees expense increased by $867,526 for the six months ended March 31, 2012, from $0 for the six months ended March 31, 2011. This increase was due to the Company’s requirements for legal, accounting and consulting services related to the Company’s ongoing day-to-day business dealings and execution of its business plan, including, accounting, financial reporting and SEC compliance. Professional fee expense increase includes $161,987 in non-cash compensation.

Payroll

Payroll expense increased by $352,841 to $493,841 for the six months ended March 31, 2012 from $144,000 for the three months ended March 31, 2011. The increase was due to an increase in personnel headcount. The payroll increase includes $321,319 in non-cash compensation.

Other expenses

Other general and administrative expense increased from $50,337 in the six months ended March 31, 2011 to $194,483 in the six months ended March 31, 2012. This increase is primarily a result of the increased in travel to third party manufacturing plant, increased investor relations activities and reporting as well as expenses associated with the Company’s fund raising activities and expenses related to other early stage development activities of the business.

Other income for the three months ended March 31, 2012 and 2011 (unaudited) was as follows:

		2012				2011
Realized gain on extinguishment of debt		$	178,702			$	-

The increase of $178,702, in the six months ended March 31, 2012 is primarily due to a gain on the early extinguishment of the December 2011 Notes. The notes were modified and included in the February 2012 Notes. As a result of the modification being significant - due to the present value cash flow of the February 2012 Notes debt were greater than 10%, we recorded a gain of $178,702.

Loss from Operations

Loss from operations for the six months ended March 31, 2012, was $2,667,358 as compared to $194,302 for the comparable six months ended March 31, 2011. The increase in operating loss is primarily attributable to the use of equity incentives that underpin the Company’s aggressive marketing plan through the use of iconic athletes to gain brand recognition for the company’s currently marketed and future products. The increase is also due to an increase in salary expense, travel, and professional fee associated with new business operations that were not present during the same period last year.

Net Loss

Net loss for the six months ended March 31, 2012, was $8,369,153 or loss per share of $(0.07), as compared to $199,352 or loss per share of $(0.00) for the comparable six months ended March 31, 2011.

Liquidity and Capital Resources

The following table summarizes total current assets, liabilities and working capital at March 31, 2012 compared to September 30, 2011.

	March 31, 2012		September 30, 2011			Increase/(Decrease)
	(unaudited)
Current Assets	$	2,530,273	$	207,171		$	2,323,102
Current Liabilities	$	890,304	$	999,227		$	(108,923	)
Working Capital (Deficit)	$	1,639,969	$	(792,056	)	$	2,432,025

As March 31, 2012, we had a working capital of $1,639,969, as compared to a working capital deficit of $792,056, at September 30, 2011, a increase of $2,432,025. The increase is primarily attributable to the Company’s issuance of $3,169,324 in convertible notes during the six months ended March 31, 2012 and conversion of certain outstanding convertible promissory notes. The Company continues to devote significant resources to aggressively pursue markets for its existing product, new product introductions, advancement of its intellectual property build out of its infrastructure and team.

Net cash used for operating activities for the six months ended March 31, 2012 and 2011 was $(2,177,602) and $(56,474), respectively. The net loss for the six months ended March 31, 2012 and 2011 was $(8,369,153) and $(199,352), respectively.

Net cash used and provided for investing activities for the six months ended March 31, 2012 and 2011 respectively, was $(21,190) and $17,876, respectively. The Company purchased computer equipment and invested in developing out its intellectual property during the six months ended March 31, 2012.

Net cash obtained through all financing activities for the six months ended March 31, 2012 was $3,115,426, as compared to ($30,125) which was used for the six months ended March 31, 2011. The Company issued convertible promissory notes in February 2012.

Going Concern

As reflected in the accompanying unaudited interim consolidated financial statements, the Company had a net loss of $8,369,153 and net cash used in operations of $2,177,602 for the six months ended March 31, 2012, and working capital and stockholders’ deficit of $1,639,969 and $1,932,774, respectively, at March 31, 2012. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

The ability of the Company to continue its operations is dependent on management's plans, which include the raising of capital through debt and/or equity markets with some additional funding from other traditional financing sources, including term notes, sale of aged debt to third parties in exchange for free trading stock, until such time that funds provided by operations are sufficient to fund working capital requirements. The Company may need to incur liabilities with certain related parties to sustain the Company’s existence.

The Company will require additional funding to finance the growth of its current and expected future operations as well as to achieve its strategic objectives. The Company believes its current available cash along with anticipated revenues may be insufficient to meet its cash needs for the near future. There can be no assurance that financing will be available in amounts or terms acceptable to the Company, if at all.

In response to these problems, management has taken the following actions:

continue with the implementation of the business plan;

generate new sales from internet sales and continuing a push to establish additional distribution to retail customers;

seeking additional third party debt and/or equity financing; and

allocate sufficient resources to continue with advertising and marketing efforts.

Financings

Our primary source of operating cash has been through the sale of equity and through the issuance of convertible secured promissory notes.

Off Balance Sheet Arrangement

None.

Contractual Obligation

None

ITEM 3:

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4:

CONTROLS AND PROCEDURES

Evaluation of disclosure controls and procedures

Under the PCAOB standards, a control deficiency exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A significant deficiency is a deficiency, or a combination of deficiencies, in internal control over financial reporting that is less severe than a material weakness, yet important enough to merit the attention by those responsible for oversight of the company’s financial reporting. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) and Rule 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended, as of March 31, 2012. Our management has determined that, as of March 31, 2012, the Company’s disclosure controls and procedures are effective.

Changes in internal control over financial reporting

As development stage entity we are constantly modifying or improving of controls, especially for certain transaction which are new to us. There have been no significant changes in internal controls or in other factors that could significantly affect these controls during the quarter ended March 31, 2012, including any corrective actions with regard to significant deficiencies and material weaknesses. As a result of implementing certain controls, which are more recent, we became aware of transactions which were not recorded in the period.

PART II – OTHER INFORMATION

ITEM 1

LEGAL PROCEEDINGS

On March 15, 2012, MusclePharm Corporation (“MPC”) commenced a trademark infringement and unfair competition action against the Company in the United States District Court for the Southern District of Florida. The suit involves Fuse’s use of its Enerjel™ mark. Fuse believes that these claims are without merit and intends to vigorously contest the action. Fuse has answered the complaint, denying MSC’s allegations and asserting various affirmative defenses.

ITEM 1A

RISK FACTORS

Not applicable.

ITEM 2

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Not applicable March 31, 2012.

ITEM 3

DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4

SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

Not applicable.

ITEM 5

OTHER INFORMATION

Not applicable.

ITEM 6

EXHIBITS

31.1	Certification pursuant to 18 U.S.C. Section 1350 Section 302 of the Sarbanes-Oxley Act of 2002

32.1	Certification pursuant to 18 U.S.C. Section 1350 Section 906 of the Sarbanes-Oxley Act of 2002

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	FUSE SCIENCE, INC.

May 15, 2012	By: /s/Brian Tuffin
	Brian Tuffin,
	Chief Executive Officer and
	Acting Chief Financial Officer, Principal Executive Officer

EX-31.1 2 v313070_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Brian Tuffin, Chief Executive Officer and Acting Chief Financial Officer of Fuse Science, Inc. certify that:

I have reviewed this report on Form 10-Q of Fuse Science, Inc. (the registrant);

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;

I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-a15(f) and 15d-15(f) for the registrant and have:

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

disclosed in this report any change in the registrant’s internal controls over financial reporting that occurred during the registrant’s current fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and;

I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions);

All significant deficiencies and material weaknesses in the design or operation of internal controls which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls.

	FUSE SCIENCE, INC.

May 15, 2012
	By:	/s/ Brian Tuffin
	Brian Tuffin Chief Executive Officer and Acting Chief Financial Officer, Principal Executive and Financial Officer

EX-32.1 3 v313070_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT

TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the accompanying Quarterly Report of Fuse Science, Inc. (the "Company") on Form 10-Q for the quarter-ended March 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Brian M. Tuffin, Chief Executive Officer and Acting Chief Financial Officer (principal executive and financial officer) of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:

(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

the information contained in the Report fully presents, in all material respects, the financial condition and results of operations of the Company.

DATED the 15^thday of May, 2012.

	FUSE SCIENCE, INC.


	By:	/s/ Brian Tuffin
		Brian Tuffin, Chief Executive
		Officer and Acting Chief Financial Officer (Principal Executive and Financial Officer)

EX-101.SCH 4 deghpk-20120331.xsd XBRL TAXONOMY EXTENSION SCHEMA 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Consolidated Balance Sheets [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Consolidated Statements of Changes in Stockholders' Deficit link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICY link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - GOING CONCERN link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - INVESTMENTS link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - DISTRIBUTION AGREEMENT link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - INTELLECTUAL PROPERTY link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - CONVERTIBLE PROMISSORY NOTES link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - WARRANT EXERCISES link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - DISCLOSURES ABOUT FAIR VALUE link:presentationLink link:definitionLink link:calculationLink EX-101.INS 5 deghpk-20120331.xml XBRL INSTANCE DOCUMENT 0000842722 2009-01-20 2009-09-30 0000842722 us-gaap:PreferredStockMember 2009-01-20 2009-09-30 0000842722 us-gaap:CommonStockMember 2009-01-20 2009-09-30 0000842722 us-gaap:AdditionalPaidInCapitalMember 2009-01-20 2009-09-30 0000842722 us-gaap:NoncontrollingInterestMember 2009-01-20 2009-09-30 0000842722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2009-01-20 2009-09-30 0000842722 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2009-01-20 2009-09-30 0000842722 deghpk:AccumulatedDeficitDevelopmentStageMember 2009-01-20 2009-09-30 0000842722 deghpk:AccumulatedDeficitOtherMember 2009-01-20 2009-09-30 0000842722 deghpk:IntrinsicValueOfCommonStockOptionsMember 2009-01-20 2009-09-30 0000842722 2009-10-01 2010-09-30 0000842722 us-gaap:PreferredStockMember 2009-10-01 2010-09-30 0000842722 us-gaap:CommonStockMember 2009-10-01 2010-09-30 0000842722 us-gaap:AdditionalPaidInCapitalMember 2009-10-01 2010-09-30 0000842722 us-gaap:NoncontrollingInterestMember 2009-10-01 2010-09-30 0000842722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2009-10-01 2010-09-30 0000842722 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2009-10-01 2010-09-30 0000842722 deghpk:AccumulatedDeficitDevelopmentStageMember 2009-10-01 2010-09-30 0000842722 deghpk:AccumulatedDeficitOtherMember 2009-10-01 2010-09-30 0000842722 deghpk:IntrinsicValueOfCommonStockOptionsMember 2009-10-01 2010-09-30 0000842722 2011-01-01 2011-03-31 0000842722 2010-10-01 2011-03-31 0000842722 2010-10-01 2011-09-30 0000842722 us-gaap:PreferredStockMember 2010-10-01 2011-09-30 0000842722 us-gaap:CommonStockMember 2010-10-01 2011-09-30 0000842722 us-gaap:AdditionalPaidInCapitalMember 2010-10-01 2011-09-30 0000842722 us-gaap:NoncontrollingInterestMember 2010-10-01 2011-09-30 0000842722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2010-10-01 2011-09-30 0000842722 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-10-01 2011-09-30 0000842722 deghpk:AccumulatedDeficitDevelopmentStageMember 2010-10-01 2011-09-30 0000842722 deghpk:AccumulatedDeficitOtherMember 2010-10-01 2011-09-30 0000842722 deghpk:IntrinsicValueOfCommonStockOptionsMember 2010-10-01 2011-09-30 0000842722 2011-09-30 0000842722 2012-01-01 2012-03-31 0000842722 2011-10-01 2012-03-31 0000842722 us-gaap:PreferredStockMember 2011-10-01 2012-03-31 0000842722 us-gaap:CommonStockMember 2011-10-01 2012-03-31 0000842722 us-gaap:AdditionalPaidInCapitalMember 2011-10-01 2012-03-31 0000842722 us-gaap:NoncontrollingInterestMember 2011-10-01 2012-03-31 0000842722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2011-10-01 2012-03-31 0000842722 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-10-01 2012-03-31 0000842722 deghpk:AccumulatedDeficitDevelopmentStageMember 2011-10-01 2012-03-31 0000842722 deghpk:AccumulatedDeficitOtherMember 2011-10-01 2012-03-31 0000842722 deghpk:IntrinsicValueOfCommonStockOptionsMember 2011-10-01 2012-03-31 0000842722 2012-03-31 0000842722 2009-01-20 2012-03-31 0000842722 2012-05-11 0000842722 2009-01-19 0000842722 2009-09-30 0000842722 us-gaap:PreferredStockMember 2009-01-19 0000842722 us-gaap:PreferredStockMember 2009-09-30 0000842722 us-gaap:CommonStockMember 2009-01-19 0000842722 us-gaap:CommonStockMember 2009-09-30 0000842722 us-gaap:AdditionalPaidInCapitalMember 2009-01-19 0000842722 us-gaap:AdditionalPaidInCapitalMember 2009-09-30 0000842722 us-gaap:NoncontrollingInterestMember 2009-01-19 0000842722 us-gaap:NoncontrollingInterestMember 2009-09-30 0000842722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2009-01-19 0000842722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2009-09-30 0000842722 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2009-01-19 0000842722 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2009-09-30 0000842722 deghpk:AccumulatedDeficitDevelopmentStageMember 2009-01-19 0000842722 deghpk:AccumulatedDeficitDevelopmentStageMember 2009-09-30 0000842722 deghpk:AccumulatedDeficitOtherMember 2009-01-19 0000842722 deghpk:AccumulatedDeficitOtherMember 2009-09-30 0000842722 deghpk:IntrinsicValueOfCommonStockOptionsMember 2009-01-19 0000842722 deghpk:IntrinsicValueOfCommonStockOptionsMember 2009-09-30 0000842722 2010-09-30 0000842722 us-gaap:PreferredStockMember 2010-09-30 0000842722 us-gaap:CommonStockMember 2010-09-30 0000842722 us-gaap:AdditionalPaidInCapitalMember 2010-09-30 0000842722 us-gaap:NoncontrollingInterestMember 2010-09-30 0000842722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2010-09-30 0000842722 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-09-30 0000842722 deghpk:AccumulatedDeficitDevelopmentStageMember 2010-09-30 0000842722 deghpk:AccumulatedDeficitOtherMember 2010-09-30 0000842722 deghpk:IntrinsicValueOfCommonStockOptionsMember 2010-09-30 0000842722 2011-03-31 0000842722 us-gaap:PreferredStockMember 2011-09-30 0000842722 us-gaap:CommonStockMember 2011-09-30 0000842722 us-gaap:AdditionalPaidInCapitalMember 2011-09-30 0000842722 us-gaap:NoncontrollingInterestMember 2011-09-30 0000842722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2011-09-30 0000842722 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-09-30 0000842722 deghpk:AccumulatedDeficitDevelopmentStageMember 2011-09-30 0000842722 deghpk:AccumulatedDeficitOtherMember 2011-09-30 0000842722 deghpk:IntrinsicValueOfCommonStockOptionsMember 2011-09-30 0000842722 us-gaap:PreferredStockMember 2012-03-31 0000842722 us-gaap:CommonStockMember 2012-03-31 0000842722 us-gaap:AdditionalPaidInCapitalMember 2012-03-31 0000842722 us-gaap:NoncontrollingInterestMember 2012-03-31 0000842722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2012-03-31 0000842722 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-03-31 0000842722 deghpk:AccumulatedDeficitDevelopmentStageMember 2012-03-31 0000842722 deghpk:AccumulatedDeficitOtherMember 2012-03-31 0000842722 deghpk:IntrinsicValueOfCommonStockOptionsMember 2012-03-31 xbrli:shares iso4217:USD iso4217:USDxbrli:shares Fuse Science, Inc. 0000842722 --09-30 Smaller Reporting Company deghpk 126202256 10-Q false 2012-03-31 Q2 2012

147907

1064541

6465

8619

146

59264

613786

207171

2530273

8320

14040

13062

126917

133024

135237

632539

342408

3162812

342009

223286

28558

35349

606976

503156

21684

128213

999227

890304

93612

119892

12667350

28034931

-126344

-541558 -724060

2590

8310

2194904

10563905

-9876854

-12071758

-20440759

-656819

1933074

276724

-69556

50926

9946022

279470

31085

-97895

-9999694

-181446

50926

9946022

-126344

-453

-174743

-9876854

93612

12667350

-126344

-541558

2590

-2194904

-9876854

-680711

119892

28034931

-126344

-724060

8310

-10563905

-9876854

-4938896

342408

3162812

0.001

10000000

100

0.001

400000000

93612039

119982297

93612039

119982297

11366

24174

35540

171139

188302

1874182

2685666

4415159

174139

194302

1874182

2685666

4421159

-174139

-194302

-1855874

-2667358

-4391486

0 0 9629

3510

7433

965695

1005408

1050554

-4726906

-4875089

-5247400

2383 0 -15552

-35

50900

-3475

-5050

-5513899

-5701795

-6176075

-97895

-80352

-4

-80348

-199352

-2020161

-8369153

-10567561

-3504

-177614

-199352

-7369773

-8369153

-10564057

-0.07

51727575 51322292 117203169 114228944

1060

7903

-4520

8310

4430

-176554

-191449

-7374293

-8360843

-10559627

50925820

93612039

119892297

-126340

3500

122840

-248385

-31538

3043

5720

543000

11850

1140150

-609000

11850000

140056

5539

134517

533918

18063

535855

5539219

18063330

78000 0 2000 76000 0 0 0 0 0 0 0 2000000

23297

-23297

23297000

310775

372311

4811694

4811693

0 0 710872 -710872 0 0 5494259 0 -444963 0 0 0 -4894793 67442 0 67442 0 0 0 345501 0 345501 0 0 0 30161 0 0 0 0 0 0 0 0 30161 799179 0 0 0 0 0 0 0 0 636608

682

1765

0 514800 582242 0 636608 666769

144000

543000

0 756719 769470 0 0 8800

4909

2348

-15552

4686

-5000

554522

613786

12777

19597

375763

-11551

6617

6660

-56474

-2177602

-2991026

-52876

-75876

17876

-21190

4686

13750

35000

7440

57440

32785

3534359

4466009

2660

219359

222019

-30125

3115426

4044416

-8473

916634

1058076

0 0 100000 0 555425 1227247 0 0 78000 0 0 23297

<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.25in;">1.</td> <td>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICY</td> </tr> </table>   CONSOLIDATION POLICY AND HISTORY OF BUSINESS   The consolidated financial statements of the Company include the accounts of the Company, Fuse Science, Inc. (“FUSE”) and FS Consumer Products Group, Inc., a Florida corporation, its wholly-owned subsidiaries and Ultimate Social Network, Inc. (“USN”) its 60%-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation. The Company was originally incorporated in 1985 in Nevada. Its common stock now trades on the OTCQB under the symbol DROP.PK.   DEVELOPMENT STAGE   From 2007 to January 20, 2009, the Company operated as a “business development company” (“BDC”) under the Investment Company Act of 1940. At the time the Company withdrew its election to operate as a BDC on January 20, 2009, the Company had limited resources and did not have sufficient capital to complete its business plans. Accordingly, the operations of the Company, is presented as those of a development stage enterprise, from January 20, 2009, which is treated as its inception for financial reporting purposes.   BASIS OF PRESENTATION   The accompanying unaudited interim consolidated financial statements have been prepared by the Company in accordance with generally accepted accounting principles for interim financial information. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. The information furnished in the interim consolidated financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. Operating results for the six months ended March 31, 2012 are not necessarily indicative of the results that may be expected for the full year. These interim consolidated financial statements should be read in conjunction with the Company’s most recent audited consolidated financial statements and notes thereto dated September 30, 2011.   USE OF ESTIMATES   The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.   REVENUE RECOGNITION   The Company records revenue when all of the following have occurred: (1) persuasive evidence of an arrangement exists, (2) product has been shipped or delivered, (3) the sales price to the customer is fixed or determinable, and (4) collectability is reasonably assured. The Company’s customers may return ordered items for a refund. The Company also provides customers incentives to purchase products at a discount. For the period ended March 31, 2012 we have record sales discount, returns and allowances of $738 which is netted against sales for the three months and the six months then ended.   INVENTORIES   Inventories consist of items or products manufactured for resale and packaging material used to produce such products. Inventories are valued at average cost and adjusted to reflect lower of cost or market. Allowances for inventory obsolescence are determined based upon the specific facts and circumstances and market conditions. As of March 31, 2012 and September 30, 2011, no obsolescence reserves were considered.   INVESTMENTS   Investments are classified into the following categories:     <table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="width: 0.25in;">·</td> <td>Trading securities reported at fair value with unrealized gains and losses included in earnings;</td> </tr> </table> <table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="width: 0.25in;">·</td> <td>Available-for-sale securities reported at fair value with unrealized gains and losses, net of applicable deferred income taxes, reported in other comprehensive income;</td> </tr> </table> <table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="width: 0.25in;">·</td> <td>Held-to-maturity securities and other investments reported at amortized cost; and</td> </tr> </table> <table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="width: 0.25in;">·</td> <td>Investments using the equity method of accounting.</td> </tr> </table>   Stock-based Compensation   The compensation cost relating to share-based payment transactions (including the cost of all employee stock options) is required to be recognized in the financial statements. That cost is measured based on the estimated fair value of the equity or liability instruments issued. A wide range of share-based compensation arrangements including share options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans are included. The Company’s financial statements would include an expense for all share-based compensation arrangements granted on or after January 1, 2006 and for any such arrangements that are modified, cancelled or repurchased after that date based on the grant-date estimated fair value.   INTANGIBLE ASSETS   Other intangible assets primarily consist of intellectual property. We apply an impairment evaluation whenever events or changes in business circumstances indicate that the carrying value of our intangible assets may not be recoverable. Other intangible assets are amortized on a straight-line basis over their estimated economic lives. We believe that the straight-line method of amortization reflects an appropriate allocation of the cost of the intangible assets to earnings in proportion to the amount of economic benefits obtained annually by the Company.    IMPAIRMENT OF LONG-LIVED ASSETS   The Company evaluates its long-lived assets and intangible assets for impairment whenever events change or if circumstances indicate that the carrying amount of any assets may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to the expected future net undiscounted cash flows generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is the excess of the carrying amount over the fair value of the asset.   <div style="font: 10pt times new roman, times, serif; margin: 0pt 0; text-align: justify;">FAIR VALUE</div>   The Company adopted fair value accounting for certain financial assets and liabilities that have been evaluated at least annually. The standard defines fair value as the price at which an asset could be exchanged in a current transaction between knowledgeable, willing parties. A liability’s fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. Management has determined that it will not, at this time, adopt fair value accounting for nonfinancial assets or liabilities currently recorded in the financial statements, which includes investments carried at cost, deposits and other assets. Impairment analyses will be made of all assets using fair value measurements.    NEW ACCOUNTING PRONOUNCEMENTS   We have evaluated all recent accounting pronouncements through March 31, 2012 and find none that would have a material impact on the financial statements of the Company.   RECLASSIFICATION   Certain reclassifications have been made in the condensed consolidated financial statements at September 30, 2011 and for the three months and six month ended March 31, 2011 to conform to the March 31, 2012 presentation. The reclassifications had no effect on net loss.

<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.25in;">6.</td> <td>CONVERTIBLE PROMISSORY NOTES</td> </tr> </table>   The Company had the following convertible notes payable at March 31, 2012 and September 30, 2011.   <table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt; font-weight: bold;"> </td> <td style="font-size: 10pt; font-weight: bold;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center;" colspan="2">March, 31</td> <td style="font-size: 10pt; font-weight: bold;"> </td> <td style="font-size: 10pt; font-weight: bold;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center;" colspan="2">September 30,</td> <td style="font-size: 10pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt; font-weight: bold; font-style: italic;"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">2012</td> <td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold;"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">2011</td> <td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="width: 68%; font-size: 10pt; text-align: left;">Convertible notes payable with interest at 12%</td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;">$</td> <td style="width: 12%; font-size: 10pt; text-align: right;">20,000</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;">$</td> <td style="width: 12%; font-size: 10pt; text-align: right;">20,000</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-size: 10pt; text-align: left;">8% One year senior secured convertible promissory note due June 20, 2012</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"></td> <td style="font-size: 10pt; text-align: right;">-</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"></td> <td style="font-size: 10pt; text-align: right;">327,405</td> <td style="font-size: 10pt; text-align: left;">*</td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="font-size: 10pt; text-align: left;">8% One year senior secured convertible promissory note due September 9, 2012</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"></td> <td style="font-size: 10pt; text-align: right;">315,147</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"></td> <td style="font-size: 10pt; text-align: right;">259,571</td> <td style="font-size: 10pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-size: 10pt; text-align: left;">8% One year senior secured convertible promissory note due October 25, 2012</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"></td> <td style="font-size: 10pt; text-align: right;">152,889</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"></td> <td style="font-size: 10pt; text-align: right;">-</td> <td style="font-size: 10pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="font-size: 10pt; text-align: left;">10% Two year senior secured convertible promissory note due February 7, 2014</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"></td> <td style="font-size: 10pt; text-align: right;">1,183,215</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"></td> <td style="font-size: 10pt; text-align: right;">-</td> <td style="font-size: 10pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt;">Discount on Warrants</td> <td style="font-size: 10pt; padding-bottom: 2.5pt;"> </td> <td style="border-bottom: black 2.5pt double; font-size: 10pt; text-align: left;"></td> <td style="border-bottom: black 2.5pt double; font-size: 10pt; text-align: right;">(843,781</td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left;">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt;"> </td> <td style="border-bottom: black 2.5pt double; font-size: 10pt; text-align: left;"></td> <td style="border-bottom: black 2.5pt double; font-size: 10pt; text-align: right;">-</td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="font-size: 10pt; font-weight: bold; font-style: italic; padding-bottom: 2.5pt;"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt;"> </td> <td style="border-bottom: black 2.5pt double; font-size: 10pt; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; font-size: 10pt; text-align: right;">827,470</td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt;"> </td> <td style="border-bottom: black 2.5pt double; font-size: 10pt; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; font-size: 10pt; text-align: right;">606,976</td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left;"> </td> </tr> </table>   <table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt; padding-bottom: 1pt;"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">March 31, 2012</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">September 30, 2011</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="width: 68%; font-size: 10pt;">Current</td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;">$</td> <td style="width: 12%; font-size: 10pt; text-align: right;">503,156</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;">$</td> <td style="width: 12%; font-size: 10pt; text-align: right;">606,976</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-size: 10pt; text-align: left;">Long term</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;">$</td> <td style="font-size: 10pt; text-align: right;">339,434</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;">$</td> <td style="font-size: 10pt; text-align: right;">-</td> <td style="font-size: 10pt; text-align: left;"> </td> </tr> </table>   Convertible notes payable includes one note in the amount of $5,000 which is convertible at $0.025 per share and one note in the amount of $15,000 which is convertible at $0.03 per share.   * These notes were originally issued with a face value of $525,000. During the quarter ended December 31, 2011, several note holders converted the notes into stock, on or around the last day of the reporting period, resulting in a reduction of $495,000 to the face value of the notes. The remaining note holder converted his note with a face value of $30,000 for 1,633,667 shares of the Company’s common stock as of March 31, 2012. A total of 17,396,663 shares were converted for by notholders during the six months ending March 31, 2012. As a result of the conversion of these notes, unamortized discount of $186,739 was charged to interest expense for the period ending March 31, 2012.   The terms of our 8% One Year Senior Subordinated Secured Convertible Promissory Notes are summarized as follows:   <table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: black 1pt solid;">Due Date</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">Face Value</td> <td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold;"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">Conversion Rate</td> <td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold;"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">Number of Warrants</td> <td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="width: 52%; font-size: 10pt;">February 7, 2014</td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;">$</td> <td style="width: 12%; font-size: 10pt; text-align: right;">3,169,359</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 12%; font-size: 10pt; text-align: right;">See below</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 12%; font-size: 10pt; text-align: right;">30,184,372</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-size: 10pt;">September 9, 2012</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;">$</td> <td style="font-size: 10pt; text-align: right;">360,000</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;">$</td> <td style="font-size: 10pt; text-align: right;">0.12</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; text-align: right;">3,000,000</td> <td style="font-size: 10pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="font-size: 10pt;">October 25, 2012</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;">$</td> <td style="font-size: 10pt; text-align: right;">180,000</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;">$</td> <td style="font-size: 10pt; text-align: right;">0.12</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; text-align: right;">750,000</td> <td style="font-size: 10pt; text-align: left;"> </td> </tr> </table>   On January 4, 2012, we executed an agreement for additional December Notes with a face value of $50,000 bearing 8% interest rate and maturing in 90 days. Similar to the previous notes issued in December 2011, these notes are convertible into Units consisting of 10 shares of the Company’s common stock and warrants to purchase an additional six shares of the Company’s common stock at a strike price $.18 per shares. The notes are convertible at $1.50 per unit/$.15 per share. The Company measured the fair value of these instruments and recorded a discount of $28,508 on the note for proceeds which were allocated to the warrants. In addition, a beneficial conversion of $145,175 was immediately expenses as a result of the notes are available for conversion immediately after execution of the agreement.   On February 9, 2012, the terms of our December Notes with were significantly modified and the note holders were now included as part of the February 2012 Notes. Detailed below is the face values of the December Notes prior to modification of the terms:   <table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: black 1pt solid;">Due Date</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">Face Value</td> <td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold;"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">Unit Conversion Rate**</td> <td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold;"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">Number of Warrants</td> <td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="width: 52%; font-size: 10pt;">March 22, 2012</td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;">$</td> <td style="width: 12%; font-size: 10pt; text-align: right;">75,000</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;">$</td> <td style="width: 12%; font-size: 10pt; text-align: right;">1.50</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 12%; font-size: 10pt; text-align: right;">300,000</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-size: 10pt;">March 29, 2012</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;">$</td> <td style="font-size: 10pt; text-align: right;">60,000</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;">$</td> <td style="font-size: 10pt; text-align: right;">1.50</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; text-align: right;">240,000</td> <td style="font-size: 10pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="font-size: 10pt;">April 4, 2012</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;">$</td> <td style="font-size: 10pt; text-align: right;">50,000</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;">$</td> <td style="font-size: 10pt; text-align: right;">1.50</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; text-align: right;">200,000</td> <td style="font-size: 10pt; text-align: left;"> </td> </tr> </table>   ** Each unit consists of ten shares of the Company’s common stock and warrants to purchase six additional shares of the Company’s stock   As a result of the terms of the December Notes, we recognized a gain on the extinguishment of the debt due the fact that the present value of the cash flow of the old notes/December Notes and the new notes/February 2012 Notes being more than 10%. The face values of the notes were increased, as well as the interest rate increased from 8% to 10 and the maturity date was extended from 90 days to two years. As a result, a gain on the extinguishment of the debt of $211,419 was record to settle the December Notes. The face values of December Notes amount to $185,000 and accrued interest of $1,642. In addition, the Company wrote of the fair value allocated to the warrants issued with these notes from additional paid in capital for $71,225 along with the beneficial conversion features of $211,038 from additional paid in capital. Unamortized discount of $70,844 associated with the December Notes was recognized.   On February 9, 2012, we consummated a private placement of (i) $3,169,359 in principal amount of Notes (“February 2012 Notes”) which is inclusive of the modified December Notes and (ii) the February 2012 Warrants, consisting of (a) series A warrants to purchase an aggregate of 15,092,185 shares of common stock (the “Series A Warrants”) and (b) series B warrants to purchase an aggregate of 15,092,185 shares of common stock (the “Series B Warrants”) at a purchase price of $3,169,359 in a private placement to a group of institutional and accredited investors pursuant to a Securities Purchase Agreement, dated as of February 7, 2012. The Notes are convertible into shares of the Company’s common stock, and are entitled to earn interest which may be paid in cash or in shares of common stock. The February 2012 Warrants are exercisable into shares of common stock. The convertible shares are all subject to standard anti-dilution provisions.   The February 2012 Notes are two (2) year senior convertible notes with an aggregate principal amount of $3,169,359. The February 2012 Notes will accrue interest at a rate of ten percent (10%) per annum beginning on February 9, 2012, which will be paid on January 15, April 15, July 15 and October 15 of each year to the record note holder of each note. The interest accrued is payable in interest shares, although the Company may, at its option and upon written notice to each note holder of the February 2012 Notes, make such interest payments in cash or in a combination of cash and interest shares.   The Series A Warrants have a term of five (5) years from the Closing Date and the Series B Warrants have a term of seven (7) months from the Closing Date. Each of the Series A Warrants and the Series B Warrants is immediately exercisable upon issuance into an aggregate of 15,092,185 fully paid and non-assessable Exercise Shares at an initial exercise price of $.026 per share in the case of the Class A Warrants and $0.21 per share in the case of the Class B Warrants   The February 2012 Notes contain a standard “blocker” provision so that no holder shall have the right to convert any portion of its Convertible Notes to the extent that, after giving effect to such conversion, the note holder and its affiliates would beneficially own in excess of 4.99% of the number of shares of common stock outstanding immediately after giving effect to such conversion. By written notice to the Company, a holder may increase or decrease such percentage to any other percentage, provided that any such increase will not be effective until the sixty-first (61st) day after such notice is delivered and such percentage may not, in any event, exceed 9.99%.   Any note holder of the February 2012 Notes is entitled to convert the notes into conversion shares at any time by delivery of a notice of conversion to the Company. On or before the third trading day after receipt of the conversion notice, the Company must deliver to the note holder such number of conversion shares to which the note holder is entitled pursuant to the conversion. The number of conversion shares the note holder will receive upon conversion of the Notes will be determined by dividing the amount of principal being converted plus any accrued and unpaid interest by the conversion price effective at the time of the conversion. The February 2012 Notes have an initial conversion price of $0.21 however it is subject to reset depending on the filing of the registration statement. At no time, however, will the Conversion Price be reset below $0.12 per share as a result of a conversion price adjustment.   The Company received net proceeds in the amount of $2,391,500 after offering cost of $558,500 and non-cash settlement for the $219,359. In recording the transaction, the Company allocate the face value of the notes between the estimated the fair values of the February 2012 Notes, the Series A Warrants and Series B Warrants. As a result, the February 2012 Notes were discounted by $1, 421,848 for Series A Warrants and $892,776 Series B Warrants. The carrying value of the February 2012 Notes as of the day of the transaction amounted to $854,735. The Company also recorded a beneficial conversion feature of $4,729,374 representing the difference between the market value of the converted shares as of February 9, 2012 and the amount of the total proceeds allocated to the carrying value of the Notes. The beneficial conversion feature was expensed in the unaudited condensed consolidated statement of operation, as a result the February 2012 Notes being available for conversion 3 days after consummation of the agreement. The discount associated with Series A Warrant is amortized over the life of the note and the discount associated with Series B Warrants is amortized over six months as a result of that being exercisable in seven months.   In connection with the February 2012 Notes, the Company paid the placement agent, a placement fee of $236,000 and issued to the placement agent and its designees, the placement agent warrants, consisting of five-year warrants to purchase an aggregate of 1,366,868 shares of common stock at an exercise price of $0.26 per share and seven-month warrants to purchase an aggregate of 1,366,868 shares of common stock at an exercise price of $0.21 per share. The Company recorded an asset related to financing charge that will be amortized over life of the February 2012 Notes and seven months - to the extent that the financing charge relates to Series B Warrants which expire in seven months after the consummation date. Total deferred financing cost recorded in the balance sheet as of February 9, 2012 amounted to $1,406,885 of which $594,574 relates to fees paid in cash to the placement agent, attorneys and other third parties. Also include in the total deferred financing charge is $477,494 which represents fair value of the Series A Warrants issue to the placement agent and $299,818 relating to the fair value of Series B Warrants which were provided to the placement agent. As of March 31, 2012, deferred financing fees of $156,445 is charged to interest expense in the unaudited condensed consolidated statement of operation. As of March 31, 2012, short term deferred financing cost amounts to $778,028 and the remaining balance of $472,413 in recorded in other assets long term.    The fair value of each warrant on the date issued was estimated using the Black-Scholes valuation model. The following assumptions were used for the calculation of the warrants granted in September, October and December 2011.   <table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt; text-align: right;"> </td> <td style="font-size: 10pt; text-align: right;"> </td> <td style="font-size: 10pt; text-align: right;" colspan="2">11-Sep</td> <td style="font-size: 10pt; text-align: right;"> </td> <td style="font-size: 10pt; text-align: right;"> </td> <td style="font-size: 10pt; text-align: right;" colspan="2">11-Dec</td> <td style="font-size: 10pt; text-align: right;"> </td> <td style="font-size: 10pt; text-align: right;"> </td> <td style="font-size: 10pt; text-align: right;" colspan="2">12-Mar (A Warrants)</td> <td style="font-size: 10pt; text-align: right;"> </td> <td style="font-size: 10pt; text-align: right;"> </td> <td style="font-size: 10pt; text-align: right;" colspan="2">12-Mar (B Warrants)</td> <td style="font-size: 10pt; text-align: right;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="font-size: 10pt; text-align: left;">Expected term</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; text-align: right;">5 years</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; text-align: right;">5 years</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; text-align: right;">5 years</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; text-align: right;">6 months</td> <td style="font-size: 10pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="width: 36%; font-size: 10pt;">Expected average volatility</td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 12%; font-size: 10pt; text-align: right;">309%</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 12%; font-size: 10pt; text-align: right;">296%</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 12%; font-size: 10pt; text-align: right;">163.06%</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 12%; font-size: 10pt; text-align: right;">163.06%</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="font-size: 10pt; text-align: left;">Expected dividend yield</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; text-align: right;">0%</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; text-align: right;">0%</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; text-align: right;">0%</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; text-align: right;">0%</td> <td style="font-size: 10pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-size: 10pt; text-align: left;">Risk-free interest rate</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; text-align: right;">3.50%</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; text-align: right;">2.90%</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; text-align: right;">.82%</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; text-align: right;">.11%</td> <td style="font-size: 10pt; text-align: left;"> </td> </tr> </table>    The recorded discount on the convertible notes payable is being amortized to interest expense over the life of the note or seven months for the discount associated with Series B Warrants and is summarized as follows as of March 31, 2012.   <table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt; font-weight: bold; text-align: center;"> </td> <td style="font-size: 10pt; padding-bottom: 1pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="padding-bottom: 1pt; font-size: 10pt;"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="14">Debt Discount</td> <td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt; font-weight: bold; text-align: center;">Due Date</td> <td style="font-size: 10pt; font-weight: bold;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center;" colspan="2">Face Value</td> <td style="font-size: 10pt; font-weight: bold;"> </td> <td style="font-size: 10pt; font-weight: bold;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center;" colspan="2">Initial Value</td> <td style="font-size: 10pt; font-weight: bold;"> </td> <td style="font-size: 10pt; font-weight: bold;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center;" colspan="2">Amortization</td> <td style="font-size: 10pt; font-weight: bold;"> </td> <td style="font-size: 10pt; font-weight: bold;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center;" colspan="2">Discount</td> <td style="font-size: 10pt; font-weight: bold;"> </td> <td style="font-size: 10pt; font-weight: bold;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center;" colspan="2">Carrying Value</td> <td style="font-size: 10pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: right;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: right;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: right;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: right;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: right;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="width: 20%; font-size: 10pt;">February 4, 2014</td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;">$</td> <td style="width: 12%; font-size: 10pt; text-align: right;">3,169,359</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;">$</td> <td style="width: 12%; font-size: 10pt; text-align: right;">854,735</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;">$</td> <td style="width: 12%; font-size: 10pt; text-align: right;">(328,480</td> <td style="width: 1%; font-size: 10pt; text-align: left;">)</td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;">$</td> <td style="width: 12%; font-size: 10pt; text-align: right;">1,986,144</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;">$</td> <td style="width: 12%; font-size: 10pt; text-align: right;">1,183,215</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-size: 10pt;">September 9, 2012</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"></td> <td style="font-size: 10pt; text-align: right;">360,000</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"></td> <td style="font-size: 10pt; text-align: right;">264,514</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"></td> <td style="font-size: 10pt; text-align: right;">(50,633</td> <td style="font-size: 10pt; text-align: left;">)</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"></td> <td style="font-size: 10pt; text-align: right;">44,853</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"></td> <td style="font-size: 10pt; text-align: right;">315,147</td> <td style="font-size: 10pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="font-size: 10pt; padding-bottom: 1pt;">October 25, 2012</td> <td style="font-size: 10pt; padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: left;"></td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: right;">180,000</td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: left;"></td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: right;">133,948</td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: left;"></td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: right;">(18,941</td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left;">)</td> <td style="font-size: 10pt; padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: left;"></td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: right;">27,111</td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: left;"></td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: right;">152,890</td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-size: 10pt; padding-bottom: 1pt;"> </td> <td style="font-size: 10pt; padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: left;">$</td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: right;">3,709,359</td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: left;">$</td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: right;">1,253,197</td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: left;">$</td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: right;">(398,054</td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left;">)</td> <td style="font-size: 10pt; padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: left;">$</td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: right;">2,058,108</td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: left;">$</td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: right;">1,651,252</td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left;"> </td> </tr> </table>

<table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.25in; font-weight: bold; text-align: justify;">8.</td> <td style="font-weight: bold; text-align: justify;">RELATED PARTY TRANSACTIONS</td> </tr> </table>   The Company operated as a BDC until it withdrew its election to be treated as a BDC on January 20, 2009. While operating as a BDC, a part of its operations and consistent with the operating parameters of a BDC, the Company developed a number of relationships with its portfolio company investments, including members of the Company’s board of directors becoming officers and directors of its portfolio company investments. The Company made loans to the portfolio companies and entered into management agreements with the portfolio companies. As a result of operating as a BDC and then converting to an operating company, a number of its previous relationships were originally required to be categorized as related party transactions. As a result of changes in relationships, with the Company no longer being actively involved in the operation of the investments, these investments are no longer considered related party transactions. Other related party amounts and transactions are described as follows: While operating as a BDC the Company had management contracts and made loans to its 60% owned subsidiary USN. These transactions are eliminated in consolidation with USN.   Related party amounts included in the balance sheet may be summarized as follows:   Accounts payable - related parties:   <table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt; font-weight: bold; text-align: center;"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">March 31, 2012</td> <td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold;"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">September 30, 2011</td> <td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="width: 68%; font-size: 10pt; text-align: left;">Hank Durschlag</td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;">$</td> <td style="width: 12%; font-size: 10pt; text-align: right;">16,178</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> <td style="width: 2%; font-size: 10pt;"> </td> <td style="width: 1%; font-size: 10pt; text-align: left;">$</td> <td style="width: 12%; font-size: 10pt; text-align: right;">16,178</td> <td style="width: 1%; font-size: 10pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-size: 10pt; text-align: left;">Rubin Hanan</td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; text-align: right;">5,706</td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; text-align: right;">-</td> <td style="font-size: 10pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt;">Aitan Zacharin</td> <td style="font-size: 10pt; padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: left;"> </td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: right;">13,465</td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: left;"> </td> <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: right;">12,554</td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-size: 10pt; padding-bottom: 2.5pt;"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt;"> </td> <td style="border-bottom: black 2.5pt double; font-size: 10pt; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; font-size: 10pt; text-align: right;">35,349</td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left;"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt;"> </td> <td style="border-bottom: black 2.5pt double; font-size: 10pt; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; font-size: 10pt; text-align: right;">28,732</td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left;"> </td> </tr> </table>   Hank Durschlag is a former officer and director in Double Eagle Holdings, LTD. Mr. Durschlag is not involved in any operational matters related to Fuse Science and these payments relate to remaining obligations to him in his former capacity. Rubin Hanan is a shareholder, the Company’s President and Chief Operating Officer and, effective March 14, 2011, a director. Aitan Zacharin is a shareholder, the Company’s Chief Marketing Officer and Chief Information Officer and a director.   Transactions with related parties in the statement of operations for the three months ended March 31, 2012 and September 30, 2011 include:   <table style="width: 100%; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td>   </td> <td style="font-weight: bold;"> </td> <td style="border-bottom: black 1pt solid; font-weight: bold; text-align: center;" colspan="2">2012</td> <td style="font-weight: bold;"> </td> <td style="font-weight: bold;"> </td> <td style="border-bottom: black 1pt solid; font-weight: bold; text-align: center;" colspan="2">2011</td> <td style="font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="width: 69%; padding-left: 9pt;">Prior CEO compensation</td> <td style="width: 1%;"> </td> <td style="width: 2%;">$</td> <td style="width: 9%; text-align: right;">10,000</td> <td style="width: 1%;"> </td> <td style="width: 2%;"> </td> <td style="width: 2%;">$</td> <td style="width: 11%; text-align: right;">3,000</td> <td style="width: 3%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="padding-left: 9pt;">New officer compensation</td> <td style="padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; padding-bottom: 1pt; padding-left: 9pt;"> </td> <td style="border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: right;">59,000</td> <td style="padding-bottom: 1pt;"> </td> <td style="padding-left: 9pt;"> </td> <td style="border-bottom: black 1pt solid;"> </td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="padding-bottom: 1pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="padding-bottom: 2.5pt;"> </td> <td style="padding-bottom: 2.5pt;"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 2.5pt;">$</td> <td style="border-bottom: black 2.25pt double; padding-bottom: 2.5pt; text-align: right;">69,000</td> <td style="padding-bottom: 2.5pt;"> </td> <td style="padding-bottom: 2.5pt;"> </td> <td style="border-bottom: windowtext 1.5pt double;">$</td> <td style="border-bottom: windowtext 1.5pt double; text-align: right;">3,000</td> <td style="padding-bottom: 2.5pt;"> </td> </tr> </table>

3597

70320

778029

472413

300

339434

-680711-4938896

-5866

-5867

0 0 300 82740 -83040 0 0 300000 444303407917444303400000007917601

24174

18308

29673

178702

3000

6000

30425

156445

70320

300

629574

0 620867 620867 2. GOING CONCERN   The Company has not established sources of revenue sufficient to fund the development of business, projected operating expenses and commitments for the next twelve months. The Company had a net loss from operations of $7,369,773 and recognized an unrealized loss on investments of $4,520 resulting in a comprehensive loss of $7,374,293 during the three months ended March 31, 2012. Included in this loss, the Company recorded non-cash compensation of $1,113,256 which relates to contracts entered into by the Company for current and future services undertaken for marketing and promotional activities by brand athletes through endorsement contracts, as well as contracts with consultants to provide professional services and employment contract with the Company’s key employees. At March 31, 2012, current assets are $2,530,273 and current liabilities are $890,304.   The Company intends to continue to raise necessary capital from different financing sources including private placements of its restricted securities, including common stock and convertible notes. The Company has demonstrated an ability to raise funds as needed to fund operations and investments. During the quarter ended March 31, 2012, the Company issued 10% secured senior convertible promissory note in the amounts of $3,169,359 (“February 2012 Notes”). The February 2012 Notes include two sets of Warrants-A and Warrants-B. Warrants-A are five-year warrants to purchase 15,092,186 shares of the common stock at $.26 per share. Warrants-B note are seven-months warrants to purchase 15,092,186 shares of the common stock at $.21 per share. The warrants are subjected to certain price adjustment based on subsequent issuance of additional convertible notes and mandatory conversion if the market value of the Company’s common stock exceeds 250% for 20 consecutive days.   In December 2011, the Company also issued two 90-Day 8% Senior Subordinated Convertible Promissory Notes with Subscription Options (the “December Notes”) in the amounts of $75,000 and $60,000. An additional December Note in the principal amount of $50,000 was issued in January 2012. These notes were extinguished as a result of being rolled into the February 2012 Notes with additional principal of 15% of the face value of the note. In the event the Company did not undertake the subsequent financing, the December Notes with accrued interest would convert into Units consisting of 10 shares of the Company’s common stock and warrants to purchase an additional six shares of the Company’s common stock. The number of units issuable upon the conversion would be equal to the value of note plus accrued interest divided by $1.50. If the subsequent financing did not take place, the December Notes would include five-year warrants to purchase 300,000 and 240,000 shares of common stock respectively at a price of $0.18 per share. However, the December Notes were converted in to subscriptions for the securities sold in the subsequent financing. There can be no assurance in any case that the Company will secure sufficient funding to fully implement the Company’s business plan.   These conditions raise serious doubt about the Company’s ability to continue as a going concern. <div> <table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.25in;">4.</td> <td>DISTRIBUTION AGREEMENT</td> </tr> </table> </div> <div>   </div> <div> On February 27, 2012, we entered into licensing and distribution agreements with Mission Product Holdings, Inc. (“Mission”), who develops, manufactures and markets the Mission Athletecare™ line of skincare products. Pursuant to the license agreement, Fuse granted Mission a restricted license to use Fuse’s proprietary transdermal delivery technology in connection with the development, manufacture and marketing of Mission Athletecare™ skincare products. Under the distribution agreement, Mission has agreed to offer for sale and distribute Fuse’s line of existing and planned sports nutrition products to a network of food, drug and sporting goods retailers that currently carry the Mission brand. </div> <div>   </div> <div> As part of the distribution agreement, the Company will make sales to Mission at an agreed upon price. The Company agrees that should it sell the products directly to the consumers at a price less than the agreed price, the charge to Mission be reduced so that Mission will be less than the lowest price being charged by the Company to consumers for the remainder of the term, Furthermore, the Company will pay Mission a one-time bonus of $50,000 for purchases in excess of $2,000,000, incremental to the first $150,000 and $25,000 for every $1,000,000 in purchases made thereafter. The $650,000 paid to Mission as part of this agreement is included in prepaid assets on the balance sheet as of March 31, 2012 and will be amortized to marketing expense over the next ten months. As March 31, 2012, the prepaid balance amounted to $585,000. </div> <div>   </div> <div> In addition to the foregoing, Mission granted warrants to the Company to acquire a minority equity position in Mission. Should the Company exercise these warrants, the Company will account for the investment at cost as a result of not having significant influence over Mission. </div> <table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.25in; font-weight: bold; text-align: justify;">7.</td> <td style="font-weight: bold; text-align: justify;">WARRANT EXERCISES</td> </tr> </table>   In January 2012, we entered into agreements with holders of outstanding warrants to purchase 3,583,333 shares of our common stock at an exercise price of $0.12 per share. These warrants were originally issued with our first round of private financing completed in May and June 2011. Pursuant to these agreements (i) such holders agreed to exercise their warrants for cash, (ii) we agreed to (a) issue to each of such holders an additional five (5) year warrant entitling them to purchase a number of shares equal to that acquired upon exercise of their Initial Warrants at an exercise price of $0.25 per share (the “ January 2012 Warrants ”) and (b) grant them certain registration rights under the Securities Act of 1933 with respect to the shares issued upon exercise of the Initial Warrants and issuable upon exercise of the January 2012 Warrants. The January 2012 Warrants also provides for cashless exercise and for anti-dilution adjustments in the event of stock dividends, stock splits, recapitalizations and similar transactions. The January 2012 Warrants generated gross proceeds of $430,000. The Company recorded the cash receive of $430,000 and a discount of $847,034 as the difference between the fair value of the new warrants of $1,337,086 issued and the shares that were delivered to the investor as a result of exercising the warrants. The discount associated with the new issue will be amortized over the life of the new warrants. For the period ended March 31, 2012, amortization of $38,253 is charged to interest expense in the unaudited condensed consolidated statement of operation.   In addition to the January 2012 warrants, we had cashless exercises of warrants for 1,644,268 shares. As a result of the shares being exercised, we adjust the additional paid in capital for the value of the warrants exercised.

430000

-0.06

4430 55330 0 EX-101.CAL 6 deghpk-20120331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 7 deghpk-20120331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 8 deghpk-20120331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Doucument and Entity Information [Abstract] Doucument and Entity Information [Abstract] Document and Entity Information. Statement [Table] Statement [Table] Statement [Line Items] Statement [Line Items] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Trading Symbol Trading Symbol Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Statement Of Financial Position [Abstract] Statement of Financial Position [Abstract] Assets [Abstract] ASSETS Cash and Cash Equivalents, At Carrying Value Cash and cash equivalents Cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Accounts Receivable, Net, Current Accounts receivable Inventory, Net Inventory Prepaid Expense, Current Prepaid expenses Prepaid expenses Deferred Finance Costs, Current, Net Deferred financing costs Assets, Current Total current assets Total current assets Assets, Noncurrent [Abstract] Other assets: Available For Sale Securities Fair Value Disclosure Affliates Available-for-sale investments Deferred Finance Costs, Noncurrent, Net Deferred financing costs Capitalized Computer Software, Net IT Property, net Property, Plant and Equipment, Net Intellectual property, net Intellectual property, net Assets, Noncurrent Total other assets Total other assets Assets Total assets Total assets Liabilities and Stockholders Equity [Abstract] LIABILITIES AND STOCKHOLDERS' DEFICIT Accounts Payable, Current Accounts payable Accounts Payable, Current, Total Accounts Payable, Related Parties, Current Accounts payable - related parties Deferred Revenue, Current Deferred sales Notes Payable, Current Convertible notes payable, net Accrued Liabilities, Current Accrued expenses Accrued expenses Liabilities, Current Total current liabilities Total current liabilities Convertible Notes Payable, Current Convertible note payable, net Commitments and Contingencies Commitments and contingencies Stockholders Equity, Including Portion Attributable To Noncontrolling Interest [Abstract] STOCKHOLDERS' DEFICIT Preferred Stock, Value, Issued Preferred stock, $0.001 par value; authorized 10,000,000 shares; no shares issued and outstanding; $100 per share liquidation preference Preferred Stock, Value, Issued, Total Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Ending Balance Common Stock, Value, Issued Common stock, $.001 par value; authorized 400,000,000 shares; 119,982,297 and 93,612,039 shares issued and outstanding at March 31, 2012 and September 30, 2010, respectively Common Stock, Value, Issued, Total Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Ending Balance Additional Paid In Capital Additional paid-in capital Additional Paid in Capital, Total Additional Paid in Capital, Beginning Balance Additional Paid in Capital, Ending Balance Intrinsic Value Of Stock Options Stock options The carrying amount of the intrinsic value of stock option as of the balance sheet date. Stockholders Equity Attributable To Noncontrolling Interest Non-controlling interest Stockholders' Equity Attributable to Noncontrolling Interest, Total Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance Deferred Consulting Fees Prepaid consulting fees Deferred consulting fees Sum of the carrying amounts as of prepaid consulting fees as of the balance sheet date. Accumulated Other Comprehensive Income (Loss), Net Of Tax Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance Retained Earnings (Accumulated Deficit) [Abstract] Accumulated deficit: Development Stage Enterprise, Deficit Accumulated During Development Stage During the development stage During the development stage Retained Earnings, Unappropriated Other Other Retained Earnings (Accumulated Deficit) Total accumulated deficit Total accumulated deficit Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Ending Balance Stockholders Equity, Including Portion Attributable To Noncontrolling Interest Stock options Total stockholders' deficit Balance Balance Liabilities and Stockholders Equity Total liabilities and stockholders' deficit Total liabilities and stockholders' deficit Balance Sheets Parenthetical [Abstract] Balance Sheets Parenthetical [Abstract] Preferred Stock, Par Or Stated Value Per Share Preferred stock, par value (in dollars per share) Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Issued, Total Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Liquidation Preference Per Share Preferred stock, liquidation preference per share (in dollars per share) Common Stock, Par Or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Issued, Total Common Stock, Shares, Outstanding Common stock, shares outstanding Common Stock, Shares, Outstanding, Beginning Balance Common Stock, Shares, Outstanding, Ending Balance Income Statement [Abstract] Income Statement [Abstract] Revenues [Abstract] Revenue Sales Revenue, Goods, Net Sales, net Revenue From Related Parties Management income - affiliate Management income - related party Revenues Total income Total income Cost Of Revenue Cost of sales Cost of sales Gross Profit Gross Profit Gross Profit Costs and Expenses [Abstract] Expenses: Costs and Expenses, Related Party Related party services General and Administrative Expense General and administrative expense General and administrative expense Costs and Expenses Total expenses Total expenses Operating Income (Loss) Loss from operations Loss from operations Nonoperating Income (Expense) [Abstract] Other income (expense): Interest Income Related Party Interest and other income Amount of interest income earned from related party by the entity during the period. Interest Expense, Related Party Interest expense Interest expense Beneficial Conversion Feature Of Convertible Notes Payable Beneficial conversion feature of convertible notes payable Beneficial conversion feature Realized Gain (Loss) Related Party Realized loss This item represents the gain (loss) realized during the period from the sale of securities of a related party. Marketable Securities, Realized Gain (Loss), Other Than Temporary Impairments, Amount Other than temporary decline in available-for-sale securities Other than temporary decline in available-for-sale securities Other than temporary decline in available-for-sale securities Gains (Losses) On Extinguishment Of Debt Gain on extinguishment of debt Gain from extinguishment of debt Nonoperating Income (Expense) Other income (expense) Other expense Net Income (Loss), Including Portion Attributable To Noncontrolling Interest Net loss Loss before non-controlling interest Loss before non-controlling interest Net Income (Loss) Attributable To Noncontrolling Interest Non-controlling interest Net Income (Loss) Attributable to Noncontrolling Interest, Total Non-controlling interest Non-controlling interest Net Income (Loss) Attributable To Parent Net loss Net loss Net loss Earnings Per Share, Basic and Diluted Loss per share, basic and diluted (in dollars per share) Loss per share, basic and diluted (in dollars per share) Loss per share, basic and diluted Weighted Avergage Number Of Shares Outstanding Basic and Diluted Weighted average shares outstanding (in shares) Weighted average shares outstanding (in shares) Number of [basic] shares, after adjustment for contingently issuable shares and other shares not deemed outstanding, determined by relating the portion of time within a reporting period that common shares have been outstanding to the total time in that period. Also includes, the average number of shares issued and outstanding that are used in calculating diluted EPS, determined based on the timing of issuance of shares in the period. Other Comprehensive Income, Available-For-Sale Securities Adjustment, Net Of Tax, Portion Attributable To Parent Unrealized (loss) gain on available-for-sale securities (none attributed to the non-controlling interest) Unrealized gain (loss) on available-for-sale securities (none attributed to the non-controlling interest) Comprehensive Income, Net Of Tax, Including Portion Attributable To Noncontrolling Interest Net comprehensive loss Net comprehensive loss Statement Of Stockholders Equity [Abstract] Statement of Stockholders' Equity [Abstract] Statement, Equity Components [Axis] Statement, Equity Components [Axis] Preferred Stock [Member] Preferred Stock [Member] Common Stock [Member] Common Stock [Member] Additional Paid-In Capital [Member] Additional Paid-in Capital [Member] Intrinsic Value of Common Stock Options [Member] Noncontrolling Interest [Member] Noncontrolling Interest [Member] Deferred Compensation, Share-Based Payments [Member] Deferred Compensation, Share-based Payments [Member] Accumulated Other Comprehensive Income (Loss) [Member] Accumulated Other Comprehensive Income (Loss) [Member] Accumulated Deficit Development Stage [Member] Accumulated Deficit Development Stage [Member] Accumulated Deficit Other [Member] Accumulated Deficit Other [Member] Shares, Outstanding Balance (in shares) Balance (in shares) Balance (in shares) Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders Noncontrolling interest Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) On Securities Arising During Period, Net Of Tax Unrealized loss from available-for-sale securities Stock Issued Or Granted During Period, Share-Based Compensation [Abstract] Common stock issued for: Stock Issued During Period, Value, Share-Based Compensation, Net Of Forfeitures Services Services Stock Issued During Period, Shares, Share-Based Compensation, Net Of Forfeitures Services (in shares) Services (in shares) Stock Issued During Period, Value, Conversion Of Convertible Securities Convertible notes payable Stock Issued During Period, Shares, Conversion Of Convertible Securities Convertible notes payable (in shares) Stock Issued During Period, Value, Acquisition Of License License Value of stock issued during period towards acquisition of license. Stock Issued During Period, Shares, Acquisition Of License License (in shares) Number of shares issued during period towards acquisition of license. Stock Issued During Period, Value, Acquisitions Acquisition of FS Research and Development, Inc. Stock Issued During Period, Shares, Acquisitions Acquisition of FS Research and Development, Inc. (in shares) Stock Issued During Period Value Deferred Consulting Fees Deferred consulting fees Value of stock issued during the period for settlement of deferred consulting fees. Stock Issued During Period Shares Deferred Consulting Fees Deferred consulting fees (in shares) Number of shares issued during the period for settlement of deferred consulting fees. Adjustments To Additional Paid In Capital [Abstract] Convertible notes payable: Stock Issued During Period Value Detachable Warrants Detachable warrants Value of stock issued during the period for detatchable warrants. Stock Issued During Period Shares Detachable Warrants Detachable warrants (in shares) Number of shares issued during the period for detatchable warrants. Adjustments To Additional Paid In Capital, Warrant Issued Detachable warrants Adjustments To Additional Paid In Capital, Convertible Debt With Conversion Feature Beneficial conversion feature Share Based Compensation Arrangement By Share Based Payment Award Stock Options Grants In Period Stock options granted The value of stock options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Intrinsic Value Of Stock Options Amortized Amortize stock options The equity impact of the intrinsic value of stock options amortized during the year. Deferred Consulting Fees Amortized Amortize deferred consulting The equity impact of amortized value of deferred consulting fees during the period. Statement Of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Net Cash Provided By (Used In) Operating Activities [Abstract] Operating activities: Adjustments To Reconcile Net Income (Loss) To Cash Provided By (Used In) Operating Activities [Abstract] Adjustments to reconcile net increase (decrease) in net assets from operations to net cash used in operating activities: Amortization Intellectual property Amortization Of Deferred Revenue Deferred consulting fees Amount of deferred revenue amortized during the period adjusted to the earning. Intrinsic Value Of Common Stock Options Stock options The intrinsic value of common stock options during the reporting period. Paid-In-Kind Interest Interest settled with common stock Amortization Of Financing Costs Deferred financing cost Issuance Of Stock and Warrants For Services Or Claims Common stock issued for services Convertible Notes Payable [Abstract] Convertible notes payable: Amortization Of Detachable Warrants Amortization of detachable warrants Amount of detachable warrants amortized during the period adjusted to the earnings. Gain (Loss) On Sale Impairment Of Investment In Related Party Investment received for management services The net realized gain (loss) on sale/impairment of investments in related party sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities. Investment received for management services Interest Income, Operating Accrued interest income Accrued interest income Gain (Loss) On Sale Of Investments Gain on sale of investment Gain on sale of investment Increase (Decrease) In Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) In Due From Related Parties, Current Accounts receivable and accrued interest - related parties Increase (Decrease) in Due from Related Parties, Current, Total Accounts receivable and accrued interest - related parties Increase (Decrease) In Inventories Inventory Inventory Increase (Decrease) In Prepaid Expense Prepaid expenses Prepaid expenses Increase (Decrease) In Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Increase (Decrease) In Due To Related Parties, Current Accounts payable and accrued expenses - related parties Increase (Decrease) in Deferred Revenue Deferred sales Proceeds From Related Party Debt Advances from related parties for working capital Advances from related parties for working capital Net Cash Provided By (Used In) Operating Activities Net cash used in operating activities Net cash used in operating activities Net Cash Provided By (Used In) Investing Activities [Abstract] Investing activities: Payments For (Proceeds From) Investments Proceeds from investments Proceeds from investments Proceeds from investments Payments For Software Additions to IT assets Additions to IT assets Payments To Acquire Intangible Assets Intellectual property Intellectual property Net Cash Provided By (Used In) Investing Activities Net cash (used in) provided by investing activities Net cash (used in) provided by investing activities Net Cash Provided By (Used In) Financing Activities [Abstract] Financing activities: Proceeds From Short-Term Debt Loan proceeds Repayments Of Short-Term Debt Loan repayment Loan repayment Proceeds From Warrant Exercises Proceed from warrants exercise Payments Of Financing Costs Financing fees Financing fees Net Cash Provided By (Used In) Financing Activities Net cash provided by (used in) financing activities Net cash provided by (used in) financing activities Cash and Cash Equivalents, Period Increase (Decrease) Net increase (decrease) in cash and cash equivalents Net increase (decrease) in cash and cash equivalents Supplemental Cash Flow Information [Abstract] Supplemental Cash Flow Information: Comon Stock Issued For Convertible Notes Payable and Accrued Interest Common stock issued for convertible notes payable and accrued interest The fair value of stock issued for convertible notes payable and accrued interest in noncash financing activities. Note Payable Issued To Acquire Investment Notes payable issued to acquire investment The fair value of notes issued to acquire investments in noncash investing and financing activities. Warrants Issued For Financing Fees Warrant issued for financing fees The value of warrants issued for financing fees in noncash investing or financing activities. Common Stock Issued For License Common stock issued for license The fair value of stock issued for license in noncash financing activities. Common Stock Issued To Acquire Fuse Science Inc. Common stock issued to acquire Fuse Science, Inc. The fair value of stock issued to acquire Fuse Science, Inc. in noncash financing activities. Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation Of Financial Statements Disclosure [Text Block] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Going Concern [Abstract] Going Concern [Abstract] Going Concern [Text Block] The entire disclosure about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). Going Concern [Text Block] Investments Disclosure [Abstract] Investments Disclosure [Abstract] Investments Disclosure [Text Block] Investments Disclosure [Text Block] The entire disclosure of investments. This may consist of investments in certain debt and equity securities, short-term investments and other assets. Distribution Agreement [Abstract] Distribution Agreement [Abstract] Distribution Agreement [Text Block] The entire disclosure for distribution agreement. Distribution Agreement [Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Intangible Assets Disclosure [Text Block] Intangible Assets Disclosure [Text Block] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Debt Disclosure [Text Block] Debt Disclosure [Text Block] Warrant Exercises [Abstract] Warrant Exercises [Abstract] Warrant Exercises [Text Block] The entire disclosure for warrant exercises. Warrant Exercises [Text Block] Related Party Transactions [Abstract] Related Party Transactions [Abstract] Related Party Transactions Disclosure [Text Block] Related Party Transactions Disclosure [Text Block] Equity [Abstract] Equity [Abstract] Stockholders Equity Note Disclosure [Text Block] Stockholders' Equity Note Disclosure [Text Block] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Disclosure [Text Block] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] Fair Value Disclosures [Text Block] Comprehensive Income, Net Of Tax, Attributable To Parent [Abstract] Other comprehensive income Equity Component [Domain] Equity Component [Domain] Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Non-cash investing and financing activities: Other Than Temporary Decline In Available For Sale Securities Other than temporary decline in available-for-sale securities This element represents the amount of loss recognized for other than temporary impairments (OTTI) decline in available-for-sale securities. EX-101.PRE 9 deghpk-20120331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 R9.htm IDEA: XBRL DOCUMENT

INVESTMENTS

6 Months Ended

Mar. 31, 2012

Investments Disclosure [Abstract]

Investments Disclosure [Text Block]

3.	INVESTMENTS

			Unrecognized
			Holding			Fair
	Cost		Gains (Losses)			Value
March 31, 2012
Efftec International, Inc.	$	4,200	$	(2,400	)	$	1,800
North American Energy		1,530		10,710			12,240
	$	5,730	$	8,310		$	14,040

September 30, 2011
Efftec International, Inc.	$	4,200	$	(2,000	)	$	2,200
North American Energy		1,530		4,590			6,120
	$	5,730	$	2,590		$	8,320

Fair value for both available-for-sale securities is based on level one inputs, the posted bid/last trading price on March 30, 2012 and September 31, 2011.

EXCEL 12 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\W960U-C%F8U]D8S5D7S0V-F9?86(U-5\X,&0T M-F,V-F1B,S0B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;G-O;&ED871E9%]3=&%T96UE;G1S7V]F7T-H M83PO>#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I% M>&-E;%=O#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/E=!4E)!3E1?15A%4D-)4T53/"]X.DYA;64^ M#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T M/@T*("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!296=I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M2!#;VUM;VX@4W1O8VLL(%-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^,C`Q,CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'!E;G-E M'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2P@;F5T M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,RPP-C(\6%B;&4@+2!R96QA=&5D('!A6%B;&4L(&YE=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W960U-C%F8U]D8S5D M7S0V-F9?86(U-5\X,&0T-F,V-F1B,S0-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO-V5D-38Q9F-?9&,U9%\T-C9F7V%B-35?.#!D-#9C-C9D8C,T M+U=O'0O M:'1M;#L@8VAAF5D/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PP,#`L,#`P/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%SF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XT,#`L,#`P+#`P,#QS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S2!D96-L:6YE(&EN M(&%V86EL86)L92UF;W(M'!E;G-E/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@U+#4Q,RPX.3DI/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$F5D(&QO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F4@9&5F97)R960@ M8V]N'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%SF4@6%B;&4\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAAF%T:6]N(&]F(&1E=&%C:&%B M;&4@=V%R'!E;G-E6UE;G0\+W1D/@T*("`@("`@ M("`\=&0@8VQA&5R8VES93PO=&0^#0H@("`@("`@(#QT M9"!C;&%S2`H=7-E9"!I;BD@9FEN86YC M:6YG(&%C=&EV:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA6%B;&4@86YD(&%C8W)U960@:6YT97)E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879AF%T:6]N+"!#;VYS;VQI9&%T:6]N(&%N9"!0'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'1A8FQE('-T>6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P+C(U M:6X[)SX\9F]N="!S:7IE/3-$,B!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE MF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;BQT:6UEF4],T0R('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;BQT:6UE6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O M;6%N+"!T:6UE'0M:6YD96YT M.B`P+C5I;CLG/CQF;VYT('-I>F4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;BQT:6UE6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C(U:6X[)SX\9F]N="!S:7IE/3-$,B!S='EL93TS1"=F M;VYT+69A;6EL>3IT:6UE2!W87,@;W)I9VEN86QL>2!I;F-O3IT:6UE3L@=&5X="UI;F1E;G0Z(#`N,C5I;CLG/CQF;VYT('-I>F4],T0R('-T>6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;BQT:6UE6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@ M;F5W(')O;6%N+"!T:6UE'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;CLG/CQF;VYT('-I M>F4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;BQT M:6UE6QE/3-$)V9O;G0Z(#$P M<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE3IT:6UE M3LG/CQF;VYT('-I>F4],T0R('-T>6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;BQT:6UE6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T M:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C(U:6X[)SX\9F]N="!S:7IE/3-$,B!S='EL M93TS1"=F;VYT+69A;6EL>3IT:6UE2!T:&4@ M0V]M<&%N>2!I;B!A8V-O2!G96YE"!M M;VYT:',@96YD960@36%R8V@@,S$L(#(P,3(@87)E(&YO="!N96-E2!I;F1I8V%T:79E(&]F('1H92!R97-U;'1S('1H870@;6%Y(&)E(&5X<&5C M=&5D(&9O3LG M/CQF;VYT('-I>F4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;BQT:6UE3LG/CQF;VYT('-I>F4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;BQT:6UE6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C(U:6X[)SX\9F]N="!S:7IE/3-$,B!S='EL93TS1"=F;VYT M+69A;6EL>3IT:6UE'!E;G-E3L@=&5X="UI;F1E;G0Z(#`N,C5I M;CLG/CQF;VYT('-I>F4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;BQT:6UE6QE M/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE3IT:6UE6QE/3-$)V9O;G0Z(#$P M<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE3IT:6UE M3L@ M=&5X="UI;F1E;G0Z(#`N,C5I;CLG/CQF;VYT('-I>F4],T0R('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;BQT:6UE"!M;VYT:',@=&AE;B!E;F1E9"X\+V9O;G0^/"]F;VYT/CPO M<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,-"B!N97<@3L@=&5X="UI;F1E;G0Z(#`N,C5I;CLG/CQF;VYT('-I>F4],T0R('-T M>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;BQT:6UE6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@ M;F5W(')O;6%N+"!T:6UE'0M M86QI9VXZ(&IU6QE/3-$ M)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT M.B`R-"XU<'0[)SX\9F]N="!S:7IE/3-$,B!S='EL93TS1"=F;VYT+69A;6EL M>3IT:6UE2!O8G-O;&5S8V5N8V4@ M87)E(&1E=&5R;6EN960@8F%S960@=7!O;B!T:&4@F4],T0R('-T>6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;BQT:6UE6QE/3-$)V9O;G0Z(#$P<'0@=&EM M97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C(U:6X[)SX\9F]N M="!S:7IE/3-$,B!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE3L@ M=&5X="UI;F1E;G0Z(#`N,C5I;CLG/CQF;VYT('-I>F4],T0R('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;BQT:6UE6QE/3-$)V9O;G0Z(#$P<'0@'0M:6YD96YT.B`M,"XR-6EN.R<^ M/&9O;G0@6QE M/3-$)VUA6QE/3-$ M)W=I9'1H.B`P+C5I;CLG/CPO=&0^#0H\=&0@6QE/3-$)V9O;G0M9F%M:6QY.B!S>6UB;VP[.R!F M;VYT+69A;6EL>3IT:6UEF4],T0R/B8C M,3@S.SPO9F]N=#X\+W1D/@T*/'1D/CQF;VYT('-I>F4],T0R('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;BQT:6UEF5D(&=A:6YS(&%N9"!L;W-S97,@:6YC;'5D960@:6X@96%R;FEN9W,[/"]F M;VYT/CPO=&0^#0H\+W1R/@T*/"]T86)L93X-"CQT86)L92!S='EL93TS1"=M M87)G:6XM=&]P.B`P<'0[('=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;BP@=&EM97,L('-E6QE M/3-$)W9E6QE/3-$)W=I9'1H.B`P+C(U:6X[ M)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@3IT:6UEF5D(&=A:6YS(&%N9"!L;W-S97,L(&YE="!O9B!A<'!L:6-A8FQE M(&1E9F5R6QE/3-$)W9E6QE/3-$)W=I9'1H.B`P+C(U:6X[)SX\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3H@3IT:6UE3IT:6UE2!O'!E;G-E(&9O2!S=6-H(&%R3L@=&5X="UI;F1E;G0Z(#`N,C5I;CLG/CQF;VYT('-I>F4] M,T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;BQT:6UE M6QE/3-$)V9O;G0Z(#$P<'0@ M=&EM97,@;F5W(')O;6%N+"!T:6UE3IT:6UE3IT M:6UEF5D(&]N(&$@6QE/3-$)V9O;G0Z(#$P<'0@ M=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C(U:6X[)SX\ M9F]N="!S:7IE/3-$,B!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE2!A M6EN9R!A;6]U;G0@;V8@=&AE(&%S M'!E8W1E9"!F=71U2!T:&4@87-S970N($EF('-U8V@@87-S M971S(&%R92!C;VYS:61E3LG/CQF;VYT('-I>F4],T0R('-T>6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;BQT:6UE6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W M(')O;6%N+"!T:6UE'0M86QI M9VXZ(&IU3L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^/&9O;G0@3L@=&5X="UI;F1E;G0Z(#`N,C5I;CLG M/CQF;VYT('-I>F4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;BQT:6UE&-H86YG M960@:6X@82!C=7)R96YT('1R86YS86-T:6]N(&)E='=E96X@:VYO=VQE9&=E M86)L92P@=VEL;&EN9R!P87)T:65S+B!!(&QI86)I;&ET>28C.#(Q-SMS(&9A M:7(@=F%L=64@:7,@9&5F:6YE9"!A2!W:71H('1H92!C6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W M(')O;6%N+"!T:6UE'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;CLG/CQF;VYT('-I>F4] M,T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;BQT:6UE M6QE/3-$)V9O;G0Z M(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU3IT:6UE6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T M:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C(U:6X[)SX\9F]N="!S:7IE/3-$,B!S='EL M93TS1"=F;VYT+69A;6EL>3IT:6UE3IT:6UE"!M;VYT:"!E;F1E9"!-87)C:"`S,2P@,C`Q,2!T;R!C M;VYF;W)M('1O('1H92!-87)C:"`S,2P@,C`Q,B!P3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\W960U-C%F8U]D8S5D7S0V-F9?86(U-5\X,&0T-F,V-F1B,S0- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-V5D-38Q9F-?9&,U9%\T M-C9F7V%B-35?.#!D-#9C-C9D8C,T+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@ M;F5W(')O;6%N+"!T:6UE'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C(U:6X[)SY4:&4@0V]M M<&%N>2!H87,@;F]T(&5S=&%B;&ES:&5D('-O=7)C97,@;V8@'0@='=E;'9E(&UO;G1H2!R96-O28C.#(Q-SMS(&ME M>2!E;7!L;WEE97,N($%T($UA3L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P M/@T*/'`@3L@=&5X="UI;F1E;G0Z(#`N,C5I;CLG/E1H92!#;VUP86YY(&EN=&5N9',@ M=&\@8V]N=&EN=64@=&\@2!N;W1E(&EN('1H92!A;6]U;G1S(&]F("0S M+#$V.2PS-3D@*"8C.#(R,#L\8CY&96)R=6%R>2`R,#$R($YO=&5S/"]B/B8C M.#(R,3LI+B!4:&4@1F5B65A3L@=&5X="UI;F1E;G0Z(#`N,C5I M;CLG/DEN($1E8V5M8F5R(#(P,3$L('1H92!#;VUP86YY(&%L28C.#(Q-SMS(&-O;6UO;B!S=&]C:RX@5&AE(&YU;6)E2!A="!A('!R:6-E(&]F("0P+C$X('!E2!C87-E('1H870@=&AE($-O;7!A;GD@=VEL;"!S96-U28C M.#(Q-SMS(&)U3L@=&5X="UI;F1E;G0Z(#`N-6EN M.R<^)B,Q-C`[/"]P/@T*/'`@3L@=&5X="UI;F1E;G0Z(#`N,C5I;CLG/E1H97-E(&-O M;F1I=&EO;G,@28C.#(Q-SMS(&%B:6QI='D@=&\@8V]N=&EN=64@87,@82!G;VEN9R!C;VYC M97)N+CPO<#X\'0O:F%V87-C3X-"B`@("`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`Q)3L@9F]N M="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!L969T.R<^)#PO=&0^#0H\=&0@ MF4Z(#$P M<'0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@9F]N M="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!L969T.R<^)#PO=&0^#0H\=&0@ MF4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0[)SXI/"]T M9#X-"CQT9"!S='EL93TS1"=W:61T:#H@,B4[(&9O;G0MF4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0[)SXD/"]T9#X-"CQT9"!S='EL M93TS1"=W:61T:#H@,3(E.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<^,2PX,#`\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@ M9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T M9#X-"CPO='(^#0H\='(@6QE/3-$ M)V9O;G0M3PO=&0^#0H\=&0@ MF4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<^,2PU,S`\+W1D/@T*/'1D('-T>6QE/3-$)W!A9&1I;FF4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<^,3`L-S$P/"]T9#X- M"CQT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T M>6QE/3-$)V9O;G0MF4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V)OF4Z(#$P<'0[('!A9&1I;F6QE/3-$)V)OF4Z(#$P<'0[('1E M>'0M86QI9VXZ(&QE9G0[)SXD/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`R+C5P="!D;W5B;&4[(&9O;G0MF4Z(#$P<'0[('1E>'0M M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M M6QE/3-$)V)OF4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<^,30L,#0P/"]T9#X-"CQT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@ M,BXU<'0[(&9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M'0M M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T* M/'1D('-T>6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X-"CQT9"!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/@T*/"]T6QE/3-$)V9O;G0M6QE/3-$ M)V9O;G0M'0M86QI9VXZ M(')I9VAT.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T M>6QE/3-$)V9O;G0M'0M M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T* M/'1D('-T>6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+W1D/@T*/"]T'0M M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M M'0M86QI9VXZ(&QE9G0[)SXD/"]T9#X-"CQT9"!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<^,BPR,#`\ M+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M6QE/3-$)W9E MF4Z(#$P<'0[('!A M9&1I;F6QE/3-$ M)V)OF4Z(#$P<'0[('!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O M6QE/3-$)V9O;G0MF4Z(#$P<'0[('1E>'0M86QI9VXZ M(&QE9G0[)SXD/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`R+C5P="!D;W5B;&4[(&9O;G0MF4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V)OF4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<^."PS,C`\+W1D/@T*/'1D('-T>6QE/3-$)W!A M9&1I;F3L@=&5X M="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@3L@=&5X="UI;F1E;G0Z(#`N M,C5I;CLG/D5F9G1E8R!);G1E2!297-O=7)C97,L($EN8RX@*"8C.#(R,#L\8CY. M0459/"]B/B8C.#(R,3LI(&ES(&%N(&]I;"!A;F0@9V%S(&1E=F5L;W!M96YT M(&%N9"!P2!I;B!/:VQA:&]M82X@5&AE($-O;7!A;GD@=F%L=65D(&ET3L@=&5X="UI;F1E;G0Z(#`N,C5I M;CLG/D9A:7(@=F%L=64@9F]R(&)O=&@@879A:6QA8FQE+69O7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV M/@T*/'1A8FQE('-T>6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P+C(U:6X[)SX\8CXT+CPO8CX\+W1D M/@T*/'1D/CQB/D1)4U1224)55$E/3B!!1U)%14U%3E0\+V(^/"]T9#X-"CPO M='(^#0H\+W1A8FQE/@T*/"]D:78^#0H\9&EV/@T*/'`@3L@=&5X="UI;F1E;G0Z(#`N M-6EN.R<^)B,Q-C`[/"]P/@T*/"]D:78^#0H\9&EV/@T*/'`@'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`P+C(U:6X[)SY/;B!&96)R=6%R>2`R-RP@ M,C`Q,BP@=V4@96YT97)E9"!I;G1O(&QI8V5N'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+W`^#0H\+V1I=CX-"CQD:78^#0H\<"!S='EL93TS1"=F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E2!A9W)E97,@=&AA="!S:&]U;&0@:70@F5D('1O(&UA'!E;G-E(&]V97(@=&AE(&YE>'0@=&5N(&UO;G1H'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W`^#0H\+V1I=CX-"CQD:78^#0H\<"!S='EL93TS1"=F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E2!T;R!A8W%U:7)E(&$@;6EN;W)I='D@97%U:71Y('!O2!E>&5R8VES92!T:&5S M92!W87)R86YT'1087)T7S=E M9#4V,69C7V1C-61?-#8V9E]A8C4U7S@P9#0V8S8V9&(S-`T*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B\W960U-C%F8U]D8S5D7S0V-F9?86(U-5\X M,&0T-F,V-F1B,S0O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'1A8FQE M('-T>6QE/3-$)VUA6QE/3-$)W=I9'1H.B`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`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0@0FQO8VM= M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N M+"!T:6UE'0M:6YD96YT.B`P M+C(U:6X[)SXF(S$V,#L\+W`^#0H\=&%B;&4@6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]T M9#X-"CQT9"!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([)R!C;VQS<&%N/3-$,CY-87)C M:"P@,S$\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O M;3H@,7!T.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([ M(&)O6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[)SY#;VYV97)T:6)L92!N;W1E M'0M86QI9VXZ(&QE9G0[)SXD/"]T9#X-"CQT9"!S='EL93TS1"=W:61T:#H@ M,3(E.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<^,C`L M,#`P/"]T9#X-"CQT9"!S='EL93TS1"=W:61T:#H@,24[(&9O;G0M XML 13 R8.htm IDEA: XBRL DOCUMENT

GOING CONCERN

6 Months Ended

Mar. 31, 2012

Going Concern [Abstract]

Going Concern [Text Block]

2. GOING CONCERN

These conditions raise serious doubt about the Company’s ability to continue as a going concern.

XML 14 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2012	Sep. 30, 2011
ASSETS
Cash and cash equivalents	$ 1,064,541	$ 147,907
Accounts receivable	3,597	0
Inventory	70,320	0
Prepaid expenses	613,786	59,264
Deferred financing costs	778,029	0
Total current assets	2,530,273	207,171
Other assets:
Available-for-sale investments	14,040	8,320
Deferred financing costs	472,413
IT Property, net	13,062	0
Intellectual property, net	133,024	126,917
Total other assets	632,539	135,237
Total assets	3,162,812	342,408
LIABILITIES AND STOCKHOLDERS' DEFICIT
Accounts payable	223,286	342,009
Accounts payable - related parties	35,349	28,558
Deferred sales	300	0
Convertible notes payable, net	503,156	606,976
Accrued expenses	128,213	21,684
Total current liabilities	890,304	999,227
Convertible note payable, net	339,434	0
Commitments and contingencies	0	0
STOCKHOLDERS' DEFICIT
Preferred stock, $0.001 par value; authorized 10,000,000 shares; no shares issued and outstanding; $100 per share liquidation preference	0	0
Common stock, $.001 par value; authorized 400,000,000 shares; 119,982,297 and 93,612,039 shares issued and outstanding at March 31, 2012 and September 30, 2010, respectively	119,892	93,612
Additional paid-in capital	28,034,931	12,667,350
Stock options	(4,938,896)	(680,711)
Non-controlling interest	(126,344)	(126,344)
Deferred consulting fees	(724,060)	(541,558)
Accumulated other comprehensive income (loss)	8,310	2,590
Accumulated deficit:
During the development stage	(10,563,905)	(2,194,904)
Other	(9,876,854)	(9,876,854)
Total accumulated deficit	(20,440,759)	(12,071,758)
Total stockholders' deficit	1,933,074	(656,819)
Total liabilities and stockholders' deficit	$ 3,162,812	$ 342,408

XML 15 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (USD $)	6 Months Ended		38 Months Ended
Condensed Consolidated Statements of Cash Flows (USD $)	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012
Operating activities:
Net loss	$ (8,369,153)	$ (199,352)	$ (10,564,057)
Adjustments to reconcile net increase (decrease) in net assets from operations to net cash used in operating activities:
Gain from extinguishment of debt	(178,702)	0	(178,702)
Intellectual property	682	0	1,765
Deferred consulting fees	514,800	0	582,242
Stock options	636,608	0	666,769
Other than temporary decline in available-for-sale securities	4,430	0	55,330
Interest settled with common stock	30,425	0	30,425
Deferred financing cost	156,445		156,445
Common stock issued for services	0	144,000	543,000
Convertible notes payable:
Amortization of detachable warrants	756,719	0	769,470
Beneficial conversion feature	4,875,089	0	5,247,400
Investment received for management services	0	0	(8,800)
Accrued interest income	0	0	(4,909)
Gain on sale of investment	0	(2,348)	15,552
Non-controlling interest	0	0	(3,504)
Changes in operating assets and liabilities:
Accounts receivable and accrued interest - related parties	0	0	(4,686)
Inventory	(70,320)	0	(70,320)
Prepaid expenses	(554,522)	5,000	(613,786)
Accounts payable and accrued expenses	19,597	12,777	375,763
Accounts payable and accrued expenses - related parties	0	(11,551)	6,617
Deferred sales	300	0	300
Advances from related parties for working capital	0	0	6,660
Net cash used in operating activities	(2,177,602)	(56,474)	(2,991,026)
Investing activities:
Proceeds from investments	0	52,876	75,876
Additions to IT assets	(13,750)	0	(13,750)
Intellectual property	(7,440)	(35,000)	(57,440)
Net cash (used in) provided by investing activities	(21,190)	17,876	4,686
Financing activities:
Loan proceeds	3,534,359	32,785	4,466,009
Loan repayment	(219,359)	(2,660)	(222,019)
Proceed from warrants exercise	430,000	0	430,000
Financing fees	(629,574)	0	(629,574)
Net cash provided by (used in) financing activities	3,115,426	(30,125)	4,044,416
Net increase (decrease) in cash and cash equivalents	916,634	(8,473)	1,058,076
Cash and cash equivalents, beginning of period	147,907	8,619	6,465
Cash and cash equivalents, end of period	1,064,541	146	1,064,541
Supplemental Cash Flow Information:
Common stock issued for convertible notes payable and accrued interest	555,425	0	1,227,247
Notes payable issued to acquire investment	0	0	100,000
Warrant issued for financing fees	620,867	0	620,867
Common stock issued for license	0	0	78,000
Common stock issued to acquire Fuse Science, Inc.	$ 0	$ 0	$ 23,297

XML 16 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'

'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'

'+ "\n"+' '+ "\n"+'

'+ "\n"+'

'+raw+'

'+ "\n"+'

'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 17 R7.htm IDEA: XBRL DOCUMENT

ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICY

6 Months Ended

Mar. 31, 2012

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

1.	ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICY

CONSOLIDATION POLICY AND HISTORY OF BUSINESS

DEVELOPMENT STAGE

BASIS OF PRESENTATION

USE OF ESTIMATES

REVENUE RECOGNITION

INVENTORIES

INVESTMENTS

Investments are classified into the following categories:

Trading securities reported at fair value with unrealized gains and losses included in earnings;

Available-for-sale securities reported at fair value with unrealized gains and losses, net of applicable deferred income taxes, reported in other comprehensive income;

Held-to-maturity securities and other investments reported at amortized cost; and

Investments using the equity method of accounting.

Stock-based Compensation

INTANGIBLE ASSETS

IMPAIRMENT OF LONG-LIVED ASSETS

FAIR VALUE

NEW ACCOUNTING PRONOUNCEMENTS

We have evaluated all recent accounting pronouncements through March 31, 2012 and find none that would have a material impact on the financial statements of the Company.

RECLASSIFICATION

- Definition

The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 720

-SubTopic 15

-URI http://asc.fasb.org/subtopic&trid=2122524

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6921930&loc=d3e5614-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6970148&loc=SL6228881-111685

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Name Statement of Position (SOP)

-Publisher AICPA

-Number 94-6

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 272

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FAS140-4/FIN46(R)-8

-Paragraph 8, C1, C7

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Name FASB Interpretation (FIN)

-Publisher FASB

-Number 46R

-Paragraph 4, 14, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 852

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2209116

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2134480

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 2-6

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 915

-SubTopic 235

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6472506&loc=d3e38932-110933

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2122150

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6359553&loc=d3e288-107754

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2197480

+ Details

XML 18 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets [Parenthetical] (USD $)	Mar. 31, 2012	Sep. 30, 2011
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Preferred stock, liquidation preference per share (in dollars per share)	$ 100	$ 100
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	119,982,297	93,612,039
Common stock, shares outstanding	119,982,297	93,612,039

- Definition

Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Shares outstanding equals shares issued minus shares held in treasury and other adjustments, if any.

+ References+ Details

- Definition

The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.

+ References+ Details

- Definition

Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References+ Details

XML 19 R17.htm IDEA: XBRL DOCUMENT

DISCLOSURES ABOUT FAIR VALUE

6 Months Ended

Mar. 31, 2012

Fair Value Disclosures [Abstract]

Fair Value Disclosures [Text Block]

11.

DISCLOSURES ABOUT FAIR VALUE

Assets and liabilities measured at fair value on a recurring basis are summarized in the following tables according to FASB ASC 820 pricing levels.

	Fair Value Measurement Using
	Recorded value		Quoted prices in active markets of identical assets (Level 1)		Significant other observable inputs (Level 2)		Significant Unobservable Inputs (Level 3)

March 31, 2012
Assets:
Available-for-sale securities	$	14,040	$	14,040	$	-	$	-

September 30, 2011
Assets:
Available-for-sale securities	$	12,320	$	12,320	$	-	$	-

Level 3 inputs have significant inputs which are not observable. The Company does not have any investments that are measured on a recurring basis using Level 3 inputs.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19296-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 159

-Paragraph 17-22, 27, 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13433-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 15C, 15D

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13504-108611

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 15A

-Subparagraph a-d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13537-108611

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 133

-Paragraph 44A, 44B

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19207-110258

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 3, 10, 14, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 15B

-Subparagraph a, b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 157

-Paragraph 32, 33, 34

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

XML 20 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information	6 Months Ended
Document and Entity Information	Mar. 31, 2012	May 11, 2012
Entity Registrant Name	Fuse Science, Inc.
Entity Central Index Key	0000842722
Current Fiscal Year End Date	--09-30
Entity Filer Category	Smaller Reporting Company
Trading Symbol	deghpk
Entity Common Stock, Shares Outstanding		126,202,256
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2012
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2012

XML 21 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations (USD $)	3 Months Ended		6 Months Ended		38 Months Ended
Condensed Consolidated Statements of Operations (USD $)	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012
Revenue
Sales, net	$ 24,174	$ 0	$ 24,174	$ 0	$ 24,174
Management income - affiliate			0	0	11,366
Total income			24,174	0	35,540
Cost of sales	5,866	0	5,866	0	5,867
Gross Profit	18,308	0	18,308	0	29,673
Expenses:
Related party services	0	3,000	0	6,000	6,000
General and administrative expense	1,874,182	171,139	2,685,666	188,302	4,415,159
Total expenses	1,874,182	174,139	2,685,666	194,302	4,421,159
Loss from operations	(1,855,874)	(174,139)	(2,667,358)	(194,302)	(4,391,486)
Other income (expense):
Interest and other income			0	0	9,629
Interest expense	(965,695)	(3,510)	(1,005,408)	(7,433)	(1,050,554)
Beneficial conversion feature of convertible notes payable	(4,726,906)		(4,875,089)	0	(5,247,400)
Realized loss			0	2,383	(15,552)
Other than temporary decline in available-for-sale securities	0	35	0	0	(50,900)
Gain on extinguishment of debt	178,702	0	178,702	0	178,702
Other expense	(5,513,899)	(3,475)	(5,701,795)	(5,050)	(6,176,075)
Loss before non-controlling interest			(8,369,153)	(199,352)	(10,567,561)
Non-controlling interest			0	0	3,504
Net loss	(7,369,773)	(177,614)	(8,369,153)	(199,352)	(10,564,057)
Loss per share, basic and diluted (in dollars per share)	$ (0.06)	$ 0	$ (0.07)	$ 0
Weighted average shares outstanding (in shares)	117,203,169	51,727,575	114,228,944	51,322,292
Other comprehensive income
Net loss	(7,369,773)	(177,614)	(8,369,153)	(199,352)	(10,564,057)
Unrealized (loss) gain on available-for-sale securities (none attributed to the non-controlling interest)	(4,520)	1,060	8,310	7,903	4,430
Net comprehensive loss	$ (7,374,293)	$ (176,554)	$ (8,360,843)	$ (191,449)	$ (10,559,627)

XML 22 R12.htm IDEA: XBRL DOCUMENT

CONVERTIBLE PROMISSORY NOTES

6 Months Ended

Mar. 31, 2012

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

6.	CONVERTIBLE PROMISSORY NOTES

The Company had the following convertible notes payable at March 31, 2012 and September 30, 2011.

	March, 31			September 30,
	2012			2011
Convertible notes payable with interest at 12%	$	20,000		$	20,000
8% One year senior secured convertible promissory note due June 20, 2012		-			327,405	*
8% One year senior secured convertible promissory note due September 9, 2012		315,147			259,571
8% One year senior secured convertible promissory note due October 25, 2012		152,889			-
10% Two year senior secured convertible promissory note due February 7, 2014		1,183,215			-
Discount on Warrants		(843,781	)		-
	$	827,470		$	606,976

	March 31, 2012		September 30, 2011
Current	$	503,156	$	606,976
Long term	$	339,434	$	-

Convertible notes payable includes one note in the amount of $5,000 which is convertible at $0.025 per share and one note in the amount of $15,000 which is convertible at $0.03 per share.

The terms of our 8% One Year Senior Subordinated Secured Convertible Promissory Notes are summarized as follows:

Due Date	Face Value		Conversion Rate		Number of Warrants
February 7, 2014	$	3,169,359		See below		30,184,372
September 9, 2012	$	360,000	$	0.12		3,000,000
October 25, 2012	$	180,000	$	0.12		750,000

Due Date	Face Value		Unit Conversion Rate**		Number of Warrants
March 22, 2012	$	75,000	$	1.50		300,000
March 29, 2012	$	60,000	$	1.50		240,000
April 4, 2012	$	50,000	$	1.50		200,000

** Each unit consists of ten shares of the Company’s common stock and warrants to purchase six additional shares of the Company’s stock

	11-Sep		11-Dec		12-Mar (A Warrants)		12-Mar (B Warrants)
Expected term		5 years		5 years		5 years		6 months
Expected average volatility		309%		296%		163.06%		163.06%
Expected dividend yield		0%		0%		0%		0%
Risk-free interest rate		3.50%		2.90%		.82%		.11%

			Debt Discount
Due Date	Face Value		Initial Value		Amortization			Discount		Carrying Value

February 4, 2014	$	3,169,359	$	854,735	$	(328,480	)	$	1,986,144	$	1,183,215
September 9, 2012		360,000		264,514		(50,633	)		44,853		315,147
October 25, 2012		180,000		133,948		(18,941	)		27,111		152,890
	$	3,709,359	$	1,253,197	$	(398,054	)	$	2,058,108	$	1,651,252

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References+ Details

XML 23 R11.htm IDEA: XBRL DOCUMENT

INTELLECTUAL PROPERTY

6 Months Ended

Mar. 31, 2012

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets Disclosure [Text Block]

5.	INTELLECTUAL PROPERTY

- Definition

The entire disclosure for all or part of the information related to intangible assets.

+ References+ Details

XML 24 R15.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS' EQUITY

6 Months Ended

Mar. 31, 2012

Equity [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

9.	STOCKHOLDERS’ EQUITY

Common stock

Transactions during the six month period ended March 31, 2012

Convertible debt

Common Stock

Warrants

Options

In addition, 2,100,000 of options with and intrinsic value of $442,947 were issued to employees and directors during the quarter ended March 31, 2012.

- Definition

The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187143-122770

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Article 4

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 4

-Section 08

-Paragraph d

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Chapter 1

-Section B

-Paragraph 7, 11A

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 20: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 21: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 22: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 23: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

XML 25 R13.htm IDEA: XBRL DOCUMENT

WARRANT EXERCISES

6 Months Ended

Mar. 31, 2012

Warrant Exercises [Abstract]

Warrant Exercises [Text Block]

7.	WARRANT EXERCISES

XML 26 R14.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS

6 Months Ended

Mar. 31, 2012

8.	RELATED PARTY TRANSACTIONS

While operating as a BDC the Company had management contracts and made loans to its 60% owned subsidiary USN. These transactions are eliminated in consolidation with USN.

Related party amounts included in the balance sheet may be summarized as follows:

Accounts payable - related parties:

	March 31, 2012		September 30, 2011

Hank Durschlag	$	16,178	$	16,178
Rubin Hanan		5,706		-
Aitan Zacharin		13,465		12,554
	$	35,349	$	28,732

Transactions with related parties in the statement of operations for the three months ended March 31, 2012 and September 30, 2011 include:

	2012		2011
Prior CEO compensation	$	10,000	$	3,000
New officer compensation		59,000		-
	$	69,000	$	3,000

- Definition

The entire disclosure for related party transactions, including the nature of the relationship(s), a description of the transactions, the amount of the transactions, the effects of any change in the method of establishing the terms of the transaction from the previous period, stated interest rate, expiration date, terms and manner of settlement per the agreement with the related party, and amounts due to or from related parties. If the entity and one or more other entities are under common ownership or management control and this control affects the operating results or financial position, disclosure includes the nature of the control relationship even if there are no transactions between the entities. Disclosure may also include the aggregate amount of current and deferred tax expense for each statement of earnings presented where the entity is a member of a group that files a consolidated tax return, the amount of any tax related balances due to or from affiliates as of the date of each statement of financial position presented, the principal provisions of the method by which the consolidated amount of current and deferred tax expense is allocated to the members of the group and the nature and effect of any changes in that method. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 3A

-Section 04

-Paragraph b

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 1-4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 4

-Section 08

-Paragraph k

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

+ Details

XML 27 R16.htm IDEA: XBRL DOCUMENT

COMMITMENTS AND CONTINGENCIES

6 Months Ended

Mar. 31, 2012

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

10.

COMMITMENTS AND CONTINGENCIES

Sales Range		Commission Rate

$0 - $100,000		0.00%
$100,001 - $10,000,000		5.00%
$10,000,001 - $50,000,000		2.50%

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Interpretation (FIN)

-Number 14

-Paragraph 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 9, 10, 11, 12

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

+ Details

XML 28 R5.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Changes in Stockholders' Deficit (USD $)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Intrinsic Value of Common Stock Options [Member]	Noncontrolling Interest [Member]	Deferred Compensation, Share-based Payments [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit Development Stage [Member]	Accumulated Deficit Other [Member]	Total
Balance at Jan. 19, 2009	$ 0	$ 50,926	$ 9,946,022	$ 0	$ 0	$ 0	$ 279,470	$ 0	$ (9,999,694)	$ 276,724
Balance (in shares) at Jan. 19, 2009	0	50,925,820
Unrealized loss from available-for-sale securities	0	0	0		0	0	(248,385)	0	0	(248,385)
Convertible notes payable:
Net loss	0	0	0	0	0	0	0	(97,895)	0	(97,895)
Balance at Sep. 30, 2009	0	50,926	9,946,022	0	0	0	31,085	(97,895)	(9,999,694)	(69,556)
Balance (in shares) at Sep. 30, 2009	0	50,925,820
Noncontrolling interest						(126,340)	0	3,500	122,840	0
Unrealized loss from available-for-sale securities	0	0	0		0		(31,538)	0	0	(31,538)
Convertible notes payable:
Net loss	0	0	0	0	(4)		0	(80,348)	0	(80,352)
Balance at Sep. 30, 2010	0	50,926	9,946,022	0	(126,344)	0	(453)	(174,743)	(9,876,854)	(181,446)
Balance (in shares) at Sep. 30, 2010	0	50,925,820
Unrealized loss from available-for-sale securities	0	0	0	0	0	0	3,043	0	0	3,043
Common stock issued for:
Services	0	11,850	1,140,150	0	0	(609,000)	0	0	0	543,000
Services (in shares)	0	11,850,000
Convertible notes payable	0	5,539	134,517	0	0	0	0	0	0	140,056
Convertible notes payable (in shares)	0	5,539,219
License	0	2,000	76,000	0	0	0	0	0	0	78,000
License (in shares)	0	2,000,000
Acquisition of FS Research and Development, Inc.		23,297	(23,297)		0	0	0	0	0	0
Acquisition of FS Research and Development, Inc. (in shares)		23,297,000
Convertible notes payable:
Detachable warrants	0	0	310,775	0	0	0	0	0	0	310,775
Beneficial conversion feature	0	0	372,311	0	0	0	0	0	0	372,311
Stock options granted	0	0	710,872	(710,872)
Amortize deferred consulting					0	67,442	0	0	0	67,442
Amortize stock options	0	0	0	30,161	0	0	0	0	0	30,161
Net loss	0	0	0	0	0		0	(2,020,161)	0	(2,020,161)
Balance at Sep. 30, 2011	0	93,612	12,667,350	(680,711)	(126,344)	(541,558)	2,590	(2,194,904)	(9,876,854)	(656,819)
Balance (in shares) at Sep. 30, 2011	0	93,612,039
Unrealized loss from available-for-sale securities	0	0	0	0	0	0	5,720	0	0	5,720
Common stock issued for:
Convertible notes payable		18,063	535,855	0	0	0	0	0	0	533,918
Convertible notes payable (in shares)		18,063,330
Deferred consulting fees	0	300	82,740	0		(83,040)				0
Deferred consulting fees (in shares)	0	300,000
Convertible notes payable:
Detachable warrants	0	7,917	4,443,034	0	0	0	0	0	0	4,443,034
Detachable warrants (in shares)	0	7,917,601
Beneficial conversion feature	0	0	4,811,693	0	0	0	0	0	0	4,811,694
Stock options granted	0	0	5,494,259	(4,894,793)	0	(444,963)	0	0	0
Amortize deferred consulting					0	345,501	0	0	0	345,501
Amortize stock options	0	0	0	636,608	0	0	0	0	0	799,179
Net loss					0	0	0	(8,369,153)	0	(8,369,153)
Balance at Mar. 31, 2012	$ 0	$ 119,892	$ 28,034,931	$ (4,938,896)	$ (126,344)	$ (724,060)	$ 8,310	$ (10,563,905)	$ (9,876,854)	$ 1,933,074
Balance (in shares) at Mar. 31, 2012	0	119,892,297

XML 29 R10.htm IDEA: XBRL DOCUMENT

DISTRIBUTION AGREEMENT

6 Months Ended

Mar. 31, 2012

Distribution Agreement [Abstract]

Distribution Agreement [Text Block]

4.	DISTRIBUTION AGREEMENT

XML 30 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 96 140 1 false 9 0 false 3 false false R1.htm 001 - Document - Document and Entity Information Sheet http://doubleeagleholdings.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 002 - Statement - Condensed Consolidated Balance Sheets Sheet http://doubleeagleholdings.com/role/StatementOfFinancialPositionClassified Condensed Consolidated Balance Sheets false false R3.htm 003 - Statement - Condensed Consolidated Balance Sheets [Parenthetical] Sheet http://doubleeagleholdings.com/role/BalanceSheetParenthetical Condensed Consolidated Balance Sheets [Parenthetical] false false R4.htm 004 - Statement - Condensed Consolidated Statements of Operations Sheet http://doubleeagleholdings.com/role/StatementOfIncomeAlternative Condensed Consolidated Statements of Operations false false R5.htm 005 - Statement - Consolidated Statements of Changes in Stockholders' Deficit Sheet http://doubleeagleholdings.com/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome Consolidated Statements of Changes in Stockholders' Deficit false false R6.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://doubleeagleholdings.com/role/StatementOfCashFlowsIndirect Condensed Consolidated Statements of Cash Flows false false R7.htm 007 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICY Sheet http://doubleeagleholdings.com/role/Organisation ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICY false false R8.htm 008 - Disclosure - GOING CONCERN Sheet http://doubleeagleholdings.com/role/GoingConcern GOING CONCERN false false R9.htm 009 - Disclosure - INVESTMENTS Sheet http://doubleeagleholdings.com/role/Investments INVESTMENTS false false R10.htm 010 - Disclosure - DISTRIBUTION AGREEMENT Sheet http://doubleeagleholdings.com/role/DistributionAgreement DISTRIBUTION AGREEMENT false false R11.htm 011 - Disclosure - INTELLECTUAL PROPERTY Sheet http://doubleeagleholdings.com/role/IntellectualProperty INTELLECTUAL PROPERTY false false R12.htm 012 - Disclosure - CONVERTIBLE PROMISSORY NOTES Notes http://doubleeagleholdings.com/role/ConvertiblePromissoryNotes CONVERTIBLE PROMISSORY NOTES false false R13.htm 013 - Disclosure - WARRANT EXERCISES Sheet http://doubleeagleholdings.com/role/WarrantExercises WARRANT EXERCISES false false R14.htm 014 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://doubleeagleholdings.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS false false R15.htm 015 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://doubleeagleholdings.com/role/StockholdersEquityDeficit STOCKHOLDERS' EQUITY false false R16.htm 016 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://doubleeagleholdings.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES false false R17.htm 017 - Disclosure - DISCLOSURES ABOUT FAIR VALUE Sheet http://doubleeagleholdings.com/role/DisclosuresAboutFairValue DISCLOSURES ABOUT FAIR VALUE false false All Reports Book All Reports Element us-gaap_EarningsPerShareBasicAndDiluted had a mix of decimals attribute values: 0 2. Process Flow-Through: 002 - Statement - Condensed Consolidated Balance Sheets Process Flow-Through: Removing column 'Mar. 31, 2011' Process Flow-Through: Removing column 'Sep. 30, 2010' Process Flow-Through: Removing column 'Sep. 30, 2009' Process Flow-Through: Removing column 'Jan. 19, 2009' Process Flow-Through: 003 - Statement - Condensed Consolidated Balance Sheets [Parenthetical] Process Flow-Through: 004 - Statement - Condensed Consolidated Statements of Operations Process Flow-Through: Removing column '9 Months Ended Sep. 30, 2009' Process Flow-Through: Removing column '12 Months Ended Sep. 30, 2011' Process Flow-Through: Removing column '12 Months Ended Sep. 30, 2010' Process Flow-Through: 006 - Statement - Condensed Consolidated Statements of Cash Flows deghpk-20120331.xml deghpk-20120331.xsd deghpk-20120331_cal.xml deghpk-20120331_def.xml deghpk-20120331_lab.xml deghpk-20120331_pre.xml true true ZIP 31 0001144204-12-029772-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-12-029772-xbrl.zip M4$L#!!0````(`&.*KT`"5@[(W6,``$3#!``3`!P`9&5G:'!K+3(P,3(P,S,Q M+GAM;%54"0`#2LBR3TK(LD]U>`L``00E#@``!#D!``#L7?MSH[B6_GFV:O\' MW_P\CA%O4CU]*Y-'W^SM[N0F/:_:VIHBMI*P8X,7<#JY?_U*X`?8!B00($`] M5=/5!G&^\^GHZ.CH]>'O;XOYZ!7Z@>.Y/YV`4^ED!-VI-W/KK\T4D\E M])\Q^F])FP!M(DM`'DGFF::>J?+H[LO_C,;CS5=_M@/T%50F^H!\"D:[A]%/ MEQN)7Q"L)RU4(3^5#U5\+=^@S,7!C/[_ MPQ=OCGD)3J?>(E))4A1PLBXV=]Q=H>_?OY_B3YYZ_C-Z4U(F^/$CTG3S.GXZ M<[8%DB_KD_CA]M6#3W]7HG>!95F3Z.GVU<`Y]B+Z*)C\_N7SP_0%+NRQXP:A M[4Y36)P<[/OO.X&GRL#(*Q&_L2G@>JZ[6AQ_?Q;ZD_!]"2?HI3%Z"_K.=%NN MN%"ZP`PN?3C%9ID)SIK8_M3WYG#R9$_#,7Q;SFW7#CW__1K]>_,A'SYE?D&? MH*=;B##,$17)0:^D:CT\6NM:7.O;5Z?>R@W]]_2[`9R>/GNOD_5#;(1@+('Q MS@RG*]]'#3BKW/KID8(SZ!PO@QX<>1V^35^.OX^?'"G@N*\P"(\7B9\=*>3: MSC0X7B9Z=*1(X$R/%T`/CKT>+OV,]]&3(P56P?C9MI?;,D]V\!C5X?I!=I&Q M'8;9Q=!#WWEC]\P%[C+(C\P3U\ M&D5>Y&S=,O)]S63I>TOHAPZ2G_!JT0QG&]_>XG:4NQ5QQNO>?H6 MS$XF$1+^^8>UXD]%&C_` MY1@WMDBO31'473CA>_3+YB=GAG]$_8<_BO1.J[FI]8N;?YY\E-`?4Y4-6?XP MV2\<2YDB?P?F;$_QYAVH4(DPB]Z5]?X.(1^DVROR46/F.,\6_QCS,D''ET9^J$,:[1S$'OQ-'-NJF=Y6IW M\G'SVC$U/TR.2EG#FASB&K:EH'\N/+??9G*@H[`1*ALYG\T<[/3M^9WMS&[< M"WOIA/:\M_:2JZ^P'2K;^>JY^#LH:$&AQO,-^HJ/`LG>FDZ>NL)RJ"SGH`2]@;\V*6'=A4V5M"K5<8'&>!0Y64YRLITV$Y&0%08BLK&<9F,[;3@B%=M6 M*K;39B/RL+SF83MM5B()RU\2MB\&)3*P/&1@>V9-(OTJ[*;8;D3NE;/<*V?6 MI'Q!U@3&7VP?6Q/H2.XU7L-,R2,JH(P54`^/>C=YE$K88ZT\IKU;WWELJI<` M8BZ`A[F`KIN)F`L0!B+F`GB<"^BZX8BY@%;F`KIN-F(N@,NY@*Z;E9@+X&PN MH$<&)>8"6I\+Z)\UB;D`83?%=B/F`GB:"^#/FLZ#/V^?.I%]C<\7"C,XV3UE M/3\B<\O(GFW))>9'Y.;F1SK#(RC11IOD4>3UNQK*J]_P`G+O/[F$*,.D'*PA83Z^)XFS`M@)M_Y9G+?O+0Q MJ,F\UIQ8X_^R7;[/FD]R$ML6L.KDI`OG[^]S4M_TXH&=B`F==B9T6FP&HLKY MJ')^6KF8CQM0^Q:5/:"6+292&YM(Y;?%"R-HS0CX\01B9KRAF7%^_8`P@99, M@!\O(!8Z<++0@5\O(4R$4Q/AQXN(=2VMKVOAUW$X^#..+CT'&(!4PL+F#KA M-H1E<&`9//L,L4Q->`=A`T/S`V+98;O+#OGU#L(R^+*,NGU&%R[O2ZW].SA2 MNU9.Q`*?]A?X\%7E8LW'@"I;3/>W,MW/EQ&(N=X6YGKY,@$QDX,A&17^(KO\2K<8C\4MOY)_>(ZX>@!3K$2H]%XG#"9%7Z$[24*H1`9Z]\7T`Y6/ORX MUB9ZN/G\YMGFW_@;QS[YR\/EP?>4?%`>_W@)76_AN,<^2TI0ZA.3-/I]Q7&=73EVS7F9_:"KI8H:C>#:^=8&K/_X"V?Q7?%T(F:QQG M8F-!69_:4^K:F:/P$/W^[/F$*CTL[#DJ-+J'2\\/T9!TA)V)[;XG-4Q]=ROS MFV_/4(&']\6C-R>3%CNF^-.IXONUL_-4<3.^78783^`"1R4=7I\RPL87O;-V M!*,9G#I(V^"G$^GD(Y!U69)E34_59([8+<)+#W6RJ#*^O2$JQ)(XW_%8I)E MMQ\\1[_,\*_7<_NX=@=??$)JP/B3J=('(.\B5TIE>#LOG<:<^M2!H-@TXW>N MT6\!F;!_R6DA!Y_)$(3;`(48_/]C@K:?B<1L$[1V\'+NSO!?N']]M>=1UQI> MV+[_CDPAZDYSS#`Q]Y4P0]QY[-F@:EB2\6%")95!U5==:I31QC$,>3E,'%A]57V2D>A68=SY!6B483W%'Y'(1EG6.]O';IIA7VYJFID)[*A4IC!) M+4E3U.RZ+(;YU0LA>Q/3)=TR$M5Z1$H5%(3<:)("-`H4B#Q_!6>?'?O1F3N, MS0GHIIJJI^.BJ@,B[7AD4P8*+:):N+$L2Y83_0U3#(1TF):D2"HQ!IR?A2&1J'^&[A2]SCCHRQ;$`A`A.R4`I==2LDK42*GAW;Z`*@#HF2@"D,AA MLE+?4O1DU+`OH;1X4I\!+-,BE9^QQBY1ADV8KQN*EAS"%8IEB)(TRC$EU$LK MH#3*+X[KH7'H^V:5&@/FQH@Z14UXO'T9I0$0DD(&8#V!NEN9Y0:K.78YUY") MJQUK*H@"O5Q!U:"0$F*@`8@ND4"A6)#TV0OP(/+VZ9O]QB*.T2PI%330R*\+ M.VD?KP!&V/?7]EQADUWZ3@#7JSV2ZS]6/JJZ_1),0DI+M9(Q2W54#2I)/-^A MZ8HE:;5I>0]#VW'A[,KV7?1N\(MK+Y>^ASZ(/\#"PUBFH9M:HI[R13)"1^IT M6*([7/7$IJ/":?7D8+Q8+D.8I$3*DJI*AF:5AAEU^R_>?`;](%Y-A+Q0G/F[ MPRL"//<\#'WG<17B`>PW[_@"=A:,ZYIN)N?$V"!K6%E2!V,IBF2HW5:6=$I6 M-G1#[KBNB7L;"JS8TI+9GR[J2GY[R=$=FH0#V2XR0WY[Q]"8(;>9PRV>^=E4 M2^YXT?P\KZI+LMQMHB@N%1LV4>06E;OQM,>>FMR4ALI0 M33?/]YBQFBYB[S%C==Q+GC\&LU2CXYS5<5UW_GH9R=2Z35D-EUCWN%'6<+%S M?A;4,*T!&UAR+VX^3^B/;O4G@R288F13Q'M[A=,2;%%MSQD#$ZAJQ],K%:]/ M'889B)Q<66H&GFIB=&\EU6JE?O,DD@/UW768:V:JI@R0L0HC-V"HACI@SL@' M)/L+??K-E`BQ*U\@)IBACCKW%NCWFYKR4>?ALOU^,R7"SAKN-R):UC\,WAC- M3*76]@^&L0K!Y\$2_*&1-M3HD]E5*ODK6$W)`*#CG%6[9*3/,6B%NSAH=FGV MFYOR0>CAKLQ^,S7P(+2>2Q"(-G0.@S;EZ%Q>S!Z`JZ"@N]324J$3F3R&4/.8K8AR/')U.>K\,7S\=&'U.P>/P]; MBO]D`=V7R@C@42Z;`7@3!"M6[!6@BD4Q0$1.%QM$9,>NLR-J_[QU!MB844:& M[;.#O.0LBM[C!_AN`E8.,&X&63"/BF8)E<;Q586:"!J:[U8(A+,$6ZU#J0"V MGJY$E0Y<=8Y,%MC(VSA+;"P[D&@&5TH>/YLAKBHDB@X76)8IRY91$1/S/H2` MJRQ?718<6]:RT-VC8;B[@M>^MT@?H4IPR07Q`8:90IA!(3[*L`XH%ZL@]!84 M9PLJNDZ+")_1'JQ?S3K8O&3M['VZHMB"\P%5D#J!IJ)H2N8535,)%?\$7>C; MZU"ET7N'ZCH6C:!0*_H&!S"#A3@KD5<9&8QO`-!5);@Z;0F%` MP#148#8(CLJZ=5/3DVV[;G"4]J^J0`-:2:N[\(+H(-SUL^.ND*X)J"#=HZ8% MT$NG,G)+31EY=>F5S)BU\I2&6ET\M2G*(&6*N0ANE_@ZP2BENCFMLK+YC??M M[XB04B!HK'"\;X:L0-`8XQC@&P"2_7(]5!0=*QBME#39HZ`TS;&J6$!-WM60 M!61WYVF4YX^?)H(XDOL0"\.T0B',H!0&T75"H:PD2Y"VNV#;PQ=TX'E`]?3CF!;C%WY@4B90F]HP/&,CGO0-B>'M4P.&XZ MD-J.3VJ:4![[CX9.PFFC]7/3@S1R'`SC'J0@8V8JN@62AY$RDQH3K1K`M$5H:7:YN\P2/8 M-BVC*I5.)8,.XGIMU&_0>7Y!OYV_0O\9=?Q?5[@CO7TZV,U9K>*/[B?5@"$; M&IY#K@BF-H6R325#(46694OF5Z%L]YBQX]>0)07H%K\:93>7#(U4638M?/8> M"XTV+2XK]C]_M9TY[M"?/#^PD^N#SF?_B]PVCG.1\[U]^F:_'3WIZ0Z!8+"B M$*1.S:L9;>O,4&U?L"1E.,S0K577Y,$:33XUZ2,5^\X,]99+I25RCHC9?(+9 MB8&40RH]M;F&,<#&E:<Z1]B2&V9NFR MT0P#-.?]D%]`6S`37'3.7/YY0*7.3^H.9'*6\^:SCP\R)4O63+EEIOF$775Y M7`LV76G%7(M,5UQ'T@;359:6$)[6QA`VJUL^&F2:R?4;64?/F5;ZZ+E\W%\< MU_.C<[3C_O(23GUH!]'Q9Y?X_"'

)E`ED=[#_B@Z$K+P).;A-CA*DU11N[ MYB&Z'F-`S#%?13`@PLJO8%`T:="4D:Z<`+)LUMX:L^S^%]=?[Z3%I=!'MAMJ MW43*R'<"].@2_1.-HJ#O>+/-X(K)-D-9-153*TYJ507+$R,UKA,6])5?QBRX M8[/*6O#(9&VHH+&6I:N"5D8QL>BZ:PJ>A;$R7Y;FD11C?)IPBC6S\1IW]\TFQAT`R2O6^]X4(, M2VKC3@Q+RA[U(X8EU4D4PY+J'(IA20V-F\FP1/328EC2))]B6$)-8B>')1&\ MFR!8H9I/O!NIL//\R?Z@\CR(IBI2E">P!,K>,*EP_) M`5`ET'7U60337=2;W<8^'5^1%/QL9]%/20N/RJBD?&[MT`H'*8CL(8 M2=/)3+<03;-ZM12\=XL%NI!>TU*'?_2&A0IQOJ)JP.@C)W4'_]UBHXZ<>'_8 M:72(T%EJ:A\X=)T9QL.);M'1Y""C;6:H5J8HB@7,3NK%-IUJ2KK21QK*!U^: MHIF:UD=.^AY\M;\@H3_L#"KX:G>%0)^9Z5GPU>ZL?>W,Q.E##O)DE?*^':." M.AN,\V4R*$Z9<<(&N_#U>&X<1["*PM8XUK<:Y36X\RF"'T0QYNW39V>*>D98 M.3%NF%&6OZ3XNJ'7D/ONIJ9T8RRYPW5:?AAEZ!U6N\I(J9L:LQP-=9,!9B.> MSJM?:533%^TI1B[=5)G5Z*0^[>.(K9UH)6L$4A9QV^I2Q]4X:B'HP0LT)AFZ M)@I77UI".%Q.RJP-*-LH4DE?W,&YKGX(' M),-(S-Q2(Z@??XW+1[NG+5T`U&E5RX=#W3=J%@%2][2N(V3J'@O,@ZA.4\`D MK.H#`R4"K>ZIS7KZOWX&$A.BE_`Q_,T)7W;SI=?0#E=^]3E.Q9`5`.C4(@'6 MFK8MQW1=YJ;6"+#+Q%2(%P?6O)J*+KO,45NQ:)*KIJBX MRR2U$4/SQ1?-KB;5!$"WU!ZI*V+KAC:"#8B8\K%UW+Z4X5`US."Z_7UD?>=, M!-1R<9+P6')[9M#)(Y- MM*R:EFI8C3G#G1-W@]4\1!W@-83!^<+S0WQU3>45:KJAJKO8OT`:8V#U]_M< MZ<.L/^:XSECWDKPJQZ+WXEPW^EZE9H5H5@*ZTCCFV M5L-RSG6KU;'M!YG)*(]=U*9(0-\U%"*9M8"L+ZO*K4YE,Y_<*E3IUFS>E6/0 MUW*K6PW'F'&K*^ONMPN*LNB*.Z0G?;?,K7),,DVM]?$TXRS#LH!A<8"R%Y%( M,W.PW"K4L4BD\5$_M[IU.Q)I-Q'0!44[%HDTGR#@5CDFD8BNZ+IDEE!VNU@V M_C7R"[=/J+SM/N-5L>=!`$.2D_2)S\',E\065'YDI)MR4[`N5D'H+8B1`4/7 MJ*"MZSW]YL;GWR.GX*Y(EF@75B*)'):`"JY-`ZHI-8**LOXT4Y83\W_$P(I] M`<-*+!;&'%I!>\QW8K7@HZQ87=<-/7LPE0%QTY#Q.3BV.]TXY'-WMCX@)[CV M_`?HOSI3&-SZ%W/;652O::"JJ7,3J:37BCN?8TX@TS9Y5:G(=H:S".WIBXV\ M_:9XC6Y\7Q1C6`5Y"DTW@-4<-LKZ1-$-RZ#_8RSD#$ M0];;)?1M/+'),AC/$,$(!KF?9PR#LM)42[+HP*1K-EF?U?VSK*B)JX!S)#%$ M1%Q3=<&AK+$QT#1-IH>%ZM2'=@`O8?SWC7NY@M>^MT@T0@<&%RL4H+LAVY9& M([E>T!3MLDW0M*U8-_6:H-_Y$/GNV=7;,O/^$QJS&&OI4+%`'FMP!8&LIFJR MW"0ZVC$84(S\FJ8">#Z=>BOD)^[L=QS`H4`=_>*OX.RS8S\Z<]*;)`O&8K)A M&'F025`THTA!9LK2+&X5H30DQ=",Y'7SM2B#O,XWKY[>90Q0+P@*7%Z&\#I1 M5^M>&@%,G?;Y?_:NMCF-)$E_GXCY#Q6[,QOV18OA54A6W$5@&7G8D\$GL"?F MOA7=A>AUT]77+V;87W^96=5O"!`M-0AA(B;&@+JKLC*KGLS*RLRJ;9ST6Y+] MV9>F$%:PI(866'JB3%MC4S]E$K2UH'='4''_W5/(ZHOPF@=3>/Z[;0GK_>)+ M(*R>F^P-.F9H?R]'4YRUSIOM3,V\[;O>'<6/V.+U6KM]7JV_-,U%MQ#UR\M: MM7[^;++CP_,;Z6I@;:_&'S9?0O>/ MV/=@%.^`A*+GWT^C8B3I^B]?E!Z_T,COV!_ML'3R'CF<:#;W3%W1T[%G49@! MZ.%4^N%(^+-2;.9&O7W16FT/YCHJC9Q'-J2M1K/1NMPM046!L@DF<[4P37?" MTS(>3,J563UGPJ_MIS1J-K.G7KO,26P7]!246+T.CQ0F:8T*O+%=[IHE;W$: M,(36H]IW1=>[H_B1A5FKM9I;;!5V3'+1I5MM-INUYU.-[W1<"__!",;OW,') MI`IA+/M"GC\Y+IKMC$^N2-^[)'HSIR]KY^>-YB%07=30JK8NJMGM1F'*]5%W M7X9">TG5;5\9U1YOJ4J,:MBFNQV0MVWDPM[(*RSN:K7Z=#*O91S=IAX'>_PZ M+:"+K3WTE,>GZ24*_SED['$XCQVS@49I'?Z8BLZP>KU=;[9W,:X'#=W:9BG' ML;F9M:Z7\HC9%D1V1$S1N+>++&(\E:8$6&ZB0`Q-6[@F9N+L4G1KNMP1F4\6 MZJ[)++IYP.O6GT9M;$(,_'ONZM!(H"*0CFVIBFNN]1G6-2@5'3:I#4_N)!DR MP0<[,!T91+X8`?7O'>AY*^[_US^<\"I$'&%!N'#$?_YMQOU[VST+I?>.5;WP MBLUM*YR^8Z`#?[UB$V@'/WLA"^T9V-NNF#/8T7+74#\8+`"C9W+%=#MC&0(? M55-_8Z9PG,#C:#0CV^B[QRU+?__'?7CU\T]$DA_30YAG,._:]^XX!85?9 M!ZWX04UGM5)OV:YZ!!]`BEE@_QN>`!'J9_''LPF?V<[BW?(XZ'OR^A@_U"KX M\;=Q_.-O^'[R);2RY)39[^#N8Z??^]_.J#?HLT[_`QOV/O9[-[WK3G_$.M?7 M@R_]4:__D7T>W/:N_]R6QM]"/_L%A9]^][*D%I$TB9A5KQC.LS/;M02^7ZV4 M)@P^\Z[^7CNOKAB=5R+]I4Z[)X,*C2,&`T)7-`H[&PV"0&7V@G1E\F)RR$ M!S%%D;L+9KNF$UF"?N,Z%F;I&8.A*F!:%Q@,M$&%O5$\O*C7J^DHMXZ[%;H8,M44T$S[[[$LK,J&OC[Z,/-6HP3B[<:0/Y,-`?$_ZI$4, M9L-S\ZETG,69G+LPLB`:![9E*S"1AFYS#F(P;=A,G$8-HI),T2]6;N\:.&_??&= M6[S">N3$1U4.LD:-ZLHYTF`!.?`;2G,PNOZ?]V`86,!]_!XL9F/IL`]W@\^5 MS_]=.:WDO4'MA^[7[NW@\Z\+30\13//Y@]6JU#88<^R=W(X`` M^&[@;Y=&#D4E!9#`TH15RUD&;<918+LB",`$3]+VF0:,#.:L1JCW'Z[7(%2Z MBC/>HYB8CADB@MPU'E*)[;X=3R8=0(=L(1A%0X4#T4-1*@`.%C M\^"GW&((:SA^,/YEY,<@:-D6`%&H\"^()IC83PQ0-46P.^2%(Z`_I"/AE@=( M&@#QH)!\M+B=A>I2$4>8NJRC;'A+;3V4&,*I!*4%3_$<[P.LF<#P*=_S[0#4 MV03%_'"$\ZEM3K'5T!>Q:)%&0&)!B9^PP?`S*M87'N:+N??,BP"I`Q'L!5(? M60RO;867BK/O.\/>$.W6SW?=(8`MF;;[Q=HE\;PF4>S?>$7[DU8SKJ+(Y9%E M*W,'%JL]V\*V3>TL#_,#?'ANO%@R=ZD7WT)+C4"0W0L70`6-+/@++&U\C23R] MDX^&Y8L):I>`AI[YHT98(^Y;>K:+1`%W8&9P5;8?=@2^@/D""B5`>,9!KQYUF$L([D1,J9I$-;/_%P&8.IZ`#84Y;[!/WH9E&#;5` MK:YZ!_'%%-ADBEM@_(?V=Q%+,FXUG/(0B(>=`&B8OSP8-;)/=S6)8/P+P7V2 M0U"$V<%41HZ%K8(JBC<._XI&PHU-I7`0PN"%$XJ/KB]?1XAR@W M-16Q"(\`-:T>'N($Q$HUK$%ZLE9["1WWZD&T5"4'6VY4<=WAJ/>I,^KNV3=S M;*+9J7Y32BE!K#7`BNL3,=H.%P45E-8;009`T<2>\6^`1X%RD*C%S8,@FNF: M*81:?#(!N-)HAH8L=C)+O$%$BH'$+98$2F@]"5B#\4UH&8.(])3"JI-0E3+AF'[:@>@ M]@L)FP[!>"_O=.`U6N]WW:_=_I#S[V>_NTW4L=QQ+S7PJ:=S>YDM?5 M6Z9TI/^.C1UN?KM*L"\VP,$6`0LYB)LXHET'#G'E4O&O#31KA36 M._:F]A87. M,`B%WC3?`J@X:.HJK%O@"QA$)?&I!4$N])7S\N9,M;BC@$Q(L+K`.H>^+*20 M@>$V"[3YFYL\8%Y'KO6X#/+>9>X$$GF#3,SVC,X-%TW;`(?O16`,8QB:%SOK M45,0XB,45]B-MFT5R*XVH>="25()7G,X;L+0X]1:"46O7.@@U5_:C8O4"^.* MD)3`/;==,&E5,[%M'4Y](6)#/E8<&=L^Q$E&U*V`]<++\.>?#G0A'HU-V^L# M](\&=[T7-F?SHJHW*RT,#3AZY5#B0-$][8;2U_'.`2`SKFT%9])/D05>BR8< MC#1?[YG!4H,U3JO9`Q3C]Z@3T#3ST5",`G@LE/I]H7;_<6,5ENT6]_#?L7B? M1?`%B(\>8!,WQ@0ZY))0K6E?!0,8`L`G08 MMM0B,$DE88^QAD`O#M9?9I&GS^$"3YAX?LAPN`JN3-LWHQD8O\GQH>H06::J M<:,SG%!QV4'AKMJ5&[![SY.$SA(?81T&IDZ);5(L>SWV*W,!O4:+%F%M.,)C MOT."M6/10#L;539/F;(?';#E8`4KU[1<,EM-@*A[0IYWQ\2$9XA6!1HLD:_^ M7VDC?7FBS_9/]9%%%>:XMQ3SMU4(XD,6QT)4#-C,^$16&0E<-/81C3CR.7(2 M)`"[1N5N2MU'H3HW(%-`.=8B%_9G#A5YIVV%\E7)`)U)^H"#O.V"^RXT&SPG M6/$TQ8YCBG6^<]M!69Z!`7A&)NKS9YN!VUOR9'B>`X+`J6+I&N(4^H7!&_PO M?##I`>:EQ-,9.O1+[K[03Y]FZFFF_BX<"P1W!GLFG)Z+[#S%J:=FCYTQ;K*S MEV?NOPA`[EPYF4YSZH>>4UE3&&.UU&F+H$M/V$R$4VD1C"7'4ROVE_N.[]_L MJ%(]T(,4LHLG;^]@L^X)WX1]^Q/D<6"NG;V-EW*(SI2S(WL'U4%M=0]@.W3` MFSR509"*3OF_?*R;1VM=L@`O%--"UC4G\J'N;Y3A'$.#I2G3^_5>]OB`UTK M:X_ILR:-6])/#J@QNB<(_4B?Q5-"7(5U4$,!57C"1*%&&2;DV)4YA8IW$+0= MP>?C\:()!UW8%!RD_D+1K@:>HE!LEFO&C?,Y]RV<&O08&(?`&%MUY=OW4^T] M3/FJ6DM.;;!9\EC$FYGUAT\KC^#G=$B>A*ZY\5&[.H?"5(BM&'&/UR4HB>![ MDQ#,CCC>EOR8U7,=``=_=1?*EYMK084H^'C$8Y'CQ6`FLLEQU'$<&"YZT)9N MG]Z@&(/<;"!2SNCW51/C=.C_\B[24:?_L??^MLLZPV%WWX[2DZ+8;E0#O7>( M2WK%P3Z>#VN*HB2SASVP^NE@'`-P/!]C^,-%A?U!B(8GXRZSDXLSF,"5J%`$ M8P,$6.<,8P5".B^"10ZH0&%22;)`_O1$AV<*!0&D@P!+**0X`7\9K2(>C]TQ MV%,K(#PH@K]6V+K!$B8GVR1$/6"BSQ&8SQP@#:$']!(VA'0`R*28`^V[* MK,=SY/[IU^>!$8/AGQSS3BXS@?#:9"I2XYTKT_ M0\"QLL&9#[&`CK931%Z&887!B,;V9'OP3=&#`I`V0^Y=_$49Y6D$JMH?3(5C M$>T4!I"S_:%IE5_GVT$&^QY200G/V&@EFQ MOU%$O79D6@<]^<6;&9-E?S_\4=T`VK*OG=LO&Y-_82@G<#U4<.66])8<"YFX M?,K'`DL7S*+,[GI-4#S!9:9*@(9M\L0[@&UA8E>I+3SBK<5]"T^)T`C.T:!0 M0P6Q\E"'4*)Y2&AGQKE$`"L$Y.1C`=#4=VEDO#GP5#A'>KZY<@Y;[7NAXEWG MMN-0;+VZ!P,=)(D#)>]52*FR`TVK%1.H\8N&/H^)PDM]")#)-ZF1+?7.P%\X MR46.0>#2-TA[/-H:C#MTQ%);2=Z4"6!LA]*OL$]IW@0&#&=BN*A=.Z2A8Y^& MRF-`A(:Y8:BYL&$FN-)],`DR?B<*CU,"<.(8ZQ! MJ]^`D7@RL,/LP8\B`E16JH!@],X"#[]IE,"_&;=$[+W31"NO?V:@6O4JC]P! M+/63D;]>Z?2[?^1J,=T-^O#YNGMX(6DG+;1I5'_HF/J,GG"<),TSFQL&^_0( M+//8C>K+Z'ZZ*H84(`93/EV115#J@Z=!MVBK8FV)]:BT5)7A$/#@Q_:GWG6O M;V$'3X78]E_]X+6OYQW,HFMM$L)BU6&D)E\N$D5J5^M^C`#',Y>MTK;#%;'@ MR='*RD29)$EF5?).315HH6S4>)>\A!W9+'QEFJX:&$(+$RK%%-`#=]88^+0. M'M):U647FLS6W,S$,IQ*4JX+5R&H:"S7E%P=5_)(C/L+QWVL1Z2UCH1]*Z@_ MIK:S5*4)J\`EU2N2DDR3I#(5*GI'%W/B%']._J>DH-.*XDWI66NED`OLD2LQFU_%&R4@31S%W.T\CP:DIU)FP3@F,V0IH MA+Y0&!IN\WBF^5PC:HNHBCXEU,!N]V$(:)9:70`DB&9X%/9OM>%5^0$Z)6`_ MBG;MM,X!5@Z?QI1N>H9YK-P+Q#L6?RH`7:7`E,*]U4A%>A:5KR(GO\A,JNRU MD@.KP_266WOZFROI0`X"+]RE:+U]T;3CT7QQ4V_U,8QG)S3E=-UIRK_R*?*[ M=!#(CF$H-]SV?Z1YSK022JSJ6ND\CC5HW`,58,!^&&U='LK@6@;AACY74>)/ES5?TN.^:)<76,1L#S?>^C%SK3%<=^;MI3B:F M662)6WCB07;W.U7;%D.>5`-YA\/^T=,1D]+:HJ#=`R'L,*@XL>>0V?-L*)A/ M[5!L=#BUZK\^A*@UE'8GDU"8C"Z/<@DMN*,J_&_@@NYG53?;LS+>)6]/ZR]; MM/;HT#,2;QKU:K54"HL,_+5S[TW=:);,ODVFR9%PK69<[&_.O839D:5OO;W7 MEWXX99V9\/'2#]9UA7^_V)\E^8B16.IR?U9?N9G3:FR:.5L9JJ4JTA]0!E6C M73L)X86%4#?JS1<0PBXMMT?%6L^4^2IEGA1M<*7TJ!%FR6CLB%)4ZG-[R4R3 MEM$NA)>*(?M=K$??]H>,IM&M1!DEB:'_9J@)]_$R75S M8L\1>K8*N[@?!NV=Q'F:[2?VO!HP>*;KZ>G.[9V+O[D4S[YE(]6!DVC=7F2P._4*(N1N'\BG-S7ULI\O>Q`EB]6J:4MB]N>D1S>-T M'/!$[>JMKM+Q73C2HS0OW:@(XZ*D4]MQL(J(E$Z%84-4X)4[CDY_Q50E7<<# M'L$D5TSW2N[\PU8JK!,NI;T:N6PR?;E4/D\,D]:H/QZR7VK&>;6:5B+%)SU) METZ-;4M7:J&L>EVT-']9GV73;=QK><9E^3>BXU0IWUB`G5:&08FU>";PZJ"]+ M20H%?1#FTN7>#^=3K=4X3:CM*+E):^1@MBTHERGC&V\/@2@H$=J@ET MRI[?F#W?*I0]/^K>WG:O1U\ZMUB>YW/W;O3GAM=/!L:JE9=%+;00'%@<5$(C M`+L1Q!VAO3&.3!/_I=QPK#8&UN:,._&MP*!E%T%RZ>[8EE@2#B[6W8#"JU@4\#Y@M7)-[0>1055Z\[!&@\QXSY`FV52W'F70`!AQ5V)@, MW^SEEJ@7'!$F]_`B2;-(YZGK!'S46>.%QP-57.UC#P=E*A5#V4;T\]B1$B>M M+_@,[`H?B(Q+RH%)-G5AIPY*;P*+Q+%#JAM*J(/U/(!*.4D9D583PB>D#YR; M1:8,N+[!'GH/J*0EZ+S0EU@#&L3F8O6S<2!]JH5OY$;+P5A3]8_Q'N89WH`4 MT)T`BID5]G[!HA`(^W=L]03?;'>IHH!+)=]M2040`!19`'.&4[4Z)4^L?^=A MV7BE9+$0-!`KO:E`$#93\7\7P%>J=JK[M7$0DFH2:=MU'GG1?0>=>#_E=0 MI]YP.+C[D_4'HP>W/_^PJN]Q+6 M7&J5='ZQ?1+D]5K5K.J-(7<%EOP.,5US`\>.),U4^:A+)?%'RFW>+_M>-J!* M'>?]R@:N8`O!H7OAVM)73E15(S596K`CG=D!;(7IBA'8O4:"_3."%^O5`Z@E M\L06,G(_*X&*@PBI+($7C7K;:%9;SZ?E/_:L/G8_Y5/+]/(HIGVCUC)JS?9I M\J<*H'5IM-J%]E\_&.P/S%#B"JBWCF()U%IUX^+B\K0$]J0+#T(%U*J_LM%< M/FG^WXBQ3S6@VS3_FZ]B1E#;;T)9\"_)\? MUHR;WO8INOR%Q7!>/3#,$/8K'1M8<25@XF*F"Z71!$<:H`QVAXH1.Z2&YU M8G6%?4CS,/\OXC[F6JC+5-.$.IUXA92"-+BCI#<%.TKXB8R$BN%5I-@NWEL? M2O.;@:Y-O*Z1$%]=8H^Y%19/;E?TA2=]=>,S)8(:^CY&_`4O3X2O<8XA4MZ\ M_/_VOFVY<2-9\'D=X7_`.N18]03()@A>[3F.8$MJC^:XI3Z2>L_.OCA`L"AB M&@1H7%JM_?K-2Q50($&*E'@3Q0>W11*HRLK*RFME)A.);.E:7%<&@FKG.G:\ M``?20-8@QM19^J4<23;GGV(.C66V;-MLM=I9\N#\UI!N.!X#L+1^O/D/CT[E M&1H]`#]QJ/VCU3;M;@N&MM70M)$YD)3"0_$0A7(M=S9K@8L)!I1--S-53"A$ MC"J@>>Q88C3):<@TT@".(^P&=GX<9-YI/)J=EMFVN]34DY.`!I1PK.Y[B>\3 M3%/*FO7*[ISE0!WNP7U.MAB??RJB9 MSK8_YU&S*SI_R&JWVL)S#9@_-'_(FBQA"A,!/SJ'W7\3IOY'Y,%KZ15VO+FL M*7C([7'^?F2\QV]O%M/3$<'+(_A*-9K6\;M$./=5WQDO;7W%!WCY^QH'XG"Q M3:O5->WFHDM-A^6R6FG855!Y*P0F]H8/1U2^F"IKIM5IF'9[41#BU7H"I\(" M>W`]>"W^O]93^1!OSO]7JZX61=MG?*RUOCC5,MHXM>R@K<@^77@NH^`??UCY MSF?G>*R/QWHYQ+2;6S[4ZXYZ+.>[WA\7W'5@_-,)R&)IJ`J)#\(0WX6;)ER8 MT;F/A*"B=.C>1+.-"S_F3G+VN\WQM;,;N2\<H'1 MK:%[/*X:M][8\YU(N;HGD?B&97J4DYW]^_!"!@6[Z36'+GD"]2@*>>:_!%0G M,@QB+TYD;22KMK)G&\!^D%8N%7Q*(W?DQ((0EJ,(/=2KCIP`$N,D\KX*61SN MI&IU\L"/].Z7KY!*5E:;-7H\A96^AY>U&%2Q+N!8.#'Y4SF6D!6]R_SB6'$S M2JFT'*TXPDXX&!]QBO[Q>L=LUCI<"%/&MY!6)E'H"C%0A:[(M>_X?NB2,U=N MK,)BU;C,46?"#'T1B*'G>H#&HL_^Q&HT3:O=)'>\-\::0S`@UNMB-WQ,A8NF MW/XYOK)*?@2C-K0^E#.D8!`=@SQ4D)^%HQ=?9R&9UZ.K5UDMN/;+F`41!);Y M\K`*%Y7)'(<#^$",)X^I9>$V>B$('U1TEKS[$R?*=CD#A*KC7'$P[%PDL.-8 M?!%M:U55*^=3V=F<@A%.7TC\AX'B0E3J65K<,:)PC"CLN7_V&%%8,T)1?S#F MAQ7^]K:QM,P+T(=&P)M!W@:C"`=;H4=G M*@<2/SB&#U;D`J\*'VOU,]8;!QD\Z(')ZBM'WFLGWBVX@E\91H['>=YQWG8L M<"-A`VM>S&#:_[,_=_#_9EPXH$&@IUFYU-F;)H*U>=31AZZ[U)\69GO9X4_D$__WW`UZ>->P=[/;!K'^;`+AQ>/**`D!QA(/H)52N2 M?M4D[TLP@8GQR4*2@NO$(V.(OECY!;8.(`?]^RD7;.8%!LSP`R4>7J,ON!-' MA!`X`:#T9PYTE/AXM701+W`C@5U["JT*\*%BB"I[SAC"[F`("\C3JF7`:0&8!24`#1Q'@F]($-:%/"09:#B0FJ"N3R6*=IB66;#XFP$CLC@T+%($E^4 M[&@9*G[\8=K9+1.18*`3J\-))K@^QW4C#K1)C%#\Q6PUZE/Q&KVCRD.$3GL) MMA97FAO[*:3KZ!$\PI]V^">.1T$_UYE@-1**X)RT+;->;\+HF`BIAI@3/AH* MW"PF!T)DS>X\-4O5^#(O,:1=,SN-!I!-'+H>K2R;?SK@(3>+C]66PD=[QHEP M3IQJ\068LG#2`X4Y*:N#HM(8F_F&IVWB`UVK4W+JO3-.LONHN(/P6.!Z$^PE MDB7:\7Z4MH,K82Z$LWZ.1]D=+LO2HTA4C/V%)+UG$:P25G;J`82S<2KEU32G MPM*GSCO".[S=FQ]MOK^/Q+W#!PYS"+MU$TZP)B<+8O84IR];^ZV:J.!CG5TY MK:.?`?9A6X!]>!(P#)QG`,B^:L,I@BBC'&S+8Z#I-<'G,>;M):ED!8H'"F`. MQ`:QUUH8Q3A1G#KJ[=N\%=QG!4%/Q8I-$@P#F0TW=4-7$C'QP(8/42G]DS"*D@Y_I,[F,'NV5I[!'$.#!@+YBSIRQYRFF= M)_PN(M>+G1+(9\?1EZG:(O*%`NP.]F_ATE[$":S&B3"`G'B5@>=S_'X2A=^\ M.&\DI/"]:C;`:B+ MD>I1**KOL$(F#8P)$`^>WU/0]][1'1I6> M<9[_S/2-O;:24=:J+;NVXV#S+>X(&E*W,((OG<`?#\"%$#7QDH`!Y?`"J>>`=/:-\+LDL1]!O",;6(_6A&M(O3-"-1C9&# M?0C)_$*4#5%M.&WRN9+*+FVT'U+7OG-U02[)1_LP=S1,4`^,T_8[E1-=.EZ5 M+79)!+,@SI_.F[YLE?-N(CW4X;&-'7/R!0K`,,4,?3IX.%L0!A50H$7,8UWP MN`!!UOK6P9,!TA7XB%"_YO*]6JNWM"H+LK""BR)824`?FRM.+?($MLM:YKTI MQ>.0A<4J<@%[YCG$"#*1JVEO?>RK)R)-0E!U4WX,Y.`#(?^F0:4D=>YI!&H9 MS?T8L^]-WKX!719U>$.DG)`#D4#%9N<@5+,FJ@8(?1"ELEA#\E@9>A%(AM.6 M%2?OJ`X&KY6&DFOP8M6N4EX#G`81UP+/4@]2A`/Y'GS"78`WNK@%;U/H+&4[ M](+')=4!W`G=)%"'<:K4B>9=B366_4@KP^(=Q>:C4XXH'4);U)6W(/G*3JFQBE67Y%M8.6<.BZ8#+-C.[LR>(?5 MQ^DW=53IIF$1*'EU>]$$4^/2J:)%?I-B=J9^B:XS]]%-B`J!%^!]5\`],)&! MJI>2*^&Y8LZ^T[S@RL1/8]H]I:&2:AE(FT]J=OW':6RS.,[/O6I+BR0PLS=5 M8\8&6\KD+:-15H)R!6$&)E012-2/P@!LUG@J8OY'1\%_D$,X'T M$E%%7[TSNQQG@'R`YSY:LD^V5Y5'![1,P'F6CS!;?*MNVEW+;*+7F_A*")0< M\":Z4HU`+"2U>)L>Q**%FH`Y,&C@I.T+AA0'_ MA"YKO,%+4V>,D=(^@*\Y,IM'XVOS-I(ET=SL')N#:'P\LV!`:6X.K2Z+TTP' M9Z8)$J5!'MX)236`]WUO6#B`V2X\-7#19)X:62M9-I.DY"02!T6WJ#3L^:U# MSCOZ\8<58;DD;2@0?,ZSR-M7N MB)\/!$@/M'RU:5$%R3`C67'?\B"3L(H$(^,3/88L)V&*7D>BID>2E:9K*<@3^:ND]$+ M3/.DT6Z;C6Y#@IG)V'@V2[5$OZ!#NNB,GM2[7;-C=7C9)+A5/4U]]'F;2TI/ M[@XIG8?TIYG:EV;9L@GA7`"V938:3:K]NJ#(Y,MD\3S`XE&(ICWZDN>1(%,3 M$V7* M%(F2PCF20RM+E>X=J2LTJ+9EUD$:*[7T`^9;56[=4>@#M#@<\YYQ.!"^O")$ M93))"8.QQA19DBI^&LM:K*Q8^F[J%W2O3&33K[]&> M3P%R:/FS@6D$7FS5)[G M:2[.5^I*=P!X**#AP[;0L!>-4B]`PW%)7=UQ-XNUTDN3P_O'Q(TC;HZX61-N M6M*BWE[&SYK3<:5&:;?FI4IGO-#!MA-@%G\+4>7VO>1QP:(/+P&[^_/.(#T8 M+-:[K2,67XQ%JV57:T=$OCI$[I=J2Q?;U5..:#FB M96_0L@>]*F^\^&ME&(FI%-N#V4&[VCS2=KD.6NWN,6:6K&J^(=Q4._7]1LL02) M^U[7U6H0-.=8Q^1<'N278G#CA5S73M+KJ3Z]\7U]7B'I;4.^?31P;Y]1"S!RPX?"6NW)OL*-8U_A0PVXKAN#,M?QB+]GXN_4KG?,1F>]Y?\7W>,\$+Q99K?3,JW& M$DSJ2'ES,&AU;+-N;>WLONWFU2_4/TA:'5;SB35@I-YJF,V%BLI;P\AILV:V M;/OEL*R2"["/B&@TS$YS#7@X&,JPK2;(R_9&,;+E:W!S@Q$O:'#^P@C'$Y&* MI<7HAF98J67ZX.^/Q6KX*N^5["7A#'(HM_7=1AF^W:4Q[0 M-WHVMX%^RZPW;=/J+E++C^C?G"9@=SMFK;G(@?"V5(%M(+T.&.^85NVH_.Z( MY;2:R'86&<7;T`CRF]!_?Y_&E7O'F?R"U_;PIHL?QFDD[F#\#UCC_;Y24XXY+WJ'X\?+@1P__XZ8S__K/UZ>)/V\(J&!5T#?ST M&RU]_Z^_)N&D7!>2X*I&BD_I4GSHB2PYT<_%'[^[BW/C,-=1X\ODCO'A_$Q6N/<2NH<^B``"+`$I M?%F5,@FQ.&$2B>);6L>9>@T=8;5NU?COD0>4+DNU41DN?IKJ4L*94JT/LF)N M?,M=5I&DTI*J!F8^"+SHC+$F>,P5I6D\O1KF0'P3/CR/E6_STN1<&@]&'GD3 MV=H'I\8F#$-@:ECVG5_GEEC4(L:4I?ZH&R-%=Q8VH>J'V#0"'AAX$6`+NVKU M!0S+Y3"'GHOOXP+SWR4"%D)1K"@Y=@;"\$/@15FEOJF7/5D-DBZV<:O#$%X+ MG'M5ST_6E8US]):,4:B8K)7`'UI(C$7ZD7<<9%'XNU)>(^S!(@5#E-)*='O4SR+/SNR`GN MJ\:F5&N8HN"M234.='[2MJ/I4/ M3H0^H$U:M(YK*B]8?$+5+J0=T)ZF&08B=B.O7T@1^65#7*>,P!.M`IGW`FH>LYLOM%9V.6,PB0?C>&-LY\6;E ME22STKKX\A:1LG'^7S;I32G1R`*FW/_<(*OQGD:Q>[(=^X7K/10;A^V3*N]R`-XO+RY/^C; MAZ(N:1\48S@ESBIY@.N_A[7.RA--LUUK[0BF_<9,9:/P[+I8VWQ]K.;:[W M=LFJ`Y;N'@UB#,*T[XO-!1Q7F$6_9=(T[<8J5TP8(]L]K0>_"_6.V;97\5:L M;1>V&/-[?@FD;8?\BB8?]?'#&E1C[@R*D:E"8`H=P^>TX\:%N1YTE92`)^ZHY MCQPJX4>YGZWJQ13V8<$R4@@_C+PQ3C;R8K48UT&?9?)8-30EGI=+W=FX"S%% M9G[\H32(]SD2&).1G;7.1IX8&M=9).,Z1Y:I=0=F'YW%N>M5B*.\>5A> MB"T981%/69U-!!@<*3I>95O9:;>ABJ7L>U1@]Z[_(N3&\G+TF<[JI=3.U>O" M+)/B\Q+W^MZM=I%G?-,^[V?UH&AU?\X5+E09?C&Z2MGZ''EPX,\NKNE:@@#> M\42UI]RW]1R_W[+^.(1XGM7S5.;4&B#QK96I?D=8_,!-,WP`1=C6+K%ORKJYHWS7$'PO&4^ M>?M[A9O=A1OAM]@+G"VW^.*O%$Q-;+^]OOO@;`-4DG!"=L"OQO.T>&E+9%B3 MT>ZMW0SG_8$'^OA'E\W0OOIR:JL+S][>79_]YS^N_SB_N+G5S&'CXK^^7-[] M:\$XV_#[;-?L+2+Q3&M&/X6&P[#OEW9F]9+E;'-SYKYIHT;:-/['/IC8<-)D MI*X3PRB6U34[W;I9[[;I<]"'E/ MV%1WG$]JU5K-0F>$['CM:KNXO\VB-P-(D9X+KIM!&JG&WK'WG?TPQ@1&#@>E MWIC-'0#^5^:W+%R%5X)#;P]`.M/:&`Q$/]DY8!LCL^7F/R^CK3*B*O(+\5VX M*7H29]M"G"K!5*_EA2R)$:$R$&>_6K^^8ZB&NPZ8DQ@GU;KEDNL<#H[D5E7C,C!0PJO"2S3VH]A/P[B0%;#FQ,*RF60,>:75:B])A9`N+7K&%Q4KOYNTO MULXK7P?M2J%_FPG]MR,MYLM_[4"7N.W/A2O5`*M,#9!T;;7,;K<+_[657,<, M(4TX&^DD5'E-,1X>C!3,[Q!#Q]PQ)@"9ZTW@J*N<"HK'P+%/.1.+&\;@(6\" M".U6NVKT\A/J^*9AF;66;=JVC4_-@8URI.1*IN&D9]<')F"Q"]J2)J"E6![" MQF8Y?TH1`RZQU28T3Q/+KD]P)I85)]N<.'ZU!_I23QX%*E+B4MK92(>9'`*Q M'+D>)GR-A!<5Y)/CRDQ!VVQVLB,T3\04#A0>[I.&399!068R\U"`1,!;/`QQ M(QZ&&/G%EN;E0G*I>1T,,^=K@G/I4N,HD.7-7(Q701XR1N1,$B##\6/.V/0% M9>,:KA./?!%K:(+!++/5:)CU5F<1.J2^L&M2V)OC>CTARV37IW6+Z7!KDK^+ M=.I[)%YX)IQD=SCDH04QAI\LTVH6S'-I1Q<.#;Z5C)#D.7X/\X+6RM%]6-\W M.$.P4LSX3/V$SN60^J_Q+WBLZ+;(`+NR<5)Q]A4KW"``886QYTJC'0^D!2MJ M--K9A0&UA`<'K%=,1Q][F)R:Q@HU']"'7+EUX:C"I&.1C,*!2E;-7D8Y+KO' M@=P=`P38`\Y_Y)39/']PHBO>%A$@WV':AY$'FS%R M@%/UA0`$.HD7#SU8Z*Z):'_(N<#MP3*1_B&Z)Z)=+*'^>R6$T6C4S2X0AJZ3 MP9X(8,KAHQ#3&?^:(O472#P@G-)SH^U/[K1>VOE<<%FC#>%Q_GDO&)SI]''T M6R_T6UNU%1S79]>?/EW>?;JXNKLU>E?GQMGUU=WEU>\75V>7%[=ORF^]*B?( M/=S$L?%X]%2-"B/'7*50!Z-0W<)1W)ZJ#63OTKDM7GTT29S(VX)G%]>FD0:H M24E&B3GP8>H/E*8'?%^Q`]7;,\#0%JI]4WHBWGITL;,HV5-920F4#"3&\);B MQ*&J)DX<`V[&ZI)A(MQ1$/KAO2S\,$3-+EN$-S3IJ0>LLY$FGH^^:G/V"B8\ MZR4^,Y\H?'1\NOX&0K-PT3)V4!IM/J%_#7*`^0L-]!\_\06EGTKOMKV*C'<) M<:.C74Z*^.)4L]J8O:TAOUSVWE80/D3.Y#]^XO\3!+>TU3=8]&1!?%7!M36P M5KELM$5LD92,R8-R4];-<@W)VLLOY/F(>]US;.X1;X_%.Z7BOX>W6L7JU^=2. MO6F#X()LZ$Q/+K,/XN7L`]`*/!^C'3%JRMJP4[7P>@-G#/_XF)RHVK0+3:KT&V-%L>CK,K6?RRD7#V, MT+'F$F+F>)R7R[0"?>P*;"^*Z-4['-'C!+0LMRN[@(UI/V`2I>@AIUBWDY2N MH-2YLIJ;I.!A^>AX$;4)SA^,CPZ5,H>*M8)#Y?SR]NR/Z]LO-Q>W1N_#]9<[ MXV/O\L;XW[T_OER\07]*Z4VX.!;R7H7O.7W/]\CH'PL':7"`X:4AT*;R5@;D M4W;3B%R0S`SQKH=6ZD]>1F'O`#DJ$8&Q=&W(^IX?>[]'QGM\_?0/%`6&M:@EQ=Q-6GZIQ_W*JEG"VQZHRZCWAE0L.NQC MN)NDH!=,TM+]J1_W9P?[\R70]N9RWM[8.]Z;`RE-6I9T]FJKE1X7H?EV%(7<.V'Y`<43/$3VO%CT[J=TX58>"G72_'+?N2-E'].P>L/V` MXK7SQ65Z$MBMLHKP<\JH%)EG(#V:YM6RU&1.NJ91_0LWP8X>WXRXM[4>Z)JO(FTQSD M#7LLJJ,ETCG]\)NHSCP#8_0=+/868@*Q,\!%Y:D66,AM.K.B)/^"$EOUQ&'7 MH>)#(MY-`S#!.J7BJ'AD\]H24A!Q78DX MD85$X:CV5$8VMANA\A"%X9"G!/ZCZD^:9W;GX(T\$:&X?*1"$5RW@,O,Y>T` MN`0=2K;^OX6;<#O>REC+OBTNV1DFQ-T\Y#:X]O`^X.8#LL6O+&J*RY\:R,/Z MRD,?9LFAQ>H-F%-%7&[H!0[P01@WZ^8:EY9R6%B/H5"YH<=8CV^HW!\>J2N1 MG,%^(4!EA1MZ\9_7PS_M6@6T"BS=8/T$>^7Q,U]NSW\"GNUZ8\>/,0_\MUH. MTZ*9U@*25DUB$4AVL]M^!E270`U!$D:/\/MZ$:./_*PIEUQXNP;FZA+3GHNA M@/4//A*UB3,X=+'$R-K7OGBN-8&U+'[:G5J]NS;8KL+`72=XC7:]8=F+P2O, M60KA#'E<_SV`AB6/=*U%:#0N@-1)YG/W!EB(QA9/-=4D>+G@K4L MDNQNPVZL!-M`W(\F7X%3R*+/)%*NAU2%69:'7P.^*JU.K6U9?W^_Q'2_O12F M)9%5:73M3J?;6A*H'*=Q[0"(6D#3]'-4U.VMC^E/57=:2&J MFYU6:Q,KW=JT9Z`TA^.59FXOFEF2')'8)=53YX8#GZGO#.MUDLGE%>$^8J7U MER*EEM'[ZI-O'O0_;Y76R[7?T>P+`ZI7]MV+__P,OL?!.O=UXU4O/!\Z;K-]B:Y`/Z,K[S`41 MXR4P4>G8M=>-BFD9K!T!*8EW?^AI:^)=\3B>?=45+X)Y]TM>Q.A*UPN\KO8T MNWOAHB65)%@<%;3FK,/C2R5PH]&P:ZBF/VOZWS8']:Z$[_XL<36)V^Y:[5>W MQ.?+V==*M^@Q@1>CT/=AMDO9^/$@Z7=MFL3K6WK/==-QZJ,3_1JCC_AS)$:` M!>^;N`0*&(M#7S?LON=ZR3G&M<()O@&OWK^59=.N'^1:MZH4K[ILI61M7^%X MF2:\1^M<6?U%Q:-5LYZ_U*S9'K9/DGZIW\-P$,^+8SS3IUDV?L'SMC0`S_1P MK@^`5?R=]8;5;FP>"SL"8D5?Z*IP_!Z%6DE1&W:EZ9Y)>,^=;A4R MLSIVK;/N%6YERE5)J-MJVTO,ZH"4_`-^$_%U[CU&2_K16N%6Z\;1RRE?G6\X!3+NAG<*\5)$GY'%/L_-F`/"%V5;#/07.5#[.)N%8NFOLW50C54S+`271Z?M@EXJ!$8=IA&EZX="( M)+./L9&KZPEN%XH-5RGI9)`'B?#I/J9$B3BFIJW_YO24,.M3*J1I(#-TLAZB ME,:#HP4`L)$\"!\3.`$5HZDTNY&#K5H#D1@^F-,ROX^'Q\N\V-2U;=JMKMEN MVS2)3*JA)%-,(@6YXM,G>C\,"GE`^'K#;-9K6MX-IB]1T]0L!BA?Y:G:#;/> MM8T!>;,F,MXCL+>J"2V%JQTWB8F??_F-A#D2Z3`$@7`W3),4&ER+Z M1CF:E%>5.%]%0(]RIB0N$Q^&[1V''/_GA$U._(4I^A$UU$U&OB!P1E&8WH\0 M%6$4<_92!I^)B<"PW9B_JT%-37-=OF=#L1$`7C8!QO\/@=JHN]$\&LI0=FW&K/&0PF"WG>#$R`4S.QB[,+M\IX7,^$:@#"*NATI0 M97PJ3Q.<1-XW[`@]\1U79,?:2S!?+DXBCSA2GJFN9QBZ%#X#K*!TD[VI5=H# M86$Y$$@OACM3(XL5@EI82]ZI<2V<2F-#5>,\YR9_ MI4Z$28)EC*3(,3P2X["-/_/R:)F!1]G/^3+PV,*3(2`75Z12!YTQ9;817[%- M"QBHW>P:I^JTU&NY./LH^E&*FT,U`R@=1)-KZ@7KUW>,K)+'59HE,/K0B&6/ M1*6-5'J$C^SCAVKA)SA90^#!E4?A1,:#"ITB>P!"@`T1AM4T:]VZ:75:1DQQ M2Y6V7=S>Q#BIUEO8YYL?TZ;YP*BA9K\H_"J2F;]X.DN?#I&3CW-3 M-B27@0'VK>S1/EU?@[O*RZ.,QZ-;JYP[CT;G9^.6#_-MVJ=,9F(X9]H.?\Y/ M-I\R$GWP>.Q&'MWN,%3.4W:63_.3BT"4'?<,5C[IVOG.WRWC(FTX%[4:4=Q) MJX9_@X`-=/(LC*R&R*HWR,%HK":]#ZE,QC%]%+=!PN6Z$2-#^I$?PM3/I!8O[$O@L?4? M>S'I;@AW;8I5/7G$<1=+N9]3V-'8^[[BR,P&@Y26!N^D!"[Q,Z3I=!)FJ>V* M5?$B^Y3L#W/*S`HB?:$;+)KM>Q4U!O\=XZP`LKANXF@0BC^(XH/1XH"/`^UJM711@ ML*@R4(44-.(Q)":#%1 MF9U8S!;?>?!\7^HGND6)*A&I/"&56P%M!M1RMA7FD9&R-'%O@J.6K6G9,6TX MG\I8JJ$X=`B'`BMV)5AO*9V/64V'S91SXJ#W(:O)Y`@J%)-8Y"C2/4GG'NK@ M_11!Z]V#H8Q;_`R7$AQEK888\0J)9D9>)0DGA,!?#=6#HE:3?3Q6V82L&AE5 M"@6MS,<^I7@"T*-&GV7=,OR\3`E-`*R\2*:$L]2%)*W(W'54+*%6>/;\\O;N MYO+#E[O+ZRNC]_O-Q<6GBZN[!>\OK(_VOH#IPH>].6*;@%$CH!)*F"U"-_]` M7@>:9M%6EMN#*+IF?.#M0:R<*P/MF!B..B=2['_RR/N!"M\@=1/@_CX2(*S@ M,G"KY4:;?*?<4`-H1J%RY,$P@)04%!IT!BF3057J$MGL/?;ON""`Y%B-3OU7 M6$=`,BK^"B(1K9H)0PE6[>B']^B$0(83H)1% MO4)YBC2/9@$7&BJD(O4$+DIP\"4K552^Q68V)CH7Z&LR!T-T?7!],BRX5Z"1 M$BRH71#?I=9''CN0DP%Z!29A!)L9I$G$Q884>#@1.5G;.$U'FF.=*\2>,L^KSH9[GC\8AU7_@+/;ALODE2 M&G@1G"O_41UV=3#M#6=M1P*I5.)(C!V/SJS$,=8!1#X589+( M.(Q$"7HG8+#GS"L,1`7)P.B'01KK]BQ.HDP#JHB(GA096JCC$_0?VA9<]"NW M=H9>!(LZL9JY.7%2;V:#"N)T)Y8:`\?.)QH[`[(V(T'UQWA_3UIRK(GC#0I4 MH=.8%^=TA27(]'IIDTC0NZHF).._[_AD%(`9CI4=:7$E94?5YCE\)8>97LYK M9=S("+\)/4XD@BQ(!$>AS#FJ@%)@L%.!AS]I=@AE1[ZT;KYTF7L%,HJ%HT+F M0R[AE)S7+>6I`^FX?Z4>2EYC[`5AA$:)+/$W"6,>'RA/#E@U;IDAZ8.([R)R M/;)$T2Y2Q*\[DUC\8JB_5K">MFDIE72B*C4L M:*AV]:GZW$L.]-^]FYO>U9UQ\7\N;LXN;R]N]Z_L](;=WVME%[HS=]8XFK:` M1K`W**7A#(9I@N5ZR7E4[G(SFQW;M&U;<[2%:303GG&"G%<4/&WUJ:"-QD78 MN09\"59/Y8*E=YJ`Q$E83E.C#!Q.Q29S)R,&]=%T(`GZR>'2I?],07O'T,", MS:1;2[%QZKWC6J8*'[F]H+,]3W-&4LC?B4A&'@'1"2\;5XMLZ'8R;QUI=VMO6:PR5AYD#G_@KM-I8S]\ M,$".0E_$$]]#F0PF`P?\Y:5L7IDJ-D[FO$/&^D+0[T4@.!Y_C_E=N`H.4-+U M'EO&HG2C)KML0T8'7K:)J,2KT%\A6!RJ_IL%ICJ-MEFS&Z@8L`'&-Q3(U$@> MA)BI(JR"0\!:LS/)=WEL&X;JM-3&JP+`DASH>!"WD8X,/K*YGH+;4-1.Y#:I MBP0/A4W/5@':>NAZA*W,`8+0,2.85#$,@4BZ(&LML-1IFO=61=$QVFDZD&HFS<:[&&M`T MS$O8.Z`%8=&B0^>=NATD":YPQ#(XLA'+`A9S-6E2M_]GI0+4'"844[R5?L)* MA7X#$??UEZ'\\0_X8'RGKY+'"6PC#$-T_Y/\-@IQY&3G`GQI,P`O9T+EST=U\&69,XD$!8'4#3NEY\ M*F"S,Z;Q+!`VLX852;;9M/=S'<]+^GCN`O[^'MFO]PO^"Q__/U!+`P04```` M"`!CBJ]`1/.EE^8*``"VF0``%P`<`&1E9VAP:RTR,#$R,#,S,5]C86PN>&UL M550)``-*R+)/2LBR3W5X"P`!!"4.```$.0$``.U=;5/C.!+^O%=U_\&7_;HA M!&;F9BBXK4P&IE('`P7,['[;$G8GT8TM924[(?/K3W+L$+_)<@A8RNXG(*BE M[N?12ZO54DY_?0Q\9PZ,8TK..OV#PXX#Q*4>)I.SSM?[B^[[SJ__^><_3O_5 M[?[^\?;2^43=*``2.E>BS!B#YRQP.'7.?W2_85@`<[ZMZG)$50?'!^\<\>M] M!-Q#RU^<*[1T^F]_<8X.^T?.X8>3H[]**`^/5Q7\?!>B$"0_U^,+3(2M M&/DWE&.I]M!'G,><=1S9QM?;T=H2CT8//@":^#"EONS'_,"E04^6ZVE6VHNU M=Y'O1GZ,TZ70-6,%/(9`/-G^ZE-9^TY5D!K\=.I3-].L+WFC+(M>TFI,SACQ MAYBAB'0#R/&A&YI`SYZ`#]N M]H_RO*)71M=8,"R M)B+FIJV(7S/\%X=*4J+'HR"(:^MBT0E2^3&C@0KDM%VZC24.91ZPL\Z1F-DC M+I2D,ZD`\CO.`O!D&HI9OP4:!ZY+(Z'N+;@@5!?CY0N$&KU/)68#:6J[$Z[> MF,75B,R%=I0MA:H*;C+%;.`B:U>"_3NSL+]A,$/8.W^<`>%0/T#*R]O`1H6E M"2WOS:+E$XQ!*.BMEG`84KZV3SU(:@1M(*K.]H2Q_J%9E*UL^T*)J^GC;!1M M0=LYPKY<'BXHNQ,K^QT(7823")H6Z(@;T=F*YA263"THS'1SRL;*D];-IXJL MK"4$:H!@IN,S1#,<(A__`&](@UD4`KNCXW"!&*BIJQ&TA+%&9Z6"N-:Q=I,ZBH7+JR_E2# M-TJ67<,F[DN,'K`?^PCU6Z:2PNW%0V[04KHZ^I&0G$#+W:<:^*I`2-Y@ M,_VXG+:W(+`%[P8QO2ZF)6XK=15@F#DSI+[H+?M" M0]"?`\M*6T-,J:F&^F*NRR+P&JVJU3+6,*0PV]`8URV$"!/PSA$C\MA16!`% M43P]BWD`NUC%F(9P&_/U''PZDP>F=R&:P#D1N]`9PQP2G3:UC)C0.R^AG-N? M77G+G5F?\.*Z\'Q@ZWVUK@FCX"M!LQFCPCAI3(,1D!.TENLZ0,QTU>Y"ZGZ7 M"13`N#S@#I M7NEQ@[`W(DG,?$-]E8]<+[S7).N`M^M]:EFNX>HS&2X7?@[';MSCKL>Q!M=Q M>V6!:!VIO:1/"RXS=[)7F%`6PU#K'12*[B67U<#L?(NK&'EID&HHND[DAT+? M"P#%F*LHOY<,U4"4TF288[.Q.;D.I\#D`3*#*8CY8@X"%AK`)>7R1/)Z?(\> MU8&D1C7M92?8&M:T>^BX3?L)FV6*=Z-3C1I!2XFK@Z/!]LXVTW;7XT19I=.U68ABWVYQ`;5=%LC M:0EIM0"8N21>ST#J*7:N@B)+;3 M-&M6_0Q1+;.[L\9X5[^JO&:EJ9=IN=O40EP\.JRTWLS%)M4XL4O3-5!)V4*9 M%@*&#OU/\"#ZF%@7XY>>-D*0'\72*6/_,MF`),]?70`*(Z;.%]VB.MMXW@ZS M5TS3N(75G=3/"!.Y0.E-GDHI6SC20L#0S`O$OD,-`GGI2)6PL:,6;.D,.T=6(^.CE5E<&L&E%<"OR?FC!";" M?+H*YQN%6F:FJ&Z>BM+=D@6[O'K+%+W2 MS*#"%PBUP@G9KB^J6O,64\\]+7P/M?Q,-@]5Q4#%HI5F(' MI,ZM>NF6_QJ=[,7YT_8Q7C332;ZL>^'3!1\1#S-PP^TSG8I5O5*F4['A-MP# MJ87P8^98F/-Q^96#-R)KYWG@AGB.:Q)7&E3RM_.IZ[@TI$5OK>F;M=;L=_#@ MV1SJ1Q-,N^4_".0*\B.&269T9I^Z4[!:(V@]I77`)'P>OT*H/JM*[BFBZEB] M6LQ:@O1`V75\I<&%UXV+MXVOO9;(VDZ4#CP)6V_-6O16UZG_BXFGL=$N*6PM MSB!QQ'LGGK9.+\`/B_888 M0R3D\MUR8'/L"A^+#7V$`Q6SS>JQGNJ&L+WFK?3\0ATB=RKC%*F"^@Y,0=): MVK2A28DR;#OX=T;0#L;LLU*$5*?2#3>2BK&[3GP@\K;*4[*#W!#-816*'!&] MU*$MZK*6XF?`E_*KV%BV$BC()INN,=!(V\Q+6,MJ+10:ST2TEOKSU`\W>Y_* MA5))6<^A$I*41\5^M)T<_+]XBL`N(^V-\@=,>])$F,$`R4=F5S]'Y%/9==[Z M5S(:5F1]%V@*7,K_OPV;"8IVI%_#J#X`5,OM(;T96%(V%<$K0]C,?HUC(T)S MHGO(:1ZQV]$ME:%>]@%](!2XXESWR+!<3&&T"^#QG"NYK$F-48I93Z<: ME)3)G650O&B>W2H^\,P\N[)*VCC67L9QC@O*-AG2"PII")O9;Q4$%H^]ZP$R M-)UK0_7T2V;UR%R7WB?VGB`P]!Y(JNL]';A_1IA!@P2\>MF]H5(!3_V-^;8B MM66VKW,PGK.*E%72KL=S-Z4LO`<6-'!WLC)F=E4%72I?)P>'F;>';F&6C*[K ML2Y_U3+6\Z>`P]2U8Z/')0DCYX_`7*Q^(5`I9CV-:E#,_+;6FW7'T\Y;K!2Q MG\!*,.H33]NYRBOL'1!/_I"ODL^1+]6_`8:IEX]G*!AM5$W;]R.W,+GD+%8[ MNF#!6Q`O"$FIOVS!._\O"$GI?/**;V<5WP$2A@A1>3"17MZ5V\_,Y=WJS+CM MJC-SJM=/CML2Q(1FQ8&\XE+S:4]J\B!ZG/CC_U!+`P04````"`!CBJ]`AOS& MA`\5``!910$`%P`<`&1E9VAP:RTR,#$R,#,S,5]D968N>&UL550)``-*R+)/ M2LBR3W5X"P`!!"4.```$.0$``.U=WW/;N!%^;F?Z/ZB^U\JV).?NDDG:46PK M]=2Q/;9S=WWBP"0DH4&\=_G?_B\(OD#:^R5IJ\>:.AX=_]AC?SY&,/#` MZF^]KV#5&[S[6V]X.ACV3M]_&+[[<#;JW7WM]?N-OW%V/.+?^!5Z./N5'].O M##[P#_W<&W?\E7>#W%=\A']_`@'L,?WBX-/1/`R7'TY.7EY>CE^?J'],Z.QD M>'HZ.DD+'B4E/[P&*%?Z9926'9S\]O7ZP9W#!>@C'(0`N]M:O)FR>H/W[]^? MQ/_*B@;H0Q#7OR8N"&/&:^7J59;@_]=/B_7Y3_W!L#\:'+\&WD8N5L8+-Y_) M-O#N)/G'(Z:N/WT$U*7$A_=PVEO_^>W^:K<>PN&)AQ8GZS(GP/?9I[@0'\+5 M$GXZ"M!BZ8")5*5->Z!V?SY>]]/G^>CI)9XX=T3AYC[Q*'*%Q=X2FABWBN.NH5 M`7HD>O(A!#,?SHG/EZS@V"6+DQBDL*GVDCZ$((2\_=OI!&$V%2/@WY$`\>;/ M?1`$\9*B*+-DH^VE_PQ\OGH\S"$,[P!E7YS#$+G`5Q2XNAVM&KYB%LD"COT0 M4LP(?(;-];K;E%9)'^9,"UP`9CM<_A&Q;L?ZWRW3"CTGBR7[)SY^GV$B17,4 M:I_1BO`PX&)Q`/PS27[@: M!_W3P=HL^F']L[/1`D,(K]B?0?H5'SQ!/_ZV4UW8.4U494;F1_"T[30B>>." MSB"5=JZ,\_X@%%R4.=7PS\8Z\!VDB'ABNZ6TK#,X/0B55PJ?ZOZ],=TGEE0BV(3] M5K;S%I9W!AWM:#OBH!3`=N-DF`ANTLK3L"GM#`YCWRH0?T-!Q>;UXTG>$=:= M;TS2[_SF)7OSDMGF)6M.U#@(8!B,G[@_R0T%1.4+'H"_K%)P_=ZRYNKGSO\Q M]OA_^`G&,_`9J&`^A"YG`;$JX@>':5R4:2X)JAAURLF350+!IC%WA9R84H2LFH8"4;#'#SCE9 M$@HBZW=&-U?Z'85+@+S+UR7$`:P?$J7E#?ON9&FHDEV_9[HY'Q=P"IE<7F+9 MPG,2A,%:4O&P$%M%&\6\6P2U"-C5+Q];NW6Q#S#)#/38P)H0_,*GR`3%ZF4Y@174221'73 M'D41$Q7<2:*RR%HNFX6WPJHO0[FZIOV1Z@Q*0;+)D#X'2Q0"'_T7>OR"711" M^D"FX0N@4$R>N*)I)Z8Z<_5X;#+%KW`(\`RQJ6*-%(:7KZX?6^NY&L$GI`?6S5C[,5W,?+WO>M-=-DFG(']%X6:8+)I)4J=AG=@Q2U7>4=I MOH(S,.MU4%*_V'VZ"\PB>[T@Y#WT61?U[@#ER)7)*ZWN#,SZ+?1360G3)DL^ MW7K((XF!6%[!&9CU(CR#V&4*$))86HI"W@V\EI9VA:0>.=GK*^T$%=HL6"P#;I.+8.QY*/GX'4#>%5Z?>67$%FUJ:BL[0]-A:7OB M64X5>IP-94E+DM_X>1=%.$!NW-ENI_&7;^./E,>3KN8AY",(.7'/22H@"F@F>@1,SLF!5K",_HVC;NC,QZTA2)K3K1TZ$&BW;3 M1:U\PV"YI(1!XA`4IHY\16=DUB.FA>QZB#;MJ>LAMUH(G)%9#U@GC);#M.EP M7L^ZU[DGW!G]GWC6]*G+)O]XW0%"BRN0SNC@+V')0*Q)NK._1"/5^:+?1"'$?A MG%`>`"5-7['B`63^E09BDSE:)NQ5$$3*5"65#B!!L!0(FXYIR@05YU>5K'D` M287ED=AT030O[35B1J47/YJ0_`-,'J&28ZVT]@&D*59#8]-)3>:PO8$5(E'[ M`!(;JZ&QZ1AE)Q&SE/$AJ'4`&9'E4-ATM+$C::W-45'C`-(IUR.PR7.DF,I= MIIKI="FM2"K@L,8M)'R?Z\TS].89^GX\0^MH2YF\L\6B!^3M*1'=)K\.SQH5 MK&7D*4\"<1*?LN*&?3AE"JX80>7"6W7*'PLW82#S(>3U8V.WCF&GC3PO(@2V MCA7Y86(^DVRS$6)?.EF>'.UVNA9/:+1FRAGVJ(.FD2@&PRNHH`%<:6 MZ6RP[0=4-OFK#2O2[1+RSL(OR*5Q%P(^2DJ;3O.JLA!5B&_3B>0-P20OY;KG M2)@*M75-YW-5X4H*C)[32'%\;7QM-)&@QB*HK6,Z7:N<3O-\2(&RR"Y(!5TC MDS3B!+5,IWIM0IHD+)NL@@OXQ#H70Q2_*)C)??2963<\0(`'U_,?`R;A!((P M$I[N-VG.=*[8-DPWQ=MYAH)[F&14_\(TP!=O7#,1"N;)*3B?JD3;\[JZIM/3MN%;"IQ-=^PJP3;9 MAYA.5]N&.2$HF^[5)8[OFHW\MI#I?+1J5U2S4MND]!L8;GT*+>-"E=LRG:=6 M:5O?!)Q-%R)S`&19-)V-MC%#V2RS-EQZ3,/'TSO-GT&`W#'V+I`?B;,FU-0T MG6U6A2$)*#6W']MOZWZ%:#9G'QNS+>4,S.!-Q/'=3G?N8M8SU+)%TRE@99C3 M`''KJ[%@&)9D;$JS-4D=:=?6-I_U5>DFL@P,K4);F3"N:OV0ZR6V[ M7M:!,FJ(U-9]O!%>F&WR+PWB+P_B.XC`V@)*.SSL\P;&W^!5)];.R M>EU%:,Q93>I&3[#/?N6#DF`)6C=4U5!:@<0B8ZP@X46\!H@VLF7EN[N%DW+2 M]W*"":BI4GG%9K8*SG=($<^`#"(_[)RJ]6?VQ=4&EQ;.!%Z'W:R!\8K^-6

5Q27S&_;[**+P_4TJK2C.&`%%5F%:'9=#.G M?"->2Z:HFN'H+E7R:J!T_NY'\?&83#**]1,R=6N@;`N&@QT5ET`%5#9=5=BUM055WKGTG?%!"HZQ.F(Z)4>->)V:8]8)4WXANFZ_"!?R:G MHYLH`IRY-D!1P!](BI])NH,4$4_B.;NN/FDZ[$HI@KA#'=@4P!&O=DG:RZRX M\2SZQ!TD6;>)[*OOJNV9#O12-@^:`+1I'UP!(M[,;WUC623JE`L:,QW(U9Q# MI3Y1HP&+SCU%"@ET=0A1:Z9#O?;4(^I48-6.0="IMQ'&W/6W"4'>KH`-IXO: M=DT'ENUSYI!2ADT[&V&G[Z#+2#9L/O!MCW.+E#;T[&\$QR:B;CUV_XB8>1S& M(EXCMR+&M&%+YD/D])#=`G[GAV+"#JB%WNJFS`?8[8-?,?Y#V4EDY&]J$&2; M,!^YM[^UOXC;ID,YV3[;>$7/@S?M@MSCXET$KN?XK^$ZO;TW@X/(Y]D0)K#4 M2FO,2:$]%D^BU#?6!3[UKTVF?UE-MR1F;]6RU'="O<-CG,90!D M7'(\"=RO*)RK)#O5]0EG9-9+MLY'=KW:#7<_%3(=H@*\YXP2\?EK^9JU+= M&9GVHDG3*(VG\R18Y?L_"4IJ*CHCT]XM:3(DD%B5N4HU.^;(?E]4N=0;K5?8 M0$:2LIR#8#[QR0N;/SU$H1N^)5YY2[SR'25>N8$A[^)L)#XC-E8^K[XQ::[P MYMV9L1NBY^0NJ,1S+LJ-'=`CNHW`V;2M:Y8'UJRMW$SIE03F<-GJ=KF';,YP MD0]S`C\2?>.TB\\9#E+4V5$Z4H]-7ER#=TE8_2RU3S7!&C?U0**F( MSB^6UN>=D'>/[=8UG-EFKU1*:<.F2+7$J_\OA#V)L/7=PJ9SC.UWJBW';],M MPOQ4,D$8,(7@6?R,KO1RFJ]F.L&?R=5T5Q,VY0[A![9,O-2'/\9>>I`_(?0! MTF?D,CN0GOL`"=UT2NV8?K!XO]U!634VI3')'-)>$SQC,];BAH0PN`,K[C`\ MCRC/:\\P\=#]]?_(/#_1N%73"4OVVW=:*JKSX[>BV2E_F:JNING,)FTU+V6E MEX&VR(MGQ8/`9GTO>KM!6TWH\;L(QG,F9P;PX?:14^X4>(;)O'>%Y1X05F_+ M=!J2O6[SFJG'JI/\_(OT&R6(S,3R&J;3C.S9(*Q60MV5@;W[U+<]--LO13L! M02W3V47V[T@7*&)#M0T)`LP^GFHXQ%?TBRC.\IZ7PA'=%:0&C32?JNL'<4LFV)=_FZK$@6(EO5 M='*0CLC<>N2R*VCJV]%V/LL5]H!+UK!)Z07Y?MJ5F#IK.#=,2] M+'2;4M:6KC+KLP"P3:?S);+7WJZ1KFLZ44A7[.ZBM"FU M$]MHN!!Z0<$^7-7<I"5!%3.W%%R+ M7!X9@1_(-'P!PI/ODM*FRVIJ.MV&5K+58-ODRZB0?'/=5H(5@:%**TRH3)= M;7UC]?(54A<%PI555,T9F74[=384RX#:9#/=;;J<=(!/515G9*5KJ2&'`I`V M+8CRH+58/<[(K.=(*\=JL&TZR^%BC[''_\,?P'T&/N^K21Z\H@==P+M*,\Z9 ME6ZF9LRK`K?IT*=<]C'3#J4KIH@X6EB9]$)]Y\Q*KY1.MDL0VW0N]!`METEJ M+>"GN=JN\)30A?1#GW(M.&=6^JR:4:V`N?/L\>7TW@NTXQSR58"Y`(F/&=IB<8U=3*U';.#+N;VE(H M"[+S$+R)LG>?TV?G^9LQ.V/<>7`2QRU]?5V"GH@7GS/`[X]JI$@#M_!G(VW`. MZ>,X6!(*Z(IM:GQ^3H#'SP#Y?!+F1[6@YI775LU]_R$[[;0MWEJ6Y(;^ M>,*_SI^V8__S/U!+`P04````"`!CBJ]`U;S`-?4Q``#WUP(`%P`<`&1E9VAP M:RTR,#$R,#,S,5]L86(N>&UL550)``-*R+)/2LBR3W5X"P`!!"4.```$.0$` M`.5]Z7/<.++GY]V(_1^PWA?1W1%5MF7/S(Y[CA=E'?T4X[84EKKG;72\F*!( ME(K;++*:9$FN^>L7%V^O^P0\P;R(L_0O MK\Y>OWT%8!IF49P^_N753_=7ZS^^^O>__H___N?_N5[_Y\([+';C\Y_KG&#[#'/Q,YP)HJM?O7_\!H!_OC["(@M,*_!BW/X+U>O0S?O?Z/7[&WV&4MI_RA^HI9]_C!_T1 M;!9^RN_/.D])XO37AZ"``+W?M/C+JUU9'KY_\^;Y^?GUUX<\>9WECV_>O7W[ M_DTU\!4=^?W7(NZ,?GY?C3U[\Y\_?KH+=W`?K..T*(,T;*CP-#RZLP\?/KPA M?T5#B_C[@M!_RL*@)%]#O`OKXIX?T@PW^1WNQQN^4PD>?X&T[])X6-0P@@_X(]K]`SZ M@/_%?OT*X$$_?;FN9R$S'(LWQV+]&`0'.DD2/,"DFNK5FT6X^X#%/_M#F[M/ M^+%#%OOO\D-G+DIDC<=;F,=9=)F.8[9';9GKNS+(RPE\M^BM<7Z?E4$RBN<6 MI35N/\-Q[[>FL_=>D;F&X]YK0SDKM^604^.7V7F+Q(I]0L_O<`:_EC"-L"FD MO\64$L-.[2%>$/"<:-(L[$R7X+4AR[N21O!Q=_AUC1>[M^^9!::_^\=%=J0+ MZ29%=J",R]-UNLWR/5E@-@]%F0=A6.%%Q'B;!-/U3W>O_EK3@2"-`*4$+5+P2T7\7W^F/,PI%-K# M/60U`/ZU9(O85HT\:@GAI+*]'DJTR;N8"?*P8@O]J!")C7@39F@#=RC7'77< MYME^!#XJ;K(1+^2-@1UH[[&V0?%`I*IV6L@ZG+V!25GOO;"].%N_/:OV;.S7 M_T#+;@DQ7_?!0V-36[9!,-"*%1`RV5>;>@#XA0QQ@.HY>;6ATW(%J+17\?4= MZ"E:<^$U^K'0T=5FL!M];3,KT0,\#)!Q/BCN'$P[T>"!:@BU>*@7III

TK`%N3FW$` M#W2QB9J=93L[";E*-+L&A3XLJZ_G""-YD%PC7^;KW^!)JK#]L98U=LBJX/NS M@8",!&BH2Z6=DVN[>BM0C:'BBO1B*N157(1!\G]@D%^FT06R]P+E M%0ZWIK\2AOO*P(8".A;@P<@[B@`>[D:-%V/>EC:KU*6MT$I=6=8:7\4)S,_1 M\QZS7&Z+NR,M6^(^FP*+1H:!:IQ+(SP3PW;M+U<9AM:7KPE+Z>E]'N!CRKO3 M_B$;O'/&?G>,-=WLL];_R.SO@`YPHXY3>;2E@=S/W-8]_C=>>*^:[?=9>E=F MX:]WNP!]H9MCB4]D,2/RC:N,T/8N5BZ$:'-(J``A6P%*"%J43G>XEB2RO/O5 M4#;.5EA'TY9"2152OT?3"O#0&6)-\WN,"8\"\-_=:/(T#FUI)N\#MW60^W67 MTK8->E*$GW:5!"+SVQUC3=_ZK/4_9_UW@`>XT;BI/-K2.>YG;BL=_QLO;>/J M%!B)X\\?:]WJ]5D5&AO=W>7]G5M%YG_UOLH*/KD]Y3P/BMTFC?!_+G\[QD]!@O!3;,KS M(,]/O1655E7I,'!+B(@B;KDAQ;I"FQ*4%$#0NY.^2=+%^(? M8$.Z@"AEZR+*BQ;D,+@+9$^<%7B`CW&:8IU#:S9E93$9FUM:-B6$Z+<2V6S: M:R-#V#?C9E;0XM8C#+,CXN0+#"'BZB&!GV')TC]D&Q$9F=UMB5R`P<+/AH-F M_`H@BA5@-`XW+2,ER>OQCO[#3Z[/]G!X`;<0/3NB42-XGA5E MP;B1+Q4*0JO(5`HQ")\S`A8.A("0U$AUO,B,%V=+8W_(;0HQD5L\Z*E6'QB: M>F4[AJGA.73&.8A@2G;4Y.\>+$0J1DDQ#A"R:P8!&>UJ$9J'5_MQ5Y5CPE53 MVW#ZC"2B+&@?#G!('(",R[@(;\U@CPX/M"2X*7`<13W$9PQ9[,KW7(;>+`3V!!GBHR`"B`Y@0-)3@*HAS M>K0`+N(B3++BF$.PV6Z3."@7<4)T\3)1VO4VR]<%EC9&SG91[OFA>JM@,M#( M`;!,U-&M!],P9.[$=&F=^S%]471=F8;.0V]&6RCO'1JNINGX-'PULWGZ?8C1 M!C;^)XS.L_WA6,+\+MN6ST$.Y9A1$%H^[U8(,3R0JPE`10$J$L=`,1;F^A[< MYMD!YN5I!5(>ZW9/$744:GA\J*5--D]*2O2.8[3,L8TD+"^_ALD1W_#Z(X$U7>=((DVM/815(!H+UE:9%2K:?;6)`J;V(JT\1\7KS\?K3]?WUY1W8 M?+X`=_91LI`_GO\:\'^A(9PO:Y)>]`F3M\R.#E:_HHMQ5@98[P^<7 MF)`N(T&.C8DQ6OGD+K$K$DBM7(P2,%+_H&TL&@,Z6(.@`-<][QH;$GAUU\+1&=<`E4Q)YR M?\Y*J+^?XXVVJM9\=OMZ049YM(W3X_H\2]%\)0[I@I1(<*@D(>N<[0`>"UJ#/=#W,1*XOD,Q+\^6MUQR5>?L MLQ1Z[B2.IP:H:V1J*8=?4-1BN9N:G30DKL`X-]>.XG\*''H!P-:NPVPOJ""T MF]>D$D*VU_)MMSA)&+QQ]&C?J*==@R0G/=6R"9+]/J;YR+AV0Y:6,C8'ZI3/9K6N&F/=PF+*4*$<3)6$A-="XRS?P@RW4%9WY)PS)] M@]/=%:B?`=A#0/LIX#X#W>>`ZD%>'`PO_\[\.RY>!DS#>H>+(,EJ_0L:,262 MJ$K-\4;;KGW!89=3CX$%L%G;#S(0H;@HD'_NM/Z%$?<%Y?[?WKY^^_8,GT.! M)TSS)Q`Z!-W'(`F6^2[: M!>CF$>F2J*%8'LO54D0&D%,K16C][/I,K/6/LC)H?ZAU[ZC'*,^;:)HS>6*E M]?FN[+/$//_N[=`^GYU]6'WXX[O5NP__FYCF#^]7?SA[MWK[_H/<;H.@!#\B M]=Z!]V=:0(LGIE%$RI\'R6T01]Z>HS;A;O>E(1?B>=UF.EZ.::V=EN&G^(;[+4KAM_!BY[6XC%[MQ!:7UJ>=F:?(XM_3/`Q^Q7D)GG(Q]O<:0E9%EZ7:$8"/'0)4X444;6S MTN:[*EL>-FQOEV%;;TMH_L*7Y[R_PYO*^MUQ7^WK>AO#@FWY#OROXO&&4([M MWE90`6RK-QF.^R.Y"D>JS.*R7SG<0;1-?8+7R*3OX:>LP/5_;K;WP5=9D,YP M)MNW'@S%Y&3E5S,`6H^W,P>@DX!O\33?D8ID17F(G^9#'!:QX:W%[S!'_?0H)%F>8 MW'(EA!E>QM"SJX<`,@8TTZXJZ((.G,G48$#HLLS"$B^&BHG=OZ@E:C&WJ!^H MJ"E\Q.R]`%'MUJ*8"__#NA6S@=_=%N2G-#C@*L`Y[I<1&6P[>H1.MQH#(93; MBQ7HTOBSFU#*0O:VKKS7N;AUN<'AJ[QJ4R/0=Y^$YI[JB[U"+#'^,SW@!5X9ULN] MF7!5^*7?#Q:]H)%9>[.M08M)1]>IHI,CXL5*M9C$'BQ-]F5[>;?614O6S,;; MGZX$D@5+2>I5%P*.7FIT'_"B#)JN/-1J)CVI;%E1TS)I5J3RJ8V"R'9HXVAB MHB`SPW9^K0V$PBU1!$L0X!2@0Z9TR/+ERF49O[> M**F<)MWIXZ27@&<`$E=E:!!7-SG:Z2)7FEP8N87Y';X8+UGF-2=P6*Q&(I2R M?@:B!3@(UP4F[ITA3;8!H0.0<810@DN2@,:(E\`920,`Q(K(!)( MA'&'')&*R1$CU"^W2*%E,0Q1PHB<(Z1F7A<=KHORC!2BBXIX*2%&U#6;]!V\ M:.:E!H4.KGN(<(OIFZ;8DB&PVY3.T=T50U>U6E1^X5Q7G"[8LT7%&5T&<*8O MY-F!\4(R^G12K&DO=&P>SUBX,GR?FMJ?MW7I3VWCQZ=V:`!%XBC5KT4(&DK_ MO&QS`9E9Y!=Y;56!]=_SENJJ''AR1752O7-$E$N'VE6-3X/P3[?,H*?!K4FB MO8BPEH$N2NHJ>A30:G%E$,V24;D"DT;HIPLBCX)8H\3P,WREH5`29'@0N!IP MHXQ:B2C<(D$8)^&AP*L2TGK\^Q2GFN?E>Q&B4JB_$KO.@E,#3O0B4U(RMPB6 M1P/XFN1%1&J<))[&HN;^+)Z%H>87SZ<(E(Y14)HTM[$G6CJ#>`LX*T>C1(6( MPJHU$[,]K+=+RJ340[VH,K$0^S9U7Z$X?;57:8W-JY9/,#TB-T"G&DMOJ.5K ME`-&AS>\Z!`OE%J?7]!A@XU:`C"0EK!Q>N3+@W(-^PS+-&-PRD:F%=<-[A63Y`LFUS%NT M099W%A;3N##%7-8%-@[@P8"-!FRX<^.L)<&/01H\TMT&JZJX!L%V&R>X.H*[ MB^O3!,C9ES@@*L[]'`<+D!@(@I5(@@(W2Y+^:N1T(>);\FIY]V/)X?-(+S%1 M'79V6W)X5YW%P_4 M8!1W<\%?W5UIMHELVHUK<;1S&,CBJ:8]"/V09T5QFV=;:6VD]BBK\.FRU__8 MY*^`_MF587?*H2:VI_!H$S$<9>SCA:>)=A<9`@AC;1/DYCC$S48@PV!Y2"8*-+4T'%X;9FDC1!5QJXF#1ZVT@KLEC=S.E!9K#! MT\2+N\708`%TN^AI+73^K&S"F!A(>U+>?DV";T)/K<1Y], MF>T!\'.69EU&F#70B&RH::V"4T<43C?F;(!61N9')Z4Q4M$^9U4K/[8H?>:)ZM:)]D"/)Q([R#$">[6'37=A&@:N=M> MN6KL],KU:0#'9OHV9889%LUHIXS*KOA0_(AJ"-`+'1YUF*E*V,'Q+X$::D+G&0T%\6R'I?P:`\ M2BL1C)K.#P+=+G>3TR4)$%CW;D1AES?[^("Q"7$SL(!L84> M4!"GX)%\CX1\C[P2;>`T4#\#_QOGRY&\.1BB0:32/_I7T/5!W/H8.LCJ>1E: ML+*W6?DQR'^%I`G)7?V:^RR2X,W]+DCOX?Z0Y4%^NMX?@CC'NE-0OU&R?YGK M"5:W-/.]EN$5AFIFT$R-'9ZAU5H!&C;#SP#U0T#K*2M`G^-N`[37,]O> M_I9S;L-K,;4)<5=@]F!QDUY^Q6'V8USL,%,W6[R3EB4W*6GMIC=IB#)(H\$T M=`V`:*]TDX(N(?:%,:G#-*>14@'DVL&N+&A+%\TLBYG!'BT+V:CJ2F,US4D7 M/H-$)VWL>'`K7/>%WE:YAS[D7T6ZGNVF?13NI=XTLP MBI2IUB#+U:M;S`W@!\MN:I1?W871Q#K5JQ4"+A1&TBZN+6&/Y$T]0+1%Q_'M M=-U^K_&"[U6OF\CLC-LM[-T'Y;!^]P"1%M=W6#;I9A-;IIO/97<_,$)4I:'R MO^?Y+&)[9A,L?,I2^"F%!5]MN4POY8N."%39%KBNZ* MX7`U&&7I:4M95]M-'?[=[C@=J[MNR`@^U M,!&ET6[P8@?$+U/"$3NC!01U:]@T;4;?U.D:C(E)6W^'\>,.S;=!2'L,'N'G MX_X!YC?;06UQM:F;.J/-9*\)8O?5KYH*5',!.AD^/ANV0/3!:B[X#@(T%WX% MPS8)Q-K07ULWHO^*`FMFU!-'_/18E.9_< M9CE.L\6'!>B?R8DTP"'^1-4/JKZ]Q'Z19B6((-RC5YJUVS5$$$V]C_'-H(<3 MS"S07]$#PB`)CTRP:FV^O+WK"A_@P5E*^8OW>"R^1(7?*^[ZV'IJZLW=J*F+ M2R^G68'ZJ>NK+%_C(K"MW$K0/)E4 MHL?+/WKZ2GBLMUA81;PBB9F9: M=!#FS$ES^DK;>>\V7JG5ZA)VS.F@4H4E6VJU#5U?F(K1.A&!R['Q(>G<3[+= M[&[FU\3I5,998=KKAD^)(?J=]19^;?@%A9U7YS*R[H^\EKO6+6%#.(WN%C$@ M%EM=5-W*D(N"^_7MLB2">7'YVS$N3QIEAO3H[;;%T!1IT/:H[C^'HV(M2D!) MO:@X-%VXK"O<-SK26>UO8:*1@ZX71NKH`&:4$VPWT.867RSY&LL.Y>5T;F`E M$$&H<:M*PQH2I&R(R`<8+2F,$]3(%$R(%JEVV4R:AEN8YS`BV/T1XM"9!!S< MX983J;D,][6G'D8M+_B%CG2H_[,S;C>-5ZPFPX1>B8XX::VN5.OA6%=-U(5Z MT>YA[8$VS\BRH];:+H.CT/#C%R/Y7:+*>SJMDJ M$09U`.OQ`!.LKU/`2#S0^:G"Q#K"V$2#EH+UD:&G7=-+C^8Q'$A=8R$*3&>P7)945RQ.F3Q*"@@M]BD[]I71.]:LD9]O6`O3[-M9O1#, MB2(I3;*4S/:U8)D`G-L$O&"R!]9X<4$L7[Q5JA7G[JU:IVP6GJ2[?NS2PK0@ M"4A5BB*N,'4B53V42#&:QG*A22,!^PI8D8,V_8KF`J[)%*":PP-T+2GL@ZZP M=LLMFJOOL,SB"-VUZ$^$X7%_)`7?1$?8:M]">PZ[?H:!:(-M>D,+Q'D^U34H M]]#T05:K7HJIV@X\%F.=G>B]M!YX0/_K@P>Q3@SG<&F]V(@ MEDSO&"UH$0-"[1!;[B6TZ)V9JF?/.S/6S=G11%!L#J$VF5O<=`70425JK#T$ MR/RB.$4"1[64ZL_3*XOGW/TT=]G9]F"LW?-L#JN#8U]V>:0URN&9M0;#'X.$ M7+58]EX/O;>!K&M>OC2F+U-E28_96+9Z_B\"WN#,7X@ZBY6VXS3+X_)4A8DN M8)A#Y)5>(;$N<$]9G"B'(ZNB1+G_H&D]$N,RVR/LUMJ>[\5HAAQ7H'H&P`\! MG:=($G@!>Y+#8)Y0ZS6M9[3UG6(/"[0 MGRY(]X5;LDA4.;P2^[+8([VXNS;#B]._M%:7F6Q=%&*/[30NN4D[5]GHTP%] M/*#/;]].\._6V@)OM?7*DKK?KL=UWI=&JN[MJ-E@:C.%.`M_O2;7M=LHMG.$4WR3)J3NC:SYG"63>8#EN7"2H'< M0R^920SB>FMPE>5;&..F<@Z=EWG>!LR?XG`1,;2N%BXLA`?V1P.*FL9'!X?. M+0^-#J2S^6![%.*:&)\J4/RBK8_I^V#(=5DURX5$'M@E':":[(I4*'5N MF8CY;+K"XBSX!U,]4WV8[HZ[US_%,KM8`!T)W8!PN@_Q+&;%U>I`T8_TJ$1N"%+/YS M6P13($S,HY+9I4WXVS$NR+VNF^TGM"'CM[@;.Y/-;*L18HY8OELS8>RRN9SE M96!CI(*.V2"\#"MC)#;[BQ]EL.<0Z+.@OO.+MSIJV.J9 M'0W,.G=V^J9Q;%RC,X4/#@Q/L&G;'?\\$AT9-UW<7=V!+["`""<[VG2AN<%` M2FPZ`N18+34)07!5U#D`!T9B=&#!.PAR19NX&_`/A%I2FJ+PA00&)D!2HK,+ MNOO-1>6T.":XP\05Y(;RQL_EP79<+JH^`EG%E=:=]FHJ@.?R;3MN)G8M5=A( MM5U&JAGB`-IB22,!32,4TI*F@&69U)5:(\$+\7*/KH%F@]B``LI+1@=FLDC2 MR3PP20IA#6P2ZR'V4HR2H>`BJ_0"P@;:,BH"!_\Z1DH'X2:AA!G,U%P%&JNV M'L5])JB+IY$6;C2-Y?*-1@(."R#6Y/A>6Z\>(F@7=_0@W7NBL,+33<=YWF.4 M=%CS<82&+NJ_E$&XPR_W[T&.;Q:,]ET&\WBP21"+.,)GJ68!U32^[0STI6T) M\SQ.F!F8&KV7F.*A1(B3LB>ZETN]XKT9^2)":"[KATRV+,*)/#`M$B''^![> M&Q<#>3G698*W,0>'LYD:,T_CQ1@;U:LS\RDFF1M[_@1CC\HQT:GHSN6=9]$7 M=;1[L:KL$S-G?OL8*K&UMD&^>1AH1WB-9\,1.`WO;"\2,`?D8[T9H]Q6\3,/(]?80IJ4B'7DS82+P5 M2>R;C3"!S1C38829J4X&]W;7!MNN1Q+%_7@:5(;>X!2Q=I<#4C2AN$[I1D7B MB"SP,*O.RB(OBUM9$'!J3;0>!#Z>0'L<>Q@@3^MUVJ`/Q-:'/M*=[V/G]1'A M,R;\(ZWGX?`,QHK0]\@U>NH&:GIOH.U$Y?"`.\\V69]!`<(@"5D!U(<3"`Z' MY%0-C^(B3#*L9G1.<,B1\49_W,-RET59DCV>'#M>RUFQOG.VH`F;N1=1^XF; M/?[@_^1Z8D;D+KL0B012M2"J>O;6%K$F=F8*QXI6_:V+<7?6;:P1"O!/Y36L`\J0IN6 M02V$I-%+)__$`UM@+DQM!3CI%>YL@;D<7"O0`+RV`*(LDF%@V*T1T,16#_ZZ MP'+0DOQF>QX4NZLD>RZTR@9*R-PT).<+(&SA3:ZW(P)`*+S(]A@M2J8MBMW\ M=+5J"7N1R_3*8FM%6&(V;O/L*8Y@]/'T$]KJ7Z,880?G>K"DNEA-@\,7W^*9P'7Z':@G`\UL7F!O%N$;Z8)ZN.-4J_$: M/.CM.%Y]'1V%?('X)<4)1*S3@K^XMN]]-A^D%WF,AF?^6;$E82T]MID;TQ8M(74J`GJ[_1JY=.DC/F;:$$60V30Y MH5WKI!)"X"X3`H>VP)1MW#PC26!8'H,$''*,P/+D&'):^C,`CY[R3&V_UWE* MY51_@4\P/4H*N,C)K+;?4P@@4VOLN-8A+D;BKOF>H2#^7>T<\2F.O0M/.1W, MCU=7QVYD58&XZ@KY-0SR%`UQ&\32PE&_UZ`6B&8^WZ+M"MK![\/,?2XOV>?UX5MMMH5,=6DM-WOPZNQ*A2G%I) M(&5O@TOSJ/X6IU'5>DRRJ>4,MKJ1Y3+;5S(\:'V=KO&PNL6>NUVL%L]U)T!Z M&3@"SSBYL8T+M]M8L9;TMZX2%7'EM5W%:9#B])OSK##PV7ID#CVV@0"JC6U- M``B%+RZ<4HYZ7[NM!0@SU[TB=91)[L`)-,D>'G!./6ZQRS(E-FE4W86YRO*J M4<--?IX$\5X&$+-YK"+&5,2!!6;T3>X3KEM5S8%;C8"ZH\5-#N@\[H`U55Q! MYS*T_OC006B4OO8Q.$Y9[8&RE;3^*4L?T6*Y_XRK"]S2X@+G1V0)TQ*QC3O$ MLG^HSU*FS&H5L-/$E]5H(-,`-H\7IQK+R>I3/8H9%+J/X3FT>>8HJ?XMI12<6C)_JR5.'4(<7W$=$41W?!=<%FB*2NE1Q MB593XR"!U_M#$.H:V2AZU'F=?H'D1LAMD)A3('M.T\N^@&@J-&5R`NB59[AG^7-<0(#0#A^SG'`9%`#M M$?!<*TZ#]Q4FW,$D6I?9>H\OC\;E:06>=W&X6Y$/21(]MDGVW(2F5\B+`@$. MV1VRE(EZR+,0PHCEBU#!NPDA'(L[_OM_H-\_A8_XC7JOZ!:7EO&VN[?83##< M%J,]+/!*,VWJ?!I97$=`83>"(V1;&"VG0U=-.IO#@(PV]YLPS(\D1XQ)$1,2 M^Y9@0=:M!HODZCX("RETW1Y.N\:D;4)D,5@9E56\RMG7V0YV]H`.@ZDC)&%[ MF^Z&QAV$EY/`)I(U`-%'LPX:;*Z\-%_X@N4-M[)9]8L&&TQB>7TV$&ZX9%.CY22.'B($Q_2P'.$5>@NM[3GZ""R&;`1(Z42.0:D04A.8:!:`I^F$96+2VIA.Y1,Z#45& MNU@<.2V8STKBIAB907]WN^Y$)Y9IV5QF""6+B\S[RC']REO95UZ!>\R?2]_$ MHX_MUCCK6"^U@=8R72Z---[!I>AI\@[T77P^"+M#:I(XQ/!!$$\:,#C!"GZ"L M%*GB'=(1L]JAJ:">@7FW\.8C0XUP`2Q<@KS:4[$LG$T:L<#PI\:W-8*^UH2. M#8*FT)IFHMZ65FEJ>$]:A==;,_ID/T:^@5K40TO4:OOM*UI-5%R-82/]=APA MP;?U9XB/B*9Q'QT1"V@0&R'5-UY$9$1?7"V@O@@_6:'#6EZR2H&=PE1Y5U^? MUC4@E5?%1;$KYY?WIPA5D&N$^X+(,&)E,SN M'5>Y`$.WA^68#:+U)](FP^'%5S-!-M$3OJW#DN5Z:PS)*GO.\E_)E4!ZM.0J M&&]?+JLW?37P,[CSJP,>'\M-2@R"P22>EI?DZ.*(LI(OH9:D0%)E.397%L2% M9'Y6RQ19E!'HR(4UM#OU9+Y5HYQ%^&M.WK^?Y6PU M-%@3J#KJ:[/&#>DJ@^]]M[OFV&L26:^!H"#.LB4.)2!V#;SL^PW=^Y.". M$XMSP68I.?1\`V^E,#M_6UH.N[6+=-$_K&6D#7TGQNPNVY;/@;3C*&^T*W/5 M8E=JGZIQ7A@C"=-5,TI2__GZGB7Y>@':&;AV!-&^3DLP.5!H^R"\SS;A;\0AW.VR MO+R'^=X@":%+XRP#H<^Z//V`C%[CX1[E'JA$^)0%:5VJQY_#=Z[2R$[>^1IC M3^._P`/;M-]L=35>3&-5XV6L]]6E&4M*!?NB\28B$(W/*P)W3NZ@7820Q$G\5J.]PFUKX?*F180!_PW/#@DIK1TDF,>K)'N^3K=9OB?UWC5.?W1GL&J#],4:]$-M45(3A&E! MB]B+8YTE!71\LF.HDGW`F>KCQ#X>YUG5=/6:M#V[RO)6EZ%V=Z&F3(.D->H< ML]KL[3%1?$X?N;J=,IV0I'"*VW&UZYRX:\ZZV,O@-M4+10V[N)4(W;4$F?EU MX.8@VR#.FT;/$]\,WGFDR":1[AL<-\AM_Z(Y#$NOW<0L5F6BO<1/80^A3+12 M\JH\>+%=U**V:?\TQ1GLA1%9;<.8H>LDORY1`][(EDT0K$$=@V:9(511R9:I M;F]FET:*-K0_U,3(A"S:-J:5Y99&'EH<$VCV+(L1+B=:D*H36VW#ZKC.%>0& M;/7H;%H-I0A]W:L;![8$+,'"(&(5+ M3\=$2>2]9Z'"S]!Q4()G;E#7.XBK8P'OPA@BT:[3 MT`#AHAF>:W>J@RUROIPZ,][PIT9B:>PZ_E1\3FKTL9'MZC7HX-XK^H26B[$:"M M>13X!3\,D*>]5-NTP(L3F2GM%_=B;)8$GK.:+QDV)SIG/V0D61>]JUR6$B(; M;=/I$K`[Z%N;T7QU,L[I!F(IOBUZ`C(5Z7>]E^G'C)HJ6PVEPUWIJLRX]C[Z MLFN*IDNLRSOV?]%LV,&-&O,>/&3'$BT,Y$_EZ9L"T.8E)^P0(Z4KXQ0YRP'Z M-7@DPH=,>!QH"P#.F,M2IINIY6+:'Q&LN=@LZYSLNLH$A5G'I7+TL8S67= M6!K^^HZ6XU8BS&MPOXL+L`].>!TOXJ+L#2#W`&!>!NB_$7PHBT[98!2F14.(2"6UJ/#I#2WS.*E"ZC8OK`53'=,R^6J*IRSQ^.!*W\C&' MQ'E4KY9R,IN60R7`H#=2:SRH"7Q8+2U(8E'GM12KI_)Z6K6$QFNLE@HZYSHO M,\DB5?%B@3&6AK_`8#\P:LL95'.Y\^GL?"C7J%:M9)K(L7>^\D.61<]QDFS2 MJ%_Y5/U9,14Q&'409*3W92@^K+OOB9?DEK\PQBE`KW#QC&Z:_-WJ0B MIG2.-G6H+?G"9:%\QN`U-M)1RV,-770'NHPJ7AC)8Y`8%5 M[`B9'O:^?2A]6YX68=XF!N0JTU=[A;ZXTG2=-4-$X5#7I>Y"7U^\6`Z6XM^= MQBLMO4IOYKGD5IWA*K#O[,EUIN9 M-5DC\"8F<:G+,K/&408O(FTF,HB#;.QB8UT=EG>XX@B@P@W+ MI&MJFWOLF/DL)K-X@2@]WT"BBMYY/.XE]0&!!O[2&)VUA\M+DF>BL8+U!EI% MUX#)OEK1`5ZL1'/P:E/#^0K05V+!U[=8KA-?E=UE203S@C*#*^^8K1[Z<]@M MV6D@VJ"F98L6,,TB);:\6S?FDO*;<6):K>-IJJN#2I[&BFJQBG>VW\35=HA;V9F=&7P[L%E66%]6N5%:.ZAH/4IE M/8.FSD)I.)%_X)0M)OKH]&+=]$5>[]"J7$5':K$]O%X%JC14NKW&)#9^F2TSE'A\Q0BY3* MBV7(BC"N,:)<4O2TR^J.[Y##'4R+^`F7"\OV\#,L;[;WP5<]%TQ);7MOIR$. M9X/34`%*M@*XZ<[-%B#2%=B4-"F?W)F_SW#TV?5%J&DBWY#[?F%'\)@0.]^X MZ>HC9[>FK8RVP^.8MRQ%*G.1[8-XD'4PB*;VQSL(E@]9%L2AZX'@%SK4>>Q\ M5M;MA](%RL*/J(LTQ6Y7/MPIZ#,MM7E=%>=&+A.G;:!9B&_JU-:[]TU\$=R. M?GA.M!RQ2J;7G58(O*ZBW@4(YW\O:*JU9F,(QRVYYD('KSG>+-"8F*-(-A+W MNR"]A\@0Y4%^NH`A(D4K\.8IB!.\8[K*\KL@@7=U*0(.Y"=-IPWSEG;.P;^) MU>#OP/"30?UHP)Z-0`[JIY.J]?CYH&'`$,P.Q.[9!K[T)9:^K*6/F/1Q"H** MB?4VR]<%EKYX0=+W*`%"@M2:"O89\>4E/A`B"W07\/L M,8W_R&UL550)``-*R+)/2LBR3W5X"P`!!"4.```$.0$` M`.U=W7+;NA&^;F?Z#JI[6\>1Y:0GF:0=Q3^IIH[ML9V3]HH#4["$AB)4D+2M M\_0%2%$B)0($2(A+\?@JB8(%]]M=`(O%8O'I'R\SK_>$64"H__F@_^;M00_[ M+AT3?_+YX/O]Q>$O!__X^Y_^^.G/AX?__G)[V3NC;C3#?MC[QML\$CSN/9-P MVCO_[?!7@I\QZ_V:]-7C7;T9O'G?XW^]CW`P1HN_]KZA1:__[J^]X[?]X][; M#Q^/WWT\&?1NOO4.#RM_X^3-0'SC!Q[[V:^\3[_2_R@^]*$WW/%7WO4_'O^R M_HI'_)\/*,`]+E\_^'PP#3H^.W;P5':\"!I^?$E M(+G6SX.T;?_HW]\N[]PIGJ%#X@BFB*[_X<.'H_A_>=.`?`QB^DOJ MHC#6>"E?/6D+\:_#M-FA^.FP?WPXZ+]Y"<8'7`9_^,2HAV_Q8R_^_L=P,<>? M#P(RFWN"[_BW*<./GP_&>#*=_SP4HGP[2#KX2ZJ>H3\^]T,2+D;^(V6SF.V# MGNCY^^UHQ?^81@\>QFCBX2GUA/4&;UPZ.Q+MCI1='=7F]"Y$(1;]7S]>$)]K MA2#OA@9$='_JH2"(KIRW>[**J=W4RX%P0"?1L[_%W&SX_9WS:7"3NELSO\+ M^P'_:,)%=11FG[&*\!0%TPN//@_2GEPX.9I1QE^7S`:>(`LXEG8N.1!""XWO$C"V7-07_,?/< MJWV@N<$(HTT^NO"(_S70T>BJL7,,I%6Y7DKTEV6]53H,L/MF0I^.QI@DZN-_ MV=0:_\E)C/<63\1FDF\[KM"L:!3*FCJ#MF@LIXF\UA3,2W76C-Q/.>,,>2.^ M[KS\"R^4@M]HZYSLE>2WN4]%WV]<]J<1$P`O^/X&>?_!B''W^XR#D8A?UMQY MMR<:4`!(E7`,-``NB(?9*>=E0IG:_',MG?=[(OIBWE.I#QJ7^CU#PGF]6\P> MJ">1=ZZ-\[<]D?0FUZF,3Z"F=CJ;43^.1\5'%,%U%(HS2\&D>IY7$#J_[(DV MM*"D*GK7N(K2'=L][U:BC&P3Y\.>B'V#Z53`[QL7\)!S,1:<7'A(9NZY-D[_ M[9[(>(OM5,I_`S/C51!1X<44MG7Z4/OHJI:]Q7XJ_5_`I)_X50EC%_RWHCVO MLKW3;\V^5U,+A1!237P`UH3PE M$0=XBUW,P?()[`J'RT"J:A@KR,#CQ;JJ+@$A#]SOEXI%1J*S!FJ^_N9HX4\T*AB`%JJN;'Y.T9SP MU87\AL?BGF048G9''\-G+ERU[M6$\(EF+"X?F+ MZT7BW.8KI>-GXA5E!9F0._UV1+2,+$`76%=V7ILB,G#JG'X[PEAF:WL!"&N; MJQ:XZ:7Z<_K[$KE:\RO/J]DG!5T2]$"\V(\<^N/M^ZD:^RK=+IP^=&3+Y-C( M!%57O*XTLGZ#%F*GH7^>D"=P^M`A+B/EJ4\9MJ%U9(>U`3!S>YY+S5CUA>1. M'SI(9M\0I$"[,@FD^\Q;_(3]2&,2*"9PCJ&C:A9T+X?6E2U77%5$>[XO:.T< M0P?3+.A9@JLS^RG791%G=2THK?F]F,8YA@Z>V9G4Y>BZUURPPTJ)P!=)AQY_K7E$)7@E7?B$]9+,5$ M,HKI8;.I,X".138V&11!AX];J4I$+AG@6[$@\L1N[`(7[E"5[9T!=/"QJ>$N MQV\M>`7M&;AN-(OBTS39@PB7-!#)3M>/]^A%':LVZB)M&0_Z!3V MW4?S.:-<'((K@VDK3^@,H*.O5DRE'&178BCEXJJUA#D#Z&CK3NRA&*BU^`CH MT:^=M7[GYSW.X'<3P[4G,&NG0*U.+*^14.X,H&.^=A-3I"#E)0MK6D*S=?;D M;T_:"2UE^P]R'RA_>J2<]K54GL;`,)&F=`)]K9/W6B>OG3K,'])SP[YF,=QQ M?!9S@UE`*4K M.^XBH*,@B(P5G1"!U]:KJ^05#/CT@MTI6/T$AB8E>`V^NJK.8^E*5D$>Z27A M>ZQQK)GD/S#W6K5U7D@-7K:ONMYE>.#S":PG(59PW32HP4OZF>A>#T]7D@RV MWOC1FH2"OA*@+64NP;1E3-WPU?*=,C@B__5 MTO$&DAW>&`%[BR5)2QIZ(68^_\P3;OX%EH2%%4\:B4(2BM?@L<'`D,OP-63\ M&C+>,QTN2X;H/*ZRV72OPL`%S'=$@Z+*;K"$)ZHL!NK*HT7-P8.[1=J1C,5B M]CNBRR6P"RZ@?`&G\F&Y30,>S=77J@I#5V+U6"ZEVNBT_&8*<`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`V;7CUO7 M)LKU6[-'^,=-=/1N`:2U\D3@)ZM;17'3@KA:63*EU&UXSL3HSI$.H'4\>,_5 M7W'IAH[NZ:I):S'OSGLCLC+7PR=$/.&-/E(6H&P@:CC^;Q3$3X6E\BLLV)>4 MLU*=U._VR_`OG=2SN`;$`W_"L/,%R7*93\M?@G^-I9Z-[D`<.\MS`;N?&[N& M^7*7OO1U@>;O[F8YE1;F5%T2T:%_O==;Q?DLD:AD4';^EF\B"#%XJ!\?=KT0 MK0N_173[=_=7@J(C2LY76OJ&Q>Y:&?K?;MZ>Z\`R5L52Y2CKPJ\(5%5T&"GZG9?#*9,9JE^\E2I5JV`/X M#6)#]9K#L[9]\>#R*PIV9J6C6D4&?O^XXJ`NP02?FV\KP3=].7$FLD=BY:1' M6B*%<1%GE)5:@$DW[;G=;&81AAB[DG.E\2IB^;*OVT=[;DL;N@`&`.$K22K< M@>UWH#:?C"MS!W1[@+\U7&O2%>6M'D9Q,P%Z7V/J^S+ M4X5MO&S=EQ<$LP;:FIW-,2-TS%&P$,S6#(I$%]13;DVP3LL"BOBW%I=K@3*_ M$9^RV+`38SW#+L-\7RJ*&9Z)2B_"ND6P2F;=_TR&A\(&;'T"_N*WD>G8A-V5 MFZ"R/>YWGRTO*OXS28I8W5?T,YE*C`3B*?+X0?*;>.BD>2,5$L;J?A+^>KF1 M->Y2#%V):<;+??*^0Q9JO`8\B%A=-H*GE>12H3_X&^WF+E(5C%T)VI#00`[IE)#`/![.G/;6+Z^:,,X MY%VUH9Q`$]:AEL#O8?>6P5[5$XT+>MW%.$(D3L5R20_ M$&.(XZVZ:&SV`U\TP%B)%9:2(M3@LT3U5:2V,<@Z<@90\=?J:JRR' MYE:-)>Q$/C67CEQ?S@`ZFEIS-JF%O"M'0SK@,\%C413Z!PFG)@\WV/J$,X". MR39H<+H"@3\R4BUMA2>K0S&4)K'C]V6Q=0EN^(S8.'M#]FL\:X_\9%97+'_V M/^8,X..\!COLW0@`_O:*P0WT+)3A3.1G_Z:J/*I%[@S@@[;Z5J`-J05E)16* M+=[Q:ZBTA-`9P(=3]96I`:8KM6%-"_8/]B+X674WL3Q"X^!UY-TZ:1[4A` M73D!VNW[J-#1METIO]C4=.31E>?=EU%(E.2%C[AJ_8DXKAIR](5I"GJ$X#4_ MF[684F&T^H`OSWT:K;[%3]B/%!6/]H[=M6O!Z MGHT:@I8\X&]D63KLB5,=_D7\L<8IP'9C^$J1S2X2Q1*`SW#=A2-Q07S$A>E/ M3FE@X$;DR>"+3$)Z$=NR@,_AL&,J(O^.0TO3&H;^.,WJO*#L#K,GXG+/FYUZ MB"@#IT;]P->W;-:8C(73E12$3,[=)?4G?*:=7=$0!S=H(8+9IQ$3RN+R$$>N MRW_H/%M;N5?X4IG-6EY-4;4[HVG3T]=/["^CA*^G65=Q6ENC(M@=.0D0H:&1 MSP42B:&6D>87[,!BA??Y MU]253I5T\-4I=V04&QCA]^"[,H(;AODV4IM0EA2]%N2-3V(99/Q.F MK=8P=%T:\=5[&>D:^F/^"XLXBP0]$*^L*G*U#N%K4>[(24*R%U)ORG`79JZITT+7Y9R5[:QC;,K)9#YQM#%>!QL>.2+ MDO1O%1E<<4JK9E`&$;Y`:=-WUJS<58,O/FGY&I,!;FL9W2'E-MPR@TGBUY8N M.2HZ@Z]E:>&68PF^KMPP6M::$NECV>E4[ZRHG!BND&5-]4I6'"W`'0F/9<#> MTAW)7RLPB[$@A+X=W3N,X_PP;7QDIIX>M#[L04E'B[$A/3 MEYP5+P*^L*-54S$#;BWNU4;_BLE44A3?W/$GSP5T_M1S?NII2% M]YC-#$(;.1KX`I(5E5D>W]C"V9'LZEL\7ZZEUX^Z^I?2P!>>M*I_)<[.N)T9 M(U_>'CA_P6B5YY#]2-LN]NJLP%,T> MG).61D:KF8H!:O@:*8H+OZ`#4 M0+=YZ[`$'SP\IC`8P?V2^01:"\WKG$NR[?-IQ#70KZ<$Y@0Y,VE>T`BI\4KY"Z]?A%+/[*?+O M\6Q.&6*+,^QZXL#6'SXAXHFE1^3Z\"W,'78C)@L^UNKN]W`[N9Z\=Y?&W^S+ M2M=L@GR2//S9_$M*R=>3@EWBQ4+JD7%B;?[X)@-X=<2`O%42@TZ6AI7^0=YF MJL7Y&0E;K=*,GL&7/@9#4M6TT&;=)GPBFV[%%-7C)RC2^HY":5,&(X7(DOF7MAW MN;DKR>R9>^%G-,Q=30=M[F7"*S;W4DQ=,7<1;_<\[(81\O@&D6\)PT7S.YNO ME(Z?B><-XQ<8>59TAI2$`GP8284J&2]R'%T9(UN9Y5;/ M]U;=EOMC,@I[KMCF%S2\,"D)M`.FD);R7+$025=L.5OJY)ZC#;A`B'C/#>#R M3C$G&O-^&2G("B!CRFQ5,.@%?*704(-DS3!#V96Q%Q][BI\Q"T1^HR@V)!ZJ M,-KEVS'6Y/,:0RW?$&1@;8M-^*=FPTJ[#_!!M25PR1`R0=25`22R!T@2"Q1I MPM07A\C8=PG$;D7!C-$FQJ@?D`&HQ:'.*#3K"'PHFFI&,E*-47=EN*[1<9>` M1N$%(BRY]M"X":\^G>.I=&RJR$"&8A%#.B-/20<^T$K$+!E799@:'D:?C@27 M#RC`_!__!U!+`P04````"`!CBJ]`K0ZX:T$*``#23P``$P`<`&1E9VAP:RTR M,#$R,#,S,2YXK=K_H.5E7H80DDZVDTIZRB$FXUJ"L^"D>W9K:TJQ!:C:R+0D)V%^_1[) M-E?9&$AOPQ8O*<4Z]T\ZNAVN?GT;ANB%<$$C=EVI'QU7$&%^%%#6OZX\>LWJ MQ\JOG_[ZEZN_5:M?;CHM=!OY\9`PB>Z!ID=)@%ZI'"#[S^H3):^$HZ=$%@)1 M1Z='YPB:7DQ$@,>_H'L\1O6S7]#)H6MU8QX>C4Z7C M,PG8K);S3$O]4BGZB*SOK.6L/J=%^`,RQ$ABWB>RC8=$C+!/KBL#*4>7M5H0 MQ<\A(;@?DD$4JFB+(S\:UI2TX]/3.J`0$F5=,^+#6]+#<2BO*]]B'&I3*PA@ M8^(R(/W!Z.L:4C7;A/[U]?7H]?0HXGT@.:[7OMRWNMKN3'Y(V=KQ_7J).`9 M2Q5+F<\&G9P^QY*(C,V/8B;Y>#Z@@OA'_>BEEG8:M/DQYS")\_C27@-C0*B9 M!SH,Y.3-'YCI58^!@;(7(J29)>DS,#%,?6'FT5T&%D%],P-TF-&1XQ$11FAT MCTF''/$<)=!C8."DESO0SFO0.T5AQ(F_8F!B[NNQV<.^K)*W48@9EA$?-^'_ M2>0BQN*A64@@>4VY5@.B*E`13OWIM)"KI\14RVH5J7C(BS]=8<8BB24DUD]7 M>#2BK!>I[S_]=*5FYJ62[@$34HW'CK,RMVESLEQNL7P<^G%8I"C]E$5^>S2ZX)=>O-Q>DS+(S12'#Y'0AC=" M+$2ZABE<2M+F(W0"L$R$0+L1L8`P<$^U1!320,TD=(-#M4B@[H`0*0Y`::#2 MH.B8/&!8%>2`2`J&)-CD=^?#<;H)'.C?<^+_IR]D M:?8L4^2#]*$<2!,2@:(>$:_UG7]9GN.VD=6^15WGKNTTG8;5]I#5:+B/;<]IWZ$' MM^4T?C^$7X?_+H+_8;SZL.0DX9_[DA_^CXOAOW-5_,A_6(Q\ MQVY9GGV+'BQ(-,@#%+I60R7]`P39T6EZK$P.M>G1,CLWY77G@W"V"$+7C;:<"$]1S%LHDI?\)A3"9[SISN?!R6#K"P[VRT MW.YCQP8<;MQ'#S4MIX.>K-:C_7\'@_JCWIT[I(?T@^ZE>F>ZK@@Z'(7J(5A_ M&^@7M^2)O)H]@?\!+AZ]#<.,2(DO>%S6^"U&)56=B4B?XHJ?G$&(WM7"]*IE MYE=J[^44(+"N4_.@[9Y+(7Y>UR5@(>%N>@/#?5UO%F;(._MT57Z$U?9)5 M+[3@3L0E8DM%*T6U%TF]2RORM9P"%O5?->.KJD_5^DGUM'[T)H+$MG4,F'BU MI@$9WYH&F"M:2JK.&)3.LS+:"@M+['HIY3RC$FWUE2_JEBM3%8*.9_C4JGI0J7#^OE6 M)I1,BC/JY=:JBRNBRIHS*\6>"EG3NL+BN3(C(^-1C6W&Q5(-5JE`+')M@XVY MT&P]*R+6+C(D+975EJA*KSB_U,MZ%I+C[/$VV:7]49(CV>WI&?+=@4X]=,!Q4B;%'+,WD7-.%9%M M#>'4G^^&88?@D/Y)@CM,62L2(M?18L)]MV1OF&_)\JMQ9%>DBGQ-"EJO@RB(8R8'S6++1\6C%B/U/3:^I:\D#`: M*9JN!``-GI9G*NGI_P349:MU95HI_^8H=\DI/;P<(6(P-5;+P8-6I(>@Y7^+ M:5*`[/9:U%=E67-^KL^\#VDLQZLD`6T:DR+N'4I<18B6V&MMPK[W0V+SN!3S M[\VPD-@?*/GI^_TZ0V*9M7@X%)M>&(6,QQE_%;J M8=^EQNIP!,DK.1^F[.?V>N5M/NPEJ3FXF03D+G4@0TP MB^>W$BLH]P#:-4]`>^'U(FZ%Z\%JXCWP.+NS<%D7A\09CC#EV8^QLE)M MA^5>?6S"O@]3'<9O.GR3!;\9\9D24UU8"JN8TF&Q``Z-H";([KOF`K2=H'T( ME?(A=2%QT8OT88F3Z1"8"TDYAGUP/9OI$VC3G_\:SA&K2/?!W9FD/G'#=)`N MI-M+1RF5^KRVFW!VP MC(::P5I%NF-@+?YHQ8A3/M'N0+1HHQF=`JH=`Z;HBJ3T7\3I2 M/RYY`PSKCRI$`0-OB1]2!OL$ZP53S0Z;)W6VZA(_YE32A7WEAA)^V%VM^>"J M8G-52PIJH/E?4$L!`AX#%`````@`8XJO0`)6#LC=8P``1,,$`!,`&``````` M`0```*2!`````&1E9VAP:RTR,#$R,#,S,2YX;6Q55`4``TK(LD]U>`L``00E M#@``!#D!``!02P$"'@,4````"`!CBJ]`1/.EE^8*``"VF0``%P`8```````! M````I($J9```9&5G:'!K+3(P,3(P,S,Q7V-A;"YX;6Q55`4``TK(LD]U>`L` M`00E#@``!#D!``!02P$"'@,4````"`!CBJ]`AOS&A`\5``!910$`%P`8```` M```!````I(%A;P``9&5G:'!K+3(P,3(P,S,Q7V1E9BYX;6Q55`4``TK(LD]U M>`L``00E#@``!#D!``!02P$"'@,4````"`!CBJ]`U;S`-?4Q``#WUP(`%P`8 M```````!````I('!A```9&5G:'!K+3(P,3(P,S,Q7VQA8BYX;6Q55`4``TK( MLD]U>`L``00E#@``!#D!``!02P$"'@,4````"`!CBJ]`223.0(,9``!WJ`$` M%P`8```````!````I($'MP``9&5G:'!K+3(P,3(P,S,Q7W!R92YX;6Q55`4` M`TK(LD]U>`L``00E#@``!#D!``!02P$"'@,4````"`!CBJ]`K0ZX:T$*``#2 M3P``$P`8```````!````I(';T```9&5G:'!K+3(P,3(P,S,Q+GAS9%54!0`# I2LBR3W5X"P`!!"4.```$.0$``%!+!08`````!@`&`"8"``!IVP`````` ` end